"AHC","PY","nTotDoc","meanAUPerArt","meanAU_IN_PerArt","meanArtWith_AU_IN_FIRST","meanArtWith_AU_IN_LAST","meanArtWith_AU_IN_CORR","mean_articles_per_internal_author","mean_articles_per_internal_first_author","mean_articles_per_internal_last_author","mean_articles_per_internal_corresponding_author","ArtOA","singleAuArt","Q1_nSJR","Q2_nSJR","Q3_nSJR","Q4_nSJR","Q1_percSJR","Q2_percSJR","Q3_percSJR","Q4_percSJR","meanTCperArt","mean_NTC","meanCitationTrend","InternCoauthorship","AffCoauthorship","GC_AUIN_wFractional","GC_AUIN_FIRSTname","GC_AUIN_LASTname","GC_AUIN_CORRESP","top_AU","top_AU_freq","top_AU_wFract","top_AU_freq_wFract","top_AUIN","top_AUIN_freq","top_AUIN_wFract","top_AUIN_freq_wFract","topAUbyCit","topAUbyCit_TC","topAUINbyCit","topAUINbyCit_TC","topAUINbyCit_norm_byYear","topAUINbyCit_TC_norm_byYear","topConcept_L0","topFreq_L0","topConcept_L1","topFreq_L1","topConcept_L2","topFreq_L2","topConcept_L3","topFreq_L3","topConcept_L4","topFreq_L4","topMESH","topMESH_n","topprimary_topic.display_name","topprimary_topic.display_name_n","topDE","topDE_n","topTI_TM","topTI_TM_n","topAB_TM","topAB_TM_n","nDoc_wALTM","percDoc_wALTM","altmetric_score_thirdQu","cited_by_accounts_count_thirdQu","cited_by_fbwalls_count_thirdQu","cited_by_feeds_count_thirdQu","cited_by_gplus_count_thirdQu","cited_by_msm_count_thirdQu","cited_by_patents_count_thirdQu","cited_by_peer_review_sites_count_thirdQu","cited_by_policies_count_thirdQu","cited_by_posts_count_thirdQu","cited_by_rdts_count_thirdQu","cited_by_rh_count_thirdQu","cited_by_tweeters_count_thirdQu","cited_by_videos_count_thirdQu","cited_by_wikipedia_count_thirdQu","cohorts.com_thirdQu","cohorts.doc_thirdQu","cohorts.pub_thirdQu","cohorts.sci_thirdQu","readers.citeulike_thirdQu","readers.connotea_thirdQu","readers.mendeley_thirdQu","readers_count_thirdQu","n_patentsDistinct","nPatentStatus_Abandoned","nPatentStatus_Granted","nPatentStatus_N/A","nPatentStatus_Pending","nPatentStatus_Active","nPatentStatus_Not-in-force","nPatentStatus_Expired - Fee Related","nPatentStatus_Withdrawn","nPatentStatus_Ceased","nPatentStatus_Revoked","nPatentStatus_Expired - Lifetime","nPatentPubType_Application","nPatentPubType_Grant","nPatentPubType_N/A","avg_citations_Patent","avg_Inventors_Patent","inventor_per_AUIN_100","avg_InstitutesInvolved_Patent","nPatent_singleInventor","n_Patents_CoAff","n_Jurisdiction_distinct","nJurisd_AU","nJurisd_CA","nJurisd_EP","nJurisd_IN","nJurisd_CN","nJurisd_US","nJurisd_DE","nJurisd_ES","nJurisd_IT","nJurisd_AT","nJurisd_BR","nJurisd_WO","nJurisd_JP","nJurisd_DK","nJurisd_IL","nJurisd_PT","nJurisd_PL","nJurisd_FR","nJurisd_SA","nJurisd_MY","nJurisd_KR","nJurisd_NL","nJurisd_CO","nJurisd_SM","nJurisd_SI","nJurisd_HR","nJurisd_RU","nJurisd_EA","nJurisd_MX","nJurisd_HK","nPatentKC_A1","nPatentKC_A","nPatentKC_A2","nPatentKC_B1","nPatentKC_D1","nPatentKC_T3","nPatentKC_B2","nPatentKC_T1","nPatentKC_A3","nPatentKC_C","nPatentKC_B","nPatentKC_C2","nPatentKC_C0","nPatentKC_A8","nPatentKC_E","nPatentKC_T4","nPatentKC_D0","nPatentKC_T2","nPatentKC_A0","nPatentKC_B8","nPatentKC_A4","nPatentKC_T8","nPatentKC_C1","nPatentKC_U1","nPatentKC_T5","nPatentKC_B3","nPatentKC_T7","nPatentKC_A9","top_Inventor names_Patent","top_Inventor names_Patent_n","top_Original assignee names_Patent","top_Original assignee names_Patent_n","top_Fields of Research (ANZSRC 2020)_Patent","top_Fields of Research (ANZSRC 2020)_Patent_n","top_RCDC Categories_Patent","top_RCDC Categories_Patent_n","top_HRCS RAC Categories_Patent","top_HRCS RAC Categories_Patent_n","top_IPCR_Patent","top_IPCR_Patent_n","top_CPC_Patent","top_CPC_Patent_n","n_clTrial","avg_durationYear_clTrial","avg_participants_clTrial","clTrial_perAUIN_100","nClTrial_w_AltmScore","cl_AltmS_rel","avg_sponsor_clTrial","nclTrialPhase_Phase 1","nclTrialPhase_Phase 1/2","nclTrialPhase_Phase 2","nclTrialPhase_Phase 2/3","nclTrialPhase_Phase 3","nclTrialPhase_Phase 3/4","nclTrialPhase_Phase 4","nclTrialPhase_N/A","nclTrialPhase_Post Authorisation Studies","nclTrial_StudyType_Interventional","nclTrial_StudyType_Observational","nclTrial_StudyType_Other","nclTrial_StudyType_Expanded access","nclTrial_StudyType_Active surveillance","nclTrial_StudyType_Non-interventional","nclTrial_StudyType_RCT","nclTrial_StudyType_CCT","nclTrial_Gender_All","nclTrial_Gender_Female","nclTrial_Gender_Male","nclTrial_Registry_ClinicalTrials.gov","nclTrial_Registry_EU-CTR","nclTrial_Registry_ENCePP","nclTrial_Registry_ISRCTN","nclTrial_Registry_ANZCTR","nclTrial_Registry_GCTR","nclTrial_Registry_PACTR","nclTrial_Registry_CTRI","nclTrial_Registry_ReBEC","nclTrial_Registry_UMIN-CTR","top_funder_country","top_funder_country_n","top_Fields of Research (ANZSRC 2020)_clTrial","top_Fields of Research (ANZSRC 2020)_clTrial_n","top_RCDC Categories_clTrial","top_RCDC Categories_clTrial_n","top_HRCS HC Categories_clTrial","top_HRCS HC Categories_clTrial_n","top_HRCS RAC Categories_clTrial","top_HRCS RAC Categories_clTrial_n","top_Cancer Types_clTrial","top_Cancer Types_clTrial_n","top_CSO Categories_clTrial","top_CSO Categories_clTrial_n","n_grants","avg_funding_EUR","avg_funding_EUR_perOrganization","avg_durationYear_grant","avg_Organization_per_grant","avg_countries_per_grant","perc_grant_internationalColl","avg_ResultingPublications_per_grant","totFundingOrgbyActivedGrant","avgPubByActivedFundingGrant_1000","top_Research Organization - standardized_Grants","top_Research Organization - standardized_n_Grants","top_Funder_Grants","top_Funder_n_Grants","top_Funder Group_Grants","top_Funder Group_n_Grants","top_Program_Grants","top_Program_n_Grants","top_Fields of Research (ANZSRC 2020)_Grants","top_Fields of Research (ANZSRC 2020)_n_Grants","top_RCDC Categories_Grants","top_RCDC Categories_n_Grants","top_HRCS HC Categories_Grants","top_HRCS HC Categories_n_Grants","top_HRCS RAC Categories_Grants","top_HRCS RAC Categories_n_Grants","top_Cancer Types_Grants","top_Cancer Types_n_Grants","top_CSO Categories_Grants","top_CSO Categories_n_Grants","top_Units of Assessment_Grants","top_Units of Assessment_n_Grants","top_Sustainable Development Goals_Grants","top_Sustainable Development Goals_n_Grants","n_dataset","top_Repository_Dataset","top_Repository_Dataset_n","top_Fields of Research (ANZSRC 2020)_Dataset","top_Fields of Research (ANZSRC 2020)_Dataset_n","top_RCDC Categories_Dataset","top_RCDC Categories_Dataset_n","top_HRCS HC Categories_Dataset","top_HRCS HC Categories_Dataset_n","top_HRCS RAC Categories_Dataset","top_HRCS RAC Categories_Dataset_n","top_Health Research Areas_Dataset","top_Health Research Areas_Dataset_n","top_Broad Research Areas_Dataset","top_Broad Research Areas_Dataset_n","top_Cancer Types_Dataset","top_Cancer Types_Dataset_n","top_Sustainable Development Goals_Dataset","top_Sustainable Development Goals_Dataset_n"
"AOUSSN_CAGLIARI",2000,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,"0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2001,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,"0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2002,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,"0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2003,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,"0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,"0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,26,0,0,0,0,43,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,"United States","1","42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","1;1","ASSISTIVE TECHNOLOGY;BIOENGINEERING;CLINICAL RESEARCH;HEALTH SERVICES;PATIENT SAFETY","1;1;1;1;1",NA,NA,NA,NA,"NOT SITE-SPECIFIC CANCER","1","4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2005,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,"0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2006,1,7,1,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,8,0.156622568441788,NA,1,1,0,0,0,0,"GUILLERMO DRELICHMAN;EKKEHARD GLIMM;NORBERT GATTERMANN;EMANUELE ANGELUCCI;J. SIEGEL;N. ZOUMBOS;D. ALBERTI","1;1;1;1;1;1;1","GUILLERMO DRELICHMAN;EKKEHARD GLIMM;NORBERT GATTERMANN;EMANUELE ANGELUCCI;J. SIEGEL;N. ZOUMBOS;D. ALBERTI","0.14;0.14;0.14;0.14;0.14;0.14;0.14","EMANUELE ANGELUCCI","1","EMANUELE ANGELUCCI","0.14","D. ALBERTI;EKKEHARD GLIMM;EMANUELE ANGELUCCI;GUILLERMO DRELICHMAN;J. SIEGEL;N. ZOUMBOS;NORBERT GATTERMANN","8;8;8;8;8;8;8","EMANUELE ANGELUCCI","8","EMANUELE ANGELUCCI","1","MEDICINE","1","GASTROENTEROLOGY;INTERNAL MEDICINE;SURGERY;UROLOGY","1;1;1;1","BONE MARROW;CREATININE;RENAL FUNCTION;THALASSEMIA","1;1;1;1","DEFERASIROX;MYELODYSPLASTIC SYNDROMES","1;1","","","","1","GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS","1","DEFERASIROX;IRON DEFICIENCY","1;1","CHELATOR DEFERASIROX;CREATININE INCREASES;DEFERASIROX EXJADE;DOSE REDUCTION;EXJADE ICL;IRON CHELATOR;IRON REMOVAL;NON-PROGRESSIVE SERUM;ONCE-DAILY ORAL;ORAL IRON;SERUM CREATININE","1;1;1;1;1;1;1;1;1;1;1","","",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2007,1,6,6,1,1,1,1,0.5,0.5,0.5,1,0,0,1,0,0,0,1,0,0,24,0.454752238139791,NA,0,0,0,0,0,0,"PINA CAVOLINA;GIORGIO TAMBURINI;ALBERTO BOCCHETTA;ANDREA LOVISELLI;MARIO ANDREA PIGA;ALESSANDRA SERRA","1;1;1;1;1;1","PINA CAVOLINA;GIORGIO TAMBURINI;ALBERTO BOCCHETTA;ANDREA LOVISELLI;MARIO ANDREA PIGA;ALESSANDRA SERRA","0.17;0.17;0.17;0.17;0.17;0.17","PINA CAVOLINA;GIORGIO TAMBURINI;ALBERTO BOCCHETTA;ANDREA LOVISELLI;MARIO ANDREA PIGA;ALESSANDRA SERRA","1;1;1;1;1;1","PINA CAVOLINA;GIORGIO TAMBURINI;ALBERTO BOCCHETTA;ANDREA LOVISELLI;MARIO ANDREA PIGA;ALESSANDRA SERRA","0.17;0.17;0.17;0.17;0.17;0.17","ALBERTO BOCCHETTA;ALESSANDRA SERRA;ANDREA LOVISELLI;GIORGIO TAMBURINI;MARIO ANDREA PIGA;PINA CAVOLINA","24;24;24;24;24;24","ALBERTO BOCCHETTA;ALESSANDRA SERRA;ANDREA LOVISELLI;GIORGIO TAMBURINI;MARIO ANDREA PIGA;PINA CAVOLINA","24;24;24;24;24;24","ALBERTO BOCCHETTA;ALESSANDRA SERRA;ANDREA LOVISELLI;GIORGIO TAMBURINI;MARIO ANDREA PIGA;PINA CAVOLINA","1;1;1;1;1;1","MEDICINE","1","IMMUNOLOGY;INTERNAL MEDICINE;PATHOLOGY;PSYCHIATRY","1;1;1;1","ANTIBODY;ANXIETY;DISEASE;ENCEPHALOPATHY;MOOD;PSYCHOSIS;THYROID","1;1;1;1;1;1;1","AUTOANTIBODY;AUTOIMMUNITY;BIPOLAR DISORDER;MOOD DISORDERS;THYROID FUNCTION;THYROIDITIS","1;1;1;1;1;1","ANTI-THYROID AUTOANTIBODIES;AUTOIMMUNE THYROIDITIS","1;1","","1","AUTOIMMUNE ENCEPHALITIS: CLINICAL CHARACTERISTICS AND MANAGEMENT","1","ANTI-THYROID AUTOANTIBODIES;AUTOIMMUNE THYROIDITIS;HASHIMOTO ENCEPHALOPATHY;HYPERTHYROIDISM;HYPOTHYROIDISM","1;1;1;1;1","AFFECTIVE PSYCHOSIS;BRAIN PERFUSION;HASHIMOTOS THYROIDITIS;PERFUSION ABNORMALITIES;PSYCHOSIS HASHIMOTOS","1;1;1;1;1","HASHIMOTOS THYROIDITIS;CORTICAL PERFUSION;HASHIMOTOS ENCEPHALOPATHY;MOOD DISORDER;MOOD DISORDERS;THYROID AUTOIMMUNITY;ADEQUATELY MAINTAINED;BIPOLAR DISORDER;BRAIN MAGNETIC;BRAIN SINGLE-PHOTON;CIRCULATING THYROID;CIRCULATING THYROPEROXIDASE;CNS INFLAMMATION;COMPUTED TOMOGRAPHY;CURRENT CNS;DEVELOPED MANIC;DISCUSS POTENTIAL;DISORDER DUE;EMISSION COMPUTED;FRONTAL LOBESWE;HEMISPHERES SUGGESTIVE;HIGHLY ELEVATED;IMAGING EVIDENCED;L-THYROXINE SUBSTITUTION;LINKING THYROID;LOBESWE HYPOTHESIZE;MAGNETIC RESONANCE;MANIC EPISODE;MANIC PSYCHOTIC;MECHANISMS LINKING","3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",1,1,3,1,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,59,59,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2008,9,6.44444444444444,3.88888888888889,0.666666666666667,0.555555555555556,0.777777777777778,1.12903225806452,0.857142857142857,0.833333333333333,1,0.222222222222222,0,2,4,2,0,0.22,0.44,0.22,0,23.44,0.427257976637386,NA,0.111111111111111,0.555555555555556,0.154,0.167,0.171,0.167,"MARTA MELONI;CARLO CIANCHETTI;TIZIANA PISANO;DARIO PRUNA;YWH-MIN TZOU;L PASCALIS;SIMONA CORONA;ALDO LUZZANI;NICOLETTA CORSO;PATRIZIO CATUREGLI;MELISSA A. LANDEK‐SALGADO;VASSILIOS FANOS;STEFANO MARIOTTI;ISABELLA LUPI;RICCARDO MACCIONI;HIROAKI KIMURA;G. MALLARINI;ENRICO POLATI;BERNARDO CARPINIELLO;ANGELIKA GUTENBERG","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DARIO PRUNA;MARTA MELONI;CARLO CIANCHETTI;TIZIANA PISANO;RICCARDO MACCIONI;BERNARDO CARPINIELLO;FABIO CALOGERO PINNA;E CORDA;L PASCALIS;ALDO LUZZANI;G. MALLARINI;ENRICO POLATI;LUCA SABA;STEFANO ISCHIA;GABRIELE FINCO;ROBERTO SANFILIPPO;VITTORIO SCHWEIGER;ROBERTO MONTISCI;NICOLETTA CORSO;VASSILIOS FANOS","0.33;0.26;0.26;0.26;0.25;0.25;0.25;0.25;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.17;0.17","MARTA MELONI;CARLO CIANCHETTI;TIZIANA PISANO;DARIO PRUNA;L PASCALIS;SIMONA CORONA;NICOLETTA CORSO;VASSILIOS FANOS;G. MALLARINI;BERNARDO CARPINIELLO;MATTEO PIGA;G. PINNA;M. LOY;FRANCESCO PERNA;PAOLA MELIS;LUCA SABA;MELANIA FALCHI;RITA MELEDDU;ROSSANO ROSSINO;GABRIELE FINCO","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DARIO PRUNA;MARTA MELONI;CARLO CIANCHETTI;TIZIANA PISANO;BERNARDO CARPINIELLO;L PASCALIS;G. MALLARINI;LUCA SABA;GABRIELE FINCO;ROBERTO SANFILIPPO;ROBERTO MONTISCI;NICOLETTA CORSO;VASSILIOS FANOS;MATTEO PIGA;M. LOY;FRANCESCO PERNA;MELANIA FALCHI;RITA MELEDDU;PAU SERRA;VIVIANA MARINELLI","0.33;0.26;0.26;0.26;0.25;0.2;0.2;0.2;0.2;0.2;0.2;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.17","ALESSANDRA SERRA;FRANCESCO BOI;M C COCCO;M. LOY;MATTEO PIGA;STEFANO MARIOTTI;ANGELIKA GUTENBERG;G. PINNA;HIROAKI KIMURA;ISABELLA LUPI;MELISSA A. LANDEK‐SALGADO;NOEL R. ROSE;PATRIZIO CATUREGLI;SHEY‐CHERNG TZOU;YWH-MIN TZOU;ALDO LUZZANI;ENRICO POLATI;GABRIELE FINCO;STEFANO ISCHIA;VITTORIO SCHWEIGER","85;85;85;85;85;85;57;57;57;57;57;57;57;57;57;32;32;32;32;32","ALESSANDRA SERRA;M. LOY;MATTEO PIGA;G. PINNA;GABRIELE FINCO;CARLO CIANCHETTI;DARIO PRUNA;MARTA MELONI;MELANIA FALCHI;TIZIANA PISANO;G. MALLARINI;L PASCALIS;LUCA SABA;ROBERTO MONTISCI;ROBERTO SANFILIPPO;BERNARDO CARPINIELLO;FRANCESCO PERNA;G PALMAS;MARIA ANTONIETTA MARCIALIS;MARIA CRISTINA PINTUS","85;85;85;57;32;22;22;22;22;22;10;10;10;10;10;5;0;0;0;0","CARLO CIANCHETTI;DARIO PRUNA;MARTA MELONI;TIZIANA PISANO;ALESSANDRA SERRA;BERNARDO CARPINIELLO;G. MALLARINI;G. PINNA;GABRIELE FINCO;L PASCALIS;LUCA SABA;M. LOY;MATTEO PIGA;MELANIA FALCHI;ROBERTO MONTISCI;ROBERTO SANFILIPPO;FRANCESCO PERNA;G PALMAS;MARIA ANTONIETTA MARCIALIS;MARIA CRISTINA PINTUS","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;0;0;0;0","MEDICINE;MATHEMATICS;PHYSICS;PSYCHOLOGY;SOCIOLOGY","9;2;1;1;1","INTERNAL MEDICINE;PATHOLOGY;PSYCHIATRY;RADIOLOGY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;NUCLEAR MEDICINE;PEDIATRICS;SURGERY;ANATOMY;DEMOGRAPHY;FAMILY MEDICINE;GEOMETRY;IMMUNOLOGY;MATHEMATICAL ANALYSIS;OPTICS;PHARMACOLOGY;UROLOGY;VIROLOGY","5;3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","POPULATION;ABDOMINAL PAIN;ADENOMA;ANGIOGRAPHY;ANTIBODY;ATRIAL FIBRILLATION;BODY MASS INDEX;BODY WEIGHT;CANCER;CELIAC PLEXUS;CIRCUMFERENCE;COMPUTED TOMOGRAPHY;CREATININE;DIFFERENTIAL DIAGNOSIS;DRUG;EPILEPSY;HORMONE;HUMAN IMMUNODEFICIENCY VIRUS (HIV);HYDROCEPHALUS;IMMUNE SYSTEM;INCIDENCE (GEOMETRY);KIDNEY;MACROCEPHALY;MAGNETIC RESONANCE IMAGING;MEGALENCEPHALY;OBESITY;PANCREAS;PATHOGENESIS;POLYDACTYLY;PRODRUG;REGIMEN;RENAL FUNCTION;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);SCINTIGRAPHY;SPIRAL (RAILWAY);SYNDACTYLY;THYROID;TOMOGRAPHY;UNIVERSITY HOSPITAL","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AMIODARONE;ANTERIOR PITUITARY;AUTOIMMUNE DISEASE;CANCER PAIN;CORTICAL DYSPLASIA;MULTIDETECTOR COMPUTED TOMOGRAPHY;PANCREATIC CANCER;PITUITARY ADENOMA;PITUITARY DISEASE;PITUITARY GLAND;POLYMICROGYRIA;SPIRAL COMPUTED TOMOGRAPHY;VIRAL LOAD;WAIST;WEIGHT GAIN;WHITE MATTER","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ABDOMINAL OBESITY;ANTIRETROVIRAL THERAPY;HEMIMEGALENCEPHALY;HYPOPHYSITIS","1;1;1;1","FEMALE;HUMANS;MALE;AGED;ANESTHETICS, LOCAL;ANGIOGRAPHY;ANTIPSYCHOTIC AGENTS;BUPIVACAINE;CRANIOFACIAL ABNORMALITIES;DEVELOPMENTAL DISABILITIES;FOLLOW-UP STUDIES;HYDROCEPHALUS;MALFORMATIONS OF CORTICAL DEVELOPMENT;MIDDLE AGED;MUSCLE HYPOTONIA;OBESITY;SCHIZOPHRENIA;SYNDACTYLY;THYROTOXICOSIS;TOMOGRAPHY, SPIRAL COMPUTED","6;6;5;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","CHALLENGES IN PAIN MANAGEMENT AND TREATMENT;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF ADRENAL INSUFFICIENCY;EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY FOR HIV;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;MANAGEMENT AND PATHOPHYSIOLOGY OF ABDOMINAL AORTIC ANEURYSMS;NEONATAL BRAIN INJURY AND DEVELOPMENTAL CONSEQUENCES;SCHIZOPHRENIA RESEARCH AND TREATMENT;THYROID DISEASE AND HORMONE REGULATION","1;1;1;1;1;1;1;1;1","ABDOMINAL OBESITY;ANEURYSM SCREENING;ANTIRETROVIRAL THERAPY;ATAZANAVIR;AUTOIMMUNE THYROID DISEASE;CANCER PAIN;CELIAC PLEXUS;CIRCUMFERENCE;COBICISTAT;EPILEPSY;EPILEPSY TREATMENT;HEMIMEGALENCEPHALY;HYPERTHYROIDISM;HYPOPHYSITIS;HYPOTHALAMIC-PITUITARY-ADRENAL AXIS DYSFUNCTION;MACROCEPHALY;MEGALENCEPHALY;MICROARRAY ANALYSIS;MULTIDETECTOR COMPUTED TOMOGRAPHY;NEUROLYTIC BLOCK","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AMIODARONE-INDUCED THYROTOXICOSIS;ANIMAL MODEL;AUTOIMMUNE HYPOPHYSITIS;AXIAL SCANS;BOOSTED PROTEASE;CANCER PAIN;CELIAC PLEXUS;CLINICAL INSIGHTS;CLINICAL SETTING;COMPUTED TOMOGRAPHY;DIAGNOSTIC SENSITIVITY;DIFFERENTIAL DIAGNOSIS;EXTREMELY LOW-BIRTHWEIGHT;FAMILIAL TRANSLOCATION;HIV PATIENTS;HYDROCEPHALUS MPPH;INFANTS LT;KIDNEY TOXICITY;LOW-BIRTHWEIGHT INFANTS;MEGALENCEPHALY POLYMICROGYRIA;MICE CLINICAL;MPPH SYNDROME;MTC-SESTAMIBI THYROID;MULTIDETECTOR-ROW SPIRAL;NEUROLYTIC CELIAC;PANCREATIC CANCER;PHARMACOTHERAPY-ASSOCIATED WEIGHT;PLEXUS BLOCK;POPULATION STUDY;PP LEADING","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACTIVE TUBULAR;EXPERIMENTAL AH;PITUITARY GLAND;TRANSPORT PATHWAYS;TUBULAR SECRETION;ADMINISTRATION TDF;ADRENAL INSUFFICIENCY;AG CHEM;AH IMMUNIZED;AL ANTIM;ANTERIOR PITUITARY;ANTIBODIES DEVELOPED;ANTIM AG;AUTOIMMUNE HYPOPHYSITIS;CHEM OCT;CIRCULATION RENALLY;CLEARANCE EXCEEDS;CLINICAL SETTING;CLOSELY MIMICKED;COMPRESSION SYMPTOMS;CREATININE CLEARANCE;DEVELOPED SEVERE;DIAGNOSTIC BIOMARKERS;DISOPROXIL FUMARATE;DRUG SUBJECT;DRUG-DRUG INTERACTIONS;ENLARGED CONSISTENT;ESTIMATED RENAL;FEMALE SJLJ;FINDINGS PROVIDE","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",1,0.11,1,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,65,65,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2009,14,10.5714285714286,7.64285714285714,0.785714285714286,0.571428571428571,0.857142857142857,1.49295774647887,1.375,1.14285714285714,1.33333333333333,0.428571428571429,1,6,6,0,2,0.43,0.43,0,0.14,19.64,0.424644113917861,NA,0.214285714285714,0.5,0.563,0.264,0.167,0.268,"CARLO CIANCHETTI;TIZIANA PISANO;IOANNIS ALEXIDIS;SOFIJA SLJIVIC;VASSILIOS FANOS;NIKOLAOS OIKONOMOPOULOS;IVANA STOJKOVIC-EFERICA;G. MALLARINI;M. MELIS;STEFANOS PATIAKAS;VERA RIBEIRO;M. MURGIA;A. SALTAMAVROS;S. DIMITRAKOPOULOS;GIAN BENEDETTO MELIS;S.G. KOLIANTZAKI;LUCA SABA;BARBARA FRAU;KONSTANTINA GIONI;MARIJA STOJANOVIĆ KRASIĆ","4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MELANIA PUDDU;CARLO CIANCHETTI;G. MALLARINI;LUCA SABA;TIZIANA PISANO;YOUSEF HMAIDAN;MARIA GIUSEPPINA LEDDA;DORIS BARCELLONA;ANTONELLA MAMELI;FRANCESCO MARONGIU;MARIA ELISABETTA CIANCHETTI;LUIGI DEMELIA;MARIA CELESTE SERCI;MARGHERITA SINI;ORAZIO SORBELLO;GABRIELE FINCO;ALBERTO CIVOLANI;M. MURGIA;BARBARA FRAU;FRANCESCO ATZORI","1;0.85;0.67;0.67;0.6;0.5;0.5;0.33;0.33;0.33;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.2;0.2;0.2","CARLO CIANCHETTI;TIZIANA PISANO;IOANNIS ALEXIDIS;SOFIJA SLJIVIC;VASSILIOS FANOS;NIKOLAOS OIKONOMOPOULOS;IVANA STOJKOVIC-EFERICA;G. MALLARINI;M. MELIS;STEFANOS PATIAKAS;M. MURGIA;A. SALTAMAVROS;S. DIMITRAKOPOULOS;GIAN BENEDETTO MELIS;S.G. KOLIANTZAKI;LUCA SABA;BARBARA FRAU;KONSTANTINA GIONI;MARIJA STOJANOVIĆ KRASIĆ;MARIA LAURA COSTA","4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MELANIA PUDDU;CARLO CIANCHETTI;G. MALLARINI;LUCA SABA;TIZIANA PISANO;MARIA GIUSEPPINA LEDDA;ANTONELLA MAMELI;LUIGI DEMELIA;MARIA CELESTE SERCI;MARGHERITA SINI;ORAZIO SORBELLO;ALBERTO CIVOLANI;M. MURGIA;BARBARA FRAU;FRANCESCO ATZORI;LUIGI MINERBA;B. MASSIDDA;MARIA TERESA IONTA;YANNICK ALLANORE;ALESSANDRO MATHIEU","1;0.85;0.67;0.67;0.6;0.5;0.33;0.25;0.25;0.25;0.25;0.25;0.2;0.2;0.2;0.2;0.2;0.2;0.17;0.17","G. MALLARINI;LUCA SABA;ALESSANDRA VACCA;ALESSANDRO MATHIEU;ANDRÉ KAHAN;CATHERINE CORMIER;MARTINA PIRAS;YANNICK ALLANORE;ANTONELLA MAMELI;DORIS BARCELLONA;FRANCESCO MARONGIU;CARLO CIANCHETTI;DIEGO RIBUFFO;MATTEO ATZENI;ROBERTO MONTISCI;ROBERTO SANFILIPPO;TIZIANA PISANO;ALBERTO CIVOLANI;LUIGI DEMELIA;MARGHERITA SINI","95;95;91;91;91;91;91;91;44;44;44;26;23;23;23;23;18;14;14;14","G. MALLARINI;LUCA SABA;ALESSANDRO MATHIEU;ANDRÉ KAHAN;CATHERINE CORMIER;MARTINA PIRAS;YANNICK ALLANORE;ANTONELLA MAMELI;CARLO CIANCHETTI;ALBERTO CIVOLANI;LUIGI DEMELIA;MARGHERITA SINI;ORAZIO SORBELLO;TIZIANA PISANO;DARIO PRUNA;MELANIA FALCHI;ROSSANO ROSSINO;B. MASSIDDA;BARBARA FRAU;FRANCESCO ATZORI","95;95;91;91;91;91;91;44;18;14;14;14;14;12;8;8;8;5;5;5","CARLO CIANCHETTI;B. MASSIDDA;BARBARA FRAU;FRANCESCO ATZORI;G. MALLARINI;LUCA SABA;LUIGI MINERBA;M. MURGIA;MARIA TERESA IONTA;TIZIANA PISANO;ALBERTO CIVOLANI;ALESSANDRO MATHIEU;ANDREA COINU;ANDRÉ KAHAN;ANTONELLA MAMELI;ANTONIO TROGU;CATHERINE CORMIER;DARIO PRUNA;F. ELTRUDIS;LUIGI DEMELIA","3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;MATHEMATICS;MATERIALS SCIENCE;COMPUTER SCIENCE;PHILOSOPHY;POLITICAL SCIENCE;PSYCHOLOGY","14;5;3;2;1;1;1;1","INTERNAL MEDICINE;GENETICS;SURGERY;ANESTHESIA;COMPOSITE MATERIAL;ENDOCRINOLOGY;GASTROENTEROLOGY;GEOMETRY;INTENSIVE CARE MEDICINE;NUCLEAR MEDICINE;OBSTETRICS;ONCOLOGY;PATHOLOGY;RADIOLOGY;STATISTICS;EMERGENCY MEDICINE;EPISTEMOLOGY;GENERAL SURGERY;LAW;PALEONTOLOGY;PEDIATRICS;PSYCHIATRY","7;4;4;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","DISEASE;MIGRAINE;PREGNANCY;CANCER;CHEMOTHERAPY;COMPRESSION (PHYSICS);SCALP;ANEMIA;ANGIOGRAPHY;ARTHRITIS;BIOPSY;BLOCK (PERMUTATION GROUP THEORY);CALCIUM;CLINICAL TRIAL;COHEN'S KAPPA;CONCORDANCE;CONFIDENCE INTERVAL;ERYTHROCYTE SEDIMENTATION RATE;GENE;HEMOCHROMATOSIS;KAPPA;LIVER DISEASE;MEDLINE;NEUROLOGY;PULMONARY ARTERY;REGIMEN;RHEUMATOID ARTHRITIS;RISK FACTOR;SIMPLE (PHILOSOPHY);STAGE (STRATIGRAPHY);STENOSIS;THROMBOSIS;TRANSFERRIN;VITAMIN;VITAMIN D AND NEUROLOGY;VULNERABLE PLAQUE","4;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BREAST CANCER;CHEMOTHERAPY REGIMEN;CISPLATIN;INFECTIOUS DISEASE (MEDICAL SPECIALTY);CLINICAL ENDPOINT;COMPUTED TOMOGRAPHY ANGIOGRAPHY;CONGENITAL MALFORMATIONS;DOCETAXEL;HEREDITARY HEMOCHROMATOSIS;IRON DEFICIENCY;LIVER BIOPSY;MUTATION;NEURORADIOLOGY;PARATHYROID HORMONE;SERUM IRON;THROMBOEMBOLIC DISEASE;VENOUS THROMBOSIS;VITAMIN D DEFICIENCY","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","TRASTUZUMAB;ANTHRACYCLINE;AXILLA;EPIRUBICIN;GENE MUTATION;TRANSFERRIN SATURATION;TRIPLE-NEGATIVE BREAST CANCER;VINORELBINE","2;1;1;1;1;1;1;1","HUMANS;MIGRAINE DISORDERS;FEMALE;MALE;TEMPORAL ARTERIES;ADULT;MIDDLE AGED;CAROTID STENOSIS;VITAMIN D;AGED;BREAST NEOPLASMS;IRON OVERLOAD;ITALY;SCALP;THROMBOSIS;TOMOGRAPHY, X-RAY COMPUTED;VITAMIN D DEFICIENCY;;ADOLESCENT;ANGIOGRAPHY","11;9;7;7;7;6;6;5;5;4;4;4;4;4;4;4;4;3;3;3","MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;HEPATITIS E INFECTION AND TREATMENT;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;COPPER AND ZINC IN HEALTH AND DISEASE;EVOLUTION OF CHILD HEALTH SERVICES IN EUROPE;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;MOLECULAR RESEARCH ON BREAST CANCER;RHEUMATOID ARTHRITIS;VITAMIN D AND HEALTH OUTCOMES","3;2;2;1;1;1;1;1;1;1","MIGRAINE;MIGRAINE PREVENTION;CHEMOTHERAPY REGIMEN;PREGNANCY;TREATMENT;AXILLA;BRACHIAL ARTERY ASSESSMENT;BREAST CANCER;CAROTID ARTERY STENOSIS;CHRONIC INFECTIONS;CLINICAL ENDPOINT;COHEN'S KAPPA;COMPUTED TOMOGRAPHY ANGIOGRAPHY;CONCORDANCE;CONGENITAL MALFORMATIONS;DISEASE CONTROL;EPIRUBICIN;ERYTHROCYTE SEDIMENTATION RATE;EXOME SEQUENCING;FOOD SAFETY","3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BREAST CANCER;CANCER PATIENTS;INFECTIOUS DISEASE;LONG-TERM OUTCOMES;MIGRAINE ATTACKS;PRIMARY CHEMOTHERAPY;ADDING CISPLATIN;ANTHRACYCLINE-BASED PRIMARY;ATTENUATE MIGRAINE;CHROMOSOME MOSAICISM;COMPLETE RESPONSE;CT ANGIOGRAPHY;DEVELOPMENTAL DELAY;ECST METHODS;EPILEPSY CHARACTERIZED;GENE MUTATIONS;GENOME ARRAY-CGH;HANDMADE DEVICE;HFE GENE;IIIB BREAST;IMPLODING HEADACHE;INDEPENDENT COHORTS;MULTI-DETECTOR-ROW CT;NEGATIVE NON-TN;NEWBORN HOSPITAL;NON-TRIPLE NEGATIVE;PATHOLOGICAL COMPLETE;PATIENTS PTS;PERIARTERIAL SALINE;PLAQUE DETECTION","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FOREIGNER PARTURIENTS;PARTURIENTS CARRIERS;INTER-OBSERVER AGREEMENT;INTRA-OBSERVER AGREEMENT;SIGNIFICANTLY WORSE;STAGE IIIB;STENOSIS DEGREE;ACHIEVED PCR;ADVISORY INTERVENTION;CAROTID STENOSIS;CESAREAN SECTIONS;DIRECT IMMUNIZATION;ECST METHODS;EPIDEMIOLOGIC EVALUATION;FEMALE POPULATION;GYNAECOLOGJCAL CLINIC;HANDMADE DEVICE;IIIB PATIENTS;INTRA- INTER-OBSERVER;MULTI-DETECTOR-ROW CT;NATIVE GREEKS;NATIVE GYPSY;OBSTETRICAL -GYNAECOLOGJCAL;OS RATES;PAEDIATRICIANS INFORMING;PERIOD -WE;PREGENITAL CHECK;PREGNANT CHARACTERISTICS;PREGNANTS CARRIERS;PROGENNITICAL EXAMINE","4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",2,0.14,2.31,1,1,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,59.5,59.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,7,170,4.29,0,0,1.33,0,0,2,0,0,0,0,1,0,0,1,0,0,0,0,0,0,2,1,0,1,2,0,0,0,0,0,0,0,0,"Italy","1","32 BIOMEDICAL AND CLINICAL SCIENCES;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3006 FOOD SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;52 PSYCHOLOGY","3;1;1;1;1;1","BREAST CANCER;CANCER;DENTAL/ORAL AND CRANIOFACIAL DISEASE;GENETICS;NUTRITION","1;1;1;1;1","CANCER;NEUROLOGICAL","1;1","6.1 PHARMACEUTICALS","1","BREAST CANCER","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2010,18,5.66666666666667,3.83333333333333,0.666666666666667,0.611111111111111,0.666666666666667,1.4375,1.5,1.375,1.5,0.333333333333333,1,6,4,3,3,0.33,0.22,0.17,0.17,16.28,0.360202787186926,NA,0.111111111111111,0.5,0.351,0.33,0.33,0.33,"G. MALLARINI;LUCA SABA;S. GUERRIERO;ROBERTO SERPE;ANTONIO MACCIÒ;S. AJOSSA;FILOMENA PANZONE;GIORGIA ANTONI;GIORGIO ASTARA;CARLO CIANCHETTI;DARIO PRUNA;ROBERTO SANFILIPPO;MARIELE DESSÌ;ELENA MASSA;CLELIA MADEDDU;ROBERTO MONTISCI;GIOVANNI MANTOVANI;G. B. MELIS;ANTONELLA MELONI;L PASCALIS","5;5;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1","CARLO CIANCHETTI;G. MALLARINI;LUCA SABA;YANNICK ALLANORE;ALESSANDRA VACCA;ROBERTO SANFILIPPO;ROBERTO MONTISCI;DARIO PRUNA;L PASCALIS;S. GUERRIERO;S. AJOSSA;G. B. MELIS;MARIO MOTTA;MAURIZIO RADICIONI;GINO TRIPODI;MARCELLA TESTA;ROBERTO SERPE;ANTONIO MACCIÒ;FILOMENA PANZONE;GIORGIA ANTONI","1.2;1.06;1.06;0.5;0.5;0.42;0.42;0.37;0.33;0.31;0.31;0.31;0.25;0.25;0.25;0.25;0.22;0.22;0.22;0.22","G. MALLARINI;LUCA SABA;S. GUERRIERO;ROBERTO SERPE;ANTONIO MACCIÒ;S. AJOSSA;FILOMENA PANZONE;GIORGIA ANTONI;GIORGIO ASTARA;CARLO CIANCHETTI;DARIO PRUNA;ROBERTO SANFILIPPO;MARIELE DESSÌ;ELENA MASSA;CLELIA MADEDDU;ROBERTO MONTISCI;GIOVANNI MANTOVANI;G. B. MELIS;L PASCALIS;MARIA VALERIA CHERCHI","5;5;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1","CARLO CIANCHETTI;G. MALLARINI;LUCA SABA;YANNICK ALLANORE;ALESSANDRA VACCA;ROBERTO SANFILIPPO;ROBERTO MONTISCI;DARIO PRUNA;L PASCALIS;S. GUERRIERO;S. AJOSSA;G. B. MELIS;MARCELLA TESTA;ROBERTO SERPE;ANTONIO MACCIÒ;FILOMENA PANZONE;GIORGIA ANTONI;GIORGIO ASTARA;MARIELE DESSÌ;ELENA MASSA","1.2;1.06;1.06;0.5;0.5;0.42;0.42;0.37;0.33;0.31;0.31;0.31;0.25;0.22;0.22;0.22;0.22;0.22;0.22;0.22","G. MALLARINI;LUCA SABA;G. B. MELIS;S. AJOSSA;S. GUERRIERO;DARIO PRUNA;MONICA PILLONI;R. SULIS;ANTONELLA MELONI;GEORGIOS LOUDIANOS;LOREDANA BOCCONE;STEFANO MARIOTTI;VALENTINA DESSÌ;CARLO CIANCHETTI;ROSA SULCIS;GINO TRIPODI;MARCELLA TESTA;MARIO MOTTA;MAURIZIO RADICIONI;ROBERTO MONTISCI","103;103;76;76;76;46;44;44;41;41;41;41;41;40;32;26;26;26;26;26","LUCA SABA;G. MALLARINI;G. B. MELIS;S. AJOSSA;S. GUERRIERO;DARIO PRUNA;MONICA PILLONI;R. SULIS;CARLO CIANCHETTI;ROSA SULCIS;MARCELLA TESTA;DAVIDE FIRINU;LOREDANA SERUSI;MARIA MADDALENA LORRAI;MARIA PINA BARCA;MONICA PERALTA;PAOLO EMILIO MANCONI;PAOLO SERRA;ROBERTO MONTISCI;ROBERTO SANFILIPPO","103;94;76;76;76;46;44;44;40;32;26;22;22;22;22;22;22;22;17;17","LUCA SABA;G. MALLARINI;ANTONIO MACCIÒ;CARLO CIANCHETTI;CLELIA MADEDDU;DARIO PRUNA;ELENA MASSA;FILOMENA PANZONE;G. B. MELIS;GIORGIA ANTONI;GIORGIO ASTARA;GIOVANNI MANTOVANI;MARIELE DESSÌ;ROBERTO SERPE;S. AJOSSA;S. GUERRIERO;ALESSANDRA ATZEI;ALESSANDRA MELONI;ALESSANDRA SERRA;ALESSIO ROCCA","5;4;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1","MEDICINE;BIOLOGY;MATHEMATICS;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;MATERIALS SCIENCE;PHILOSOPHY;PHYSICS;PSYCHOLOGY","17;3;2;1;1;1;1;1;1;1","INTERNAL MEDICINE;RADIOLOGY;PATHOLOGY;SURGERY;NUCLEAR MEDICINE;DERMATOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;GENETICS;GYNECOLOGY;IMMUNOLOGY;PHYSICAL THERAPY;ALGORITHM;ANATOMY;ANESTHESIA;ASTROBIOLOGY;CARDIOLOGY;COMBINATORICS;EMERGENCY MEDICINE;LINGUISTICS;MECHANICAL ENGINEERING;MEDICAL EMERGENCY;MICROBIOLOGY;NANOTECHNOLOGY;OBSTETRICS;ONCOLOGY;OPTICS;OPTOELECTRONICS;ORGANIC CHEMISTRY;PEDAGOGY;PEDIATRICS;PROGRAMMING LANGUAGE;PSYCHIATRY;UROLOGY","9;6;4;4;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MAGNETIC RESONANCE IMAGING;CANCER;DISEASE;ENDOMETRIOSIS;GENE;ABDOMINAL PAIN;ADVERSE EFFECT;ANGIOGRAPHY;ANTIFUNGAL;AORTA;ARTERY;BIOMOLECULE;BLOOD TRANSFUSION;BODY MASS INDEX;BODY WEIGHT;CALCIUM;CANDIDA ALBICANS;CAROTID ARTERIES;CEREBRAL PALSY;CLUSTER (SPACECRAFT);CYST;DIABETES MELLITUS;DIFFERENTIAL DIAGNOSIS;DISSECTION (MEDICAL);GRIP STRENGTH;HELMINTHIASIS;HORMONE;HYPERPARATHYROIDISM;INFERIOR MESENTERIC ARTERY;INTERFEROMETRY;KAPPA;LASER;LESION;LOGISTIC REGRESSION;MIGRAINE;MUCOUS MEMBRANE;MULTIPLE SCLEROSIS;MULTIPLEX;NEUROFIBROMATOSIS;NEUROLOGY;NEUROSURGERY;OBESITY;OPTICAL TWEEZERS;PATHOGENESIS;PATHOLOGICAL;PHASE (MATTER);PLATELET;PONS;RANDOMIZED CONTROLLED TRIAL;RECEPTOR;REFRACTORY (PLANETARY SCIENCE);RETROSPECTIVE COHORT STUDY;RISK FACTOR;SCINTIGRAPHY;SMA*;STATISTICAL SIGNIFICANCE;STROKE (ENGINE);SUPERIOR MESENTERIC ARTERY;THYROID;TRACKING (EDUCATION);ULTRASOUND;VAGINA;WOUND HEALING","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CACHEXIA;AGONIST;ALLELE;AORTIC DISSECTION;AZOLE;CAPSAICIN;CELIAC ARTERY;CHRONIC MUCOCUTANEOUS CANDIDIASIS;COMPUTED TOMOGRAPHY ANGIOGRAPHY;CORPUS ALBICANS;DIFFUSION MRI;DYSLIPIDEMIA;FLUCONAZOLE;HYDATID CYST;ITRACONAZOLE;LEAN BODY MASS;LEPTIN;LEUKOREDUCTION;MUCOCUTANEOUS ZONE;NEUROFIBROMIN 1;NEUROPEPTIDE;NEURORADIOLOGY;NOCICEPTION;OLIGONUCLEOTIDE;PARATHYROID HORMONE;PLATELET TRANSFUSION;POLYMERASE CHAIN REACTION;SPASTIC;THYROID CARCINOMA;TOLERABILITY;TRANSIENT RECEPTOR POTENTIAL CHANNEL;TRANSPORTER;TRIIODOTHYRONINE;UTEROSACRAL LIGAMENT;VASELINE","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CALCITONIN GENE-RELATED PEPTIDE;CANCER CACHEXIA;DEIODINASE;MOLECULAR BEACON;MONOCARBOXYLATE TRANSPORTER;MULTIPLEX POLYMERASE CHAIN REACTION;NOCICEPTOR;PAPILLARY CARCINOMA;PARATHYROIDECTOMY;POSACONAZOLE;SECONDARY HYPERPARATHYROIDISM;SUBSTANCE P;SUMATRIPTAN;TRPV1","1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;ADULT;MALE;MIDDLE AGED;ENDOMETRIOSIS;MAGNETIC RESONANCE IMAGING;;ABNORMALITIES, MULTIPLE;ANEURYSM, DISSECTING;COLONIC DISEASES;INTESTINAL OBSTRUCTION;ITALY;MULTIPLE SCLEROSIS;NEUROFIBROMATOSIS 1;TOMOGRAPHY, X-RAY COMPUTED;BLOOD TRANSFUSION;CANDIDIASIS, CHRONIC MUCOCUTANEOUS;CARCINOMA, PAPILLARY;CAROTID ARTERY DISEASES","14;9;7;7;7;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3","DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;SARCOPENIA: DEFINITION, DIAGNOSIS, AND IMPLICATIONS;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;BIOLOGICAL, EPIDEMIOLOGICAL, AND CLINICAL ASPECTS OF ECHINOCOCCOSIS;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;MANAGEMENT OF HYPERBILIRUBINEMIA IN NEWBORN INFANTS;MANAGEMENT OF MESENTERIC ISCHEMIA AND ANEURYSMS;MANAGEMENT OF VASCULAR MALFORMATIONS IN THE BRAIN;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;MINERAL METABOLISM IN CHRONIC KIDNEY DISEASE;MORTALITY AND SEQUELAE OF PRETERM BIRTH;NEUROFIBROMATOSIS TYPE 1 AND TYPE 2;REAL-TIME POLYMERASE CHAIN REACTION;STRATEGIES TO REDUCE LOW-VALUE HEALTH CARE SERVICES;THYROID DISEASE AND HORMONE REGULATION","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER CACHEXIA;MRI GUIDANCE;NUTRITIONAL STATUS;ARTERIAL STIFFNESS;AZOLE;BIOMOLECULE;CALCIMIMETIC;CANDIDIASIS;CAPSAICIN;CELIAC ARTERY;CEREBROSPINAL FLUID SHUNTING;CHRONIC MUCOCUTANEOUS CANDIDIASIS;CINACALCET;COMPUTED TOMOGRAPHY ANGIOGRAPHY;DYSLIPIDEMIA;HEREDITARY SPASTIC PARAPLEGIA;HIGH-CONTENT SCREENING;HIGH-RESOLUTION CT;HYDATID CYST;HYPERTHYROIDISM","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MAGNETIC RESONANCE;ACID FUNCTIONAL;AMINO ACID;CANCER CACHEXIA;CLUSTER SUPPLEMENTATION;FUNCTIONAL CLUSTER;II STUDY;ORAL AMINO;PHASE II;RESONANCE IMAGING;AHDS CAUSED;ALBICANSIWITH POSACONAZOLE;ALLANHERNDONDUDLEY SYNDROME;ALLELE DETECTION;ARTERY SPONTANEOUS;ARTERY WALL;AZOLE-RESISTANTICANDIDA ALBICANSIWITH;BRAF ALLELE;CALCIFIED HEPATIC;CANDIDIASIS CAUSED;CAPILLARY TELANGECTASIA;CAPSAICIN JELLY;CARDIOVASCULAR RISK;CAROTID ARTERY;CHRONIC MUCOCUTANEOUS;CINACALCET THERAPY;COLONIC OBSTRUCTION;CYST MIGRATED;DEEP ENDOMETRIOSIS;DIALYZED PATIENT","3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DIABETES MELLITUS;TOPICAL CAPSAICIN;ARTERIAL PAIN;CARDIOVASCULAR RISK;HYPERTENSION DIABETES;INCREASED CAWT;MELLITUS DYSLIPIDEMIA;MIBI SCINTIGRAPHY;MIGRAINE ATTACK;MMLMATH XMLNSMMLHTTPWWWWORGMATHMATHMLMMLMIΡMMLMIMMLMATHGML;OPTICAL TRAPS;TRAPPED PARTICLES;ABILITY RELIES;ACCESSIBLE HIGHLY;ACTIVE CAPSACINOIDS;ADMINISTERED MG;ADMINISTERED TOPICAL;AFFERENT FIBRES;ALBICANS ISOLATE;AMELIORATE PAIN;ARTERIAL TENDERNESS;ATTACKON MIGRAINEURS;ATTACKTOPICAL CAPSAICIN;AZOLE-RESISTANT CANDIDA;BIOLOGICAL FORCES;BIOPHYSICAL APPLICATIONS;BOUND PROTEIN;BOUND PROTEINS;BROADLY COMPATIBLE;CALCIFIED CYST","3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",3,0.17,3.5,3.5,1,0,0,0,1,0,0,3.5,0,0,6,0,0,0,0,6,0,0,0,35,35,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,5,253,12.5,1,0.17,28.17,0,0,2,0,3,0,1,0,0,2,0,0,0,0,0,0,0,4,2,0,2,4,0,0,0,0,0,0,0,0,"United States","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3202 CLINICAL SCIENCES;34 CHEMICAL SCIENCES;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3505 HUMAN RESOURCES AND INDUSTRIAL RELATIONS;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4205 NURSING","5;3;3;2;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD);BREAST CANCER;CARDIOVASCULAR;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE;HEMATOLOGY;MENTAL HEALTH;PEDIATRIC;PREVENTION;RARE DISEASES","3;3;2;1;1;1;1;1;1;1;1;1;1","CANCER;BLOOD;NEUROLOGICAL","3;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","5;1","BREAST CANCER;LUNG CANCER;NOT SITE-SPECIFIC CANCER","2;1;1","6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2011,22,7.04545454545455,3.22727272727273,0.590909090909091,0.409090909090909,0.590909090909091,1.57777777777778,2.16666666666667,1.5,2.16666666666667,0.454545454545455,1,15,1,2,1,0.68,0.05,0.09,0.05,38.59,0.907289432419013,NA,0.318181818181818,0.727272727272727,0.577,0.565,0.514,0.565,"LUCA SABA;G. MALLARINI;ROBERTO SANFILIPPO;ROBERTO MONTISCI;JASJIT S. SURI;MICHELE ANZIDEI;FILIPPO MOLINARI;L PASCALIS;NIRANJAN TALLAPALLY;GIORGIA ANTONI;ANDREW NICOLAIDES;MARIELE DESSÌ;U. RAJENDRA ACHARYA;CLELIA MADEDDU;GIOVANNI MANTOVANI;G ANGELETTI;ANNAMARIA COLAO;MARIA LUIGIA VANNINI;S. GUERRIERO;MARCELLO FILOPANTI","13;10;6;6;5;4;4;3;2;2;2;2;2;2;2;1;1;1;1;1","LUCA SABA;G. MALLARINI;ROBERTO MONTISCI;ROBERTO SANFILIPPO;JASJIT S. SURI;MICHELE ANZIDEI;FILIPPO MOLINARI;L PASCALIS;NIRANJAN TALLAPALLY;ANDREW NICOLAIDES;U. RAJENDRA ACHARYA;MARIA LUIGIA VANNINI;DORIS BARCELLONA;ANTONELLA MAMELI;FRANCESCO MARONGIU;LUIGI DEMELIA;G D’ALIA;MAURO GIOVANNI CARTA;LUIGI ZORCOLO;MARGHERITA SINI","3.52;2.3;0.96;0.94;0.75;0.57;0.55;0.48;0.29;0.27;0.27;0.25;0.25;0.25;0.25;0.2;0.2;0.2;0.2;0.2","LUCA SABA;G. MALLARINI;ROBERTO SANFILIPPO;ROBERTO MONTISCI;MICHELE ANZIDEI;L PASCALIS;GIOVANNI MANTOVANI;MARIA LUIGIA VANNINI;S. GUERRIERO;S. AJOSSA;BEATRICE CAVALLO MARINCOLA;LUIGI DEMELIA;MARIA GIOVANNA MARROSU;LIZ SECCHI;GIUSEPPE MURGIA;LORENZO SERUSI;ROSA SULCIS;G D’ALIA;R. BURA;F. COLLU","13;10;6;6;4;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1","LUCA SABA;G. MALLARINI;ROBERTO MONTISCI;ROBERTO SANFILIPPO;MICHELE ANZIDEI;L PASCALIS;MARIA LUIGIA VANNINI;DORIS BARCELLONA;ANTONELLA MAMELI;FRANCESCO MARONGIU;LUIGI DEMELIA;G D’ALIA;MARGHERITA SINI;ORAZIO SORBELLO;DIEGO RIBUFFO;MATTEO ATZENI;DANIELA RICCIO;M. G. CABRAS;GIOVANNI MANTOVANI;S. GUERRIERO","3.52;2.3;0.96;0.94;0.57;0.48;0.25;0.25;0.25;0.25;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.19;0.14","LUCA SABA;JASJIT S. SURI;G. MALLARINI;FILIPPO MOLINARI;ANDREW NICOLAIDES;U. RAJENDRA ACHARYA;CLELIA MADEDDU;GIORGIA ANTONI;GIOVANNI MANTOVANI;MARIELE DESSÌ;ROBERTO SANFILIPPO;GUANG ZENG;ANTONIO MACCIÒ;FILOMENA PANZONE;FRANCESCA MARIA TANCA;GIORGIO ASTARA;L. MONTALDO;M.C. CAU;MARCO MURA;QUIRICO MELA","563;269;262;256;199;199;183;183;183;183;164;149;130;130;130;130;130;130;130;130","LUCA SABA;G. MALLARINI;ROBERTO SANFILIPPO;L. MONTALDO;QUIRICO MELA;BEATRICE CAVALLO MARINCOLA;ROBERTO MONTISCI;G. B. MELIS;MONICA PILLONI;ROSA SULCIS;S. AJOSSA;S. GUERRIERO;GIOVANNI MANTOVANI;FRANCESCA PIGLIARU;ANTONINO CANNAS;GIANLUCA FLORIS;GIUSEPPE BORGHERO;LIZ SECCHI;MARIA GIOVANNA MARROSU;DANIELA RICCIO","520;253;162;130;130;97;85;79;79;79;79;79;53;40;29;29;29;29;29;21","LUCA SABA;G. MALLARINI;ROBERTO MONTISCI;ROBERTO SANFILIPPO;L PASCALIS;ANTONELLA MAMELI;ANTONINO CANNAS;BEATRICE CAVALLO MARINCOLA;DANIELA RICCIO;DAVIDE FIRINU;DIEGO RIBUFFO;DORIS BARCELLONA;F. COLLU;FRANCESCA PIGLIARU;FRANCESCO MARONGIU;G. B. MELIS;GIANLUCA FLORIS;GIOVANNI MANTOVANI;GIUSEPPE BORGHERO;GIUSEPPE MURGIA","12;8;5;5;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;MATHEMATICS;COMPUTER SCIENCE;ENGINEERING;BIOLOGY;PHYSICS;PSYCHOLOGY","22;7;6;4;2;1;1","RADIOLOGY;INTERNAL MEDICINE;NUCLEAR MEDICINE;ARTIFICIAL INTELLIGENCE;STATISTICS;CARDIOLOGY;GASTROENTEROLOGY;MECHANICAL ENGINEERING;PATHOLOGY;SURGERY;ENDOCRINOLOGY;PHARMACOLOGY;PSYCHIATRY;ANATOMY;ARITHMETIC;AUDIOLOGY;CLINICAL PSYCHOLOGY;COMBINATORICS;COMPUTER VISION;DATA MINING;ECOLOGY;ENGINEERING DRAWING;ENVIRONMENTAL HEALTH;GYNECOLOGY;IMMUNOLOGY;MEDICAL PHYSICS;ONCOLOGY;OPTICS;PALEONTOLOGY;PHYSICAL MEDICINE AND REHABILITATION;THERMODYNAMICS;VIROLOGY","15;13;9;5;5;4;3;3;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANGIOGRAPHY;CAROTID ARTERIES;MAGNETIC RESONANCE IMAGING;ASYMPTOMATIC;COMPUTED TOMOGRAPHY;IMAGE (MATHEMATICS);LOGISTIC REGRESSION;RECEIVER OPERATING CHARACTERISTIC;STENOSIS;STROKE (ENGINE);CANCER;COHEN'S KAPPA;DISEASE;FEATURE EXTRACTION;GROUND TRUTH;LIMITS OF AGREEMENT;PATTERN RECOGNITION (PSYCHOLOGY);ULTRASOUND;ADVERSE EFFECT;AMYLOIDOSIS;ANATOMIC VARIATION;ANEURYSM;ANOREXIA;ANTIBODY;ANXIETY;ARTERY;ARTIFICIAL NEURAL NETWORK;BLOOD PRESSURE;BODY WEIGHT;CAD;CARNITINE;CELECOXIB;CIRRHOSIS;CLASSIFIER (UML);COGNITION;COMPUTER-AIDED DIAGNOSIS;CONCORDANCE;CONFIDENCE INTERVAL;CROSS-VALIDATION;CYST;ENDOMETRIOSIS;ENDOSCOPY;FALSE NEGATIVE REACTIONS;HAUSDORFF DISTANCE;HOMOGENEOUS;HORMONE;HUMAN IMMUNODEFICIENCY VIRUS (HIV);INCIDENCE (GEOMETRY);INFLAMMATION;KERNEL (ALGEBRA);LIVER DISEASE;LUMEN (ANATOMY);MANN–WHITNEY U TEST;MCNEMAR'S TEST;MEASURE (DATA WAREHOUSE);MOOD;OXIDATIVE STRESS;PATHOLOGICAL;POPULATION;PSYCHOSIS;RANDOMIZED CONTROLLED TRIAL;RECEPTOR;RENDERING (COMPUTER GRAPHICS);REPRODUCIBILITY;SEGMENTATION;SOMATOSTATIN;STANDARD DEVIATION;SUBTRACTION;SUPPORT VECTOR MACHINE;TEST (BIOLOGY);THROMBOSIS;TOMOGRAPHY;TRANSPLANTATION;TRUNK","7;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","COMPUTED TOMOGRAPHY ANGIOGRAPHY;BLAND–ALTMAN PLOT;DIGITAL SUBTRACTION ANGIOGRAPHY;HOUNSFIELD SCALE;IMAGE QUALITY;MAGNETIC RESONANCE ANGIOGRAPHY;MAXIMUM INTENSITY PROJECTION;AMYOTROPHIC LATERAL SCLEROSIS;ANGIOTENSIN II;ANTIPHOSPHOLIPID SYNDROME;BREAST CANCER;CACHEXIA;CEREBRAL ANGIOGRAPHY;CLINICAL ENDPOINT;COGNITIVE IMPAIRMENT;COMMON VARIABLE IMMUNODEFICIENCY;CONTEXTUAL IMAGE CLASSIFICATION;CONVENTIONAL ANGIOGRAPHY;GROWTH HORMONE;IMAGE SEGMENTATION;KERNEL METHOD;LEAN BODY MASS;LIVER TRANSPLANTATION;LUPUS ANTICOAGULANT;MEGESTROL ACETATE;MOOD DISORDERS;NEUROPSYCHOLOGY;PERFORATING ARTERIES;PROINFLAMMATORY CYTOKINE;PSYCHIATRIC DISEASE;SIGMOID FUNCTION;SOMATOSTATIN RECEPTOR;SUPEROXIDE DISMUTASE;TELMISARTAN;VOLUME RENDERING;WHITE MATTER;WILCOXON SIGNED-RANK TEST;WILSON'S DISEASE","4;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACROMEGALY;ANGIOTENSIN RECEPTOR;COGNITIVE DEFICIT;DYSEXECUTIVE SYNDROME;EPIRUBICIN;GLUTATHIONE PEROXIDASE;GROWTH HORMONE RECEPTOR;LEUKOARAIOSIS;MEGESTROL;NEUROPSYCHOLOGICAL ASSESSMENT;NEUROPSYCHOLOGICAL TESTING;POLYNOMIAL KERNEL","1;1;1;1;1;1;1;1;1;1;1;1","TOMOGRAPHY, X-RAY COMPUTED;HUMANS;ANGIOGRAPHY;MIDDLE AGED;FEMALE;MALE;AGED;CAROTID STENOSIS;ADULT;AGED, 80 AND OVER;RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED;SENSITIVITY AND SPECIFICITY;SIGMOID DISEASES;CAROTID ARTERIES;REPRODUCIBILITY OF RESULTS;;ALGORITHMS;CAROTID ARTERY DISEASES;IMAGE INTERPRETATION, COMPUTER-ASSISTED;ACROMEGALY","20;17;14;13;12;12;11;9;8;8;7;7;7;6;6;5;5;5;5;4","DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;LIVER TRANSPLANTATION AND GRAFT SURVIVAL ANALYSIS;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;CARDIOTOXICITY OF CANCER TREATMENTS;COPPER AND ZINC IN HEALTH AND DISEASE;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;INTUSSUSCEPTION AND MECKEL'S DIVERTICULUM;MICROSURGICAL RECONSTRUCTION TECHNIQUES;PROTEIN METABOLISM IN EXERCISE AND NUTRITION;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME","8;2;2;1;1;1;1;1;1;1;1;1;1","CAROTID INTIMA-MEDIA THICKNESS;CAROTID ARTERY STENOSIS;COMPUTED TOMOGRAPHY ANGIOGRAPHY;STROKE (ENGINE);ARTERIAL STIFFNESS;ATHEROSCLEROTIC PLAQUE;BLAND–ALTMAN PLOT;BRACHIAL ARTERY ASSESSMENT;CARDIAC IMAGING;COHEN'S KAPPA;DIGITAL SUBTRACTION ANGIOGRAPHY;GROUND TRUTH;HISTOPATHOLOGIC STAGING;HOUNSFIELD SCALE;MAGNETIC RESONANCE ANGIOGRAPHY;MAXIMUM INTENSITY PROJECTION;ANATOMIC VARIATION;ANOREXIA;ANTIPHOSPHOLIPID SYNDROME;AORTIC STIFFNESS","6;5;5;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1","CT ANGIOGRAPHY;WALL THICKNESS;ARTERY WALL;CAROTID ARTERY;CAROTID ULTRASOUND;CAROTID WALL;COMPUTED TOMOGRAPHY;MULTIDETECTOR ROW;ROW CT;AA AMYLOIDOSIS;ACCURATE CAROTID;ACROMEGALIC PATIENTS;AGREEMENT ANALYSIS;AMYOTROPHIC LATERAL;ANATOMIC VARIATIONS;ANGIOTENSIN RECEPTOR;ANOREXIACACHEXIA SYNDROME;ANTIPHOSPHOLIPID ANTIBODIES;ARTERIAL LIVER;ASSESSING CAROTID;ASYMMETRY INDEX;ASYMPTOMATIC PATIENTS;AUTOMATED ANALYSIS;AUTOMATED MULTIRESOLUTION;BLOCKER TELMISARTAN;CALCIFIED CYST;CANCER-RELATED ANOREXIACACHEXIA;CARNITINE CELECOXIB;CAROTID ARTERIES;CAROTID PLAQUE","4;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","POTENTIALLY JUSTIFIED;ADEQUATELY JUSTIFIED;JUSTIFIED REQUESTS;LOGISTIC REGRESSION;MGM EPI;MONTH FU;PLA ARM;RECTO-SIGMOID ENDOMETRIOSIS;ADVERSE EFFECTS;APL SCREENING;INCREASED CAWT;ROC CURVE;STATISTICALLY SIGNIFICANT;TEL ARM;WILSONS DISEASE;ACROMEGALIC PATIENTS;APL TESTING;AΒ GPI;CEREBROVASCULAR SYMPTOMS;COHEN STATISTIC;DIAGNOSTIC ACCURACY;FATTY PLAQUES;HARDY-WEINBERG EQUILIBRIUM;IGF-I NORMALIZATION;INTER-TECHNIQUE CONCORDANCE;INTRAOBSERVER AGREEMENT;IPI LT;LIVER TRANSPLANTATION;MULTIPLE LOGISTIC;OXIDATIVE STRESS","5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",1,0.05,3,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,37,37,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,2.67,575,11.63,0,0,47.6,0,0,2,0,0,0,2,1,0,2,1,0,0,0,0,0,0,5,0,0,3,2,0,0,0,0,0,0,0,0,"United Kingdom;United States","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","5;4;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;MENTAL HEALTH;ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD);BEHAVIORAL AND SOCIAL SCIENCE;BRAIN DISORDERS;CHRONIC LIVER DISEASE AND CIRRHOSIS;DEPRESSION;DIGESTIVE DISEASES;HEPATITIS;HEPATITIS - B;INFECTIOUS DISEASES;LIVER DISEASE;MAJOR DEPRESSIVE DISORDER;PEDIATRIC;SERIOUS MENTAL ILLNESS","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","INFECTION;MENTAL HEALTH;NEUROLOGICAL","1;1;1","6.1 PHARMACEUTICALS;7.3 MANAGEMENT AND DECISION MAKING","2;1","LIVER CANCER","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2012,29,8.79310344827586,3.13793103448276,0.448275862068966,0.448275862068966,0.482758620689655,1.44444444444444,1.3,1.3,1.4,0.551724137931034,0,13,9,3,2,0.45,0.31,0.1,0.07,28.72,0.68770129454051,2.70175438596491,0.551724137931034,0.896551724137931,0.499,0.452,0.498,0.412,"LUCA SABA;JASJIT S. SURI;LUIGI DEMELIA;U. RAJENDRA ACHARYA;FILIPPO MOLINARI;ORAZIO SORBELLO;ALBERTO CIVOLANI;S. GUERRIERO;EYTAN RAZ;S. VINITHA SREE;MATTEO PIGA;MARGHERITA SINI;MAURO LIGGI;ROBERTO MONTISCI;STEFANO SANNIA;MARIA GIOVANNA MARROSU;ANDREW NICOLAIDES;ROBERTO SANFILIPPO;ENRICO DEMELIA;MARIA RITA MURRU","12;7;6;6;5;5;5;4;4;4;3;3;3;3;2;2;2;2;2;2","LUCA SABA;JASJIT S. SURI;LUIGI DEMELIA;ORAZIO SORBELLO;ALBERTO CIVOLANI;U. RAJENDRA ACHARYA;FILIPPO MOLINARI;EYTAN RAZ;MATTEO PIGA;S. GUERRIERO;S. VINITHA SREE;MARGHERITA SINI;MAURO LIGGI;ROBERTO MONTISCI;ENRICO DEMELIA;STEFANO SANNIA;ROBERTO SANFILIPPO;PAOLO SIOTTO;ANDREW NICOLAIDES;GIOVANNI MARIA ARGIOLAS","1.94;1.04;0.96;0.91;0.91;0.89;0.73;0.7;0.62;0.6;0.6;0.58;0.53;0.51;0.33;0.31;0.31;0.25;0.25;0.25","LUCA SABA;LUIGI DEMELIA;ORAZIO SORBELLO;ALBERTO CIVOLANI;S. GUERRIERO;EYTAN RAZ;S. VINITHA SREE;MATTEO PIGA;MARGHERITA SINI;MAURO LIGGI;ROBERTO MONTISCI;STEFANO SANNIA;ROBERTO SANFILIPPO;ENRICO DEMELIA;E. NALLI;FRANCISCU SEDDA;L. SABA;ROBERTO SERPE;S. AJOSSA;FILOMENA PANZONE","12;6;5;5;4;4;4;3;3;3;3;2;2;2;1;1;1;1;1;1","LUCA SABA;LUIGI DEMELIA;ORAZIO SORBELLO;ALBERTO CIVOLANI;EYTAN RAZ;MATTEO PIGA;S. GUERRIERO;S. VINITHA SREE;MARGHERITA SINI;MAURO LIGGI;ROBERTO MONTISCI;ENRICO DEMELIA;STEFANO SANNIA;ROBERTO SANFILIPPO;L. SABA;DAVID ZAGZAG;DEBORA MURGIA;MARIA KATARINA JACOBSON;GIUSEPPE LEDDA;FRANCESCA ALESSANDRA AMBROSIO","1.94;0.96;0.91;0.91;0.7;0.62;0.6;0.6;0.58;0.53;0.51;0.33;0.31;0.31;0.17;0.17;0.17;0.17;0.17;0.17","LUCA SABA;JASJIT S. SURI;U. RAJENDRA ACHARYA;FILIPPO MOLINARI;LUIGI DEMELIA;ALBERTO CIVOLANI;ORAZIO SORBELLO;S. GUERRIERO;S. VINITHA SREE;MAURO LIGGI;ROBERTO MONTISCI;MARIA GIOVANNA MARROSU;MARIA RITA MURRU;ROBERTO SANFILIPPO;STEFANO SANNIA;EYTAN RAZ;G. MALLARINI;MICHELE ANZIDEI;ENRICO DEMELIA;MARGHERITA SINI","386;262;183;168;159;139;139;137;127;113;113;100;100;96;94;91;79;79;71;68","LUCA SABA;ORAZIO SORBELLO;LUIGI DEMELIA;ALBERTO CIVOLANI;MAURO LIGGI;ROBERTO MONTISCI;STEFANO SANNIA;G. MALLARINI;ROBERTO SANFILIPPO;ENRICO DEMELIA;FRANCESCO MARROSU;GIANLUCA FLORIS;GIUSEPPE BORGHERO;PAOLO TACCONI;STEFANO MARIOTTI;MARIA KATARINA JACOBSON;DAVID ZAGZAG;EYTAN RAZ;FRANCESCA ALESSANDRA AMBROSIO;LORENZO MANNELLI","369;139;137;117;113;96;94;79;79;71;61;61;61;61;51;48;46;46;46;46","LUCA SABA;LUIGI DEMELIA;ORAZIO SORBELLO;ALBERTO CIVOLANI;MAURO LIGGI;ENRICO DEMELIA;MARGHERITA SINI;MATTEO PIGA;ROBERTO MONTISCI;STEFANO SANNIA;ALBERTO M. SETTEMBRINI;ALESSANDRA MELONI;ALESSANDRO LODDO;ANNA MARIA PAOLETTI;BRUNO PIRAS;CARLO CIANCHETTI;DANIELA PORRU;DARIO PRUNA;DAVID ZAGZAG;DAVIDE FIRINU","11;5;5;4;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;COMPUTER SCIENCE;MATHEMATICS;ENGINEERING;PSYCHOLOGY;CHEMISTRY;GEOGRAPHY;HISTORY;PHYSICS","27;10;8;3;2;2;1;1;1;1","INTERNAL MEDICINE;PATHOLOGY;RADIOLOGY;ARTIFICIAL INTELLIGENCE;GASTROENTEROLOGY;GENETICS;NUCLEAR MEDICINE;CARDIOLOGY;IMMUNOLOGY;PALEONTOLOGY;STATISTICS;SURGERY;CLINICAL PSYCHOLOGY;COMPUTER VISION;ENDOCRINOLOGY;ENGINEERING DRAWING;ONCOLOGY;PROGRAMMING LANGUAGE;PSYCHIATRY;ANATOMY;ANESTHESIA;ARCHAEOLOGY;AUDIOLOGY;BIOCHEMISTRY;BIOMEDICAL ENGINEERING;CANCER RESEARCH;CARTOGRAPHY;COMPUTER NETWORK;DERMATOLOGY;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;MACHINE LEARNING;NEUROSCIENCE;NURSING;OBSTETRICS;OPERATING SYSTEM;OPTICS;ORGANIC CHEMISTRY;PEDIATRICS;PHARMACOLOGY","17;8;8;7;5;5;5;3;3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DISEASE;CAROTID ARTERIES;CANCER;GENE;BIOPSY;CLASSIFIER (UML);IMAGE (MATHEMATICS);PATTERN RECOGNITION (PSYCHOLOGY);INTERNAL CAROTID ARTERY;LIVER DISEASE;PIXEL;ASYMPTOMATIC;CAD;CIRRHOSIS;COMPUTER-AIDED DIAGNOSIS;DECISION TREE;EPILEPSY;FIBROSIS;HISTOLOGY;NODULE (GEOLOGY);RETROSPECTIVE COHORT STUDY;SOFTWARE;SUPPORT VECTOR MACHINE","7;6;5;5;4;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","LIVER BIOPSY;ALLELE;MUTATION;OVARIAN CANCER;WILSON'S DISEASE;COMMON CAROTID ARTERY;CONTEXTUAL IMAGE CLASSIFICATION;DECISION TREE LEARNING;GENOTYPE;HEPATIC FIBROSIS;HISTOGRAM;AMYOTROPHIC LATERAL SCLEROSIS;ASTROCYTOMA;AUTOIMMUNE DISEASE;AUTOIMMUNITY;BRAIN DISEASE;BREAST CANCER;CAESAREAN SECTION;CANDIDATE GENE;CARDIOTOXICITY;CHEMODECTOMA;CHEMOKINE;CHRONIC LIVER DISEASE;CONFIRMATORY FACTOR ANALYSIS;CONTRAST ENHANCEMENT;DEMENTIA;DOXORUBICIN;EXTERNAL CAROTID ARTERY;FATTY LIVER;FLEISCHER;GANGLIOGLIOMA;GENETIC ANALYSIS;GENETIC LINKAGE;HEALTH PROMOTION;HEPATITIS C VIRUS;HEREDITARY HEMOCHROMATOSIS;HUMAN LEUKOCYTE ANTIGEN;ICTAL;INTERLEUKIN 8;INTIMA-MEDIA THICKNESS;INTRACLASS CORRELATION;IRON DEFICIENCY;KERNEL METHOD;LIVER FIBROSIS;LOCUS (GENETICS);MUTANT;MYOCLONIC EPILEPSY;MYOCLONIC JERK;MYOMETRIUM;NEURORADIOLOGY;PHENOTYPE;PROINFLAMMATORY CYTOKINE;REFLEX EPILEPSY;SCLERODERMA (FUNGUS);TOLERABILITY;TRIGLYCERIDE;WILCOXON SIGNED-RANK TEST","4;3;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","OVARIAN TUMOR;LOCAL BINARY PATTERNS;ANTHRACYCLINE;CONNECTIVE TISSUE DISEASE;CXCL10;FRAMESHIFT MUTATION;FRONTOTEMPORAL DEMENTIA;GENE MUTATION;HAPLOTYPE;METASTATIC BREAST CANCER;MISSENSE MUTATION;MUTATION TESTING;PILOCYTIC ASTROCYTOMA;PLEOMORPHIC XANTHOASTROCYTOMA;RADIAL BASIS FUNCTION KERNEL;RIBAVIRIN;SALUTOGENESIS;SOD1;STEATOHEPATITIS;TRANSFERRIN SATURATION;TRANSIENT ELASTOGRAPHY;TRINUCLEOTIDE REPEAT EXPANSION","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;HEPATOLENTICULAR DEGENERATION;ADULT;MALE;MIDDLE AGED;CAROTID ARTERY DISEASES;AGED;CAROTID STENOSIS;IMAGE INTERPRETATION, COMPUTER-ASSISTED;LIVER CIRRHOSIS;RETROSPECTIVE STUDIES;ITALY;OVARIAN NEOPLASMS;TOMOGRAPHY, X-RAY COMPUTED;;CAROTID ARTERIES;REPRODUCIBILITY OF RESULTS;SENSITIVITY AND SPECIFICITY;ULTRASONOGRAPHY","23;20;17;16;16;14;10;8;8;8;8;8;7;7;7;6;6;6;6;6","DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;COPPER AND ZINC IN HEALTH AND DISEASE;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;BIOMEDICAL APPLICATIONS OF SPECTROSCOPY TECHNIQUES;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND MANAGEMENT OF SJÖGREN'S SYNDROME;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;EPILEPSY AND SEIZURES;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;GLIOMAS;LIPID METABOLISM IN CANCER PATHOGENESIS;MANAGEMENT AND PATHOPHYSIOLOGY OF INTRACEREBRAL HEMORRHAGE;MATERNAL AND NEONATAL OUTCOMES OF CESAREAN SECTION;PATHOGENESIS AND TREATMENT OF SYSTEMIC SCLEROSIS;REGULATION OF IRON METABOLISM AND ANEMIA;ROLE OF CHEMOKINE RECEPTORS IN CANCER METASTASIS;SALUTOGENESIS AND SENSE OF COHERENCE IN HEALTH","5;4;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CAROTID INTIMA-MEDIA THICKNESS;BRACHIAL ARTERY ASSESSMENT;CAROTID ARTERY STENOSIS;LIVER DISEASE;OVARIAN TUMOR;TUMOR MODELS;WILSON'S DISEASE;BREAST CANCER DIAGNOSIS;COMPUTER-AIDED DIAGNOSIS;CONTEXTUAL IMAGE CLASSIFICATION;HEPATIC FIBROSIS;HISTOLOGY;LOCAL BINARY PATTERNS;MEDICAL IMAGE ANALYSIS;NODULE (GEOLOGY);OVARIAN CANCER;ANTHRACYCLINES;ARTERIAL STIFFNESS;ATHEROSCLEROTIC PLAQUE;BRAIN DISEASE","5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1","ARTERY PLAQUE;CAROTID ARTERY;WILSONS DISEASE;OVARIAN TUMOR;TUMOR CHARACTERIZATION;ADVANCED CANCER;ALSFTD PHENOTYPE;ANTONOVSKYS SENSE;ASIA SYNDROME;ATHEROMATIC SYSTEMS;ATPB GENE;AUTOMATED DUAL-SNAKE;AUTOSOMAL DOMINANT;AXONAL CHARCOT-MARIE-TOOTH;BREAST CANCER;BREAST IMPLANTS;CAESAREAN SECTION;CARDIAC TOLERABILITY;CAROTID INTIMA-MEDIA;CARRYING BOTHICORFIANDITARDBPIMUTATIONS;CEREBRAL MICROBLEEDS;CHARCOT-MARIE-TOOTH DISEASE;CHRONIC HEPATITIS;CHRONIC TRIGEMINAL;CLINICAL ACTIVITY;CLINICAL STUDY;COHERENCE SCALE;COHORT STUDY;CONTRAST ENHANCEMENT;CT IMAGES","5;5;5;3;3;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PAROTID GLAND;CAROTID ARTERY;CAROTID ARTERIES;GLAND ATROPHY;STATISTICALLY SIGNIFICANT;FATTY PLAQUES;HU VALUES;PROMOTER REGION;ARTERY PLAQUES;CANCER PATIENTS;CM ADMINISTRATION;CONSECUTIVE PATIENTS;CONTRAST MATERIAL;CT SCANNER;DT CLASSIFIER;HEXANUCLEOTIDE REPEAT;HUMAN THYROCYTES;ITARDBPI GENE;REPEAT EXPANSION;SIGNIFICANT DIFFERENCE;SPINAL ALS;AD INHERITANCE;ALLELES CARRYING;ANALYZED CAROTID;ARTERY PLAQUE;ASYMMETRY INDEX;CALCIFIED MIXED;CALCIFIED PLAQUES;CANONICAL VDRE;CAPILLARY MICROSCOPY","8;7;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2",6,0.21,5.48,4,1,1,1,0,14,0,0,4,0,0,2,0,1,1,0,2.5,0,0,0,43.5,43.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,0,0,1.64,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2013,32,8.78125,2.625,0.46875,0.3125,0.4375,1.42372881355932,1.66666666666667,1.11111111111111,1.55555555555556,0.4375,1,13,10,2,6,0.41,0.31,0.06,0.19,22.28,0.638567276371249,3.49295774647887,0.5625,0.875,0.411,0.567,0.292,0.567,"LUCA SABA;U. RAJENDRA ACHARYA;FILIPPO MOLINARI;JASJIT S. SURI;EYTAN RAZ;MARIO PIGA;KRISTEN M. MEIBURGER;VASSILIOS FANOS;G. MALLARINI;NIRANJAN TALLAPALLY;HAO GAO;ANDREW NICOLAIDES;S. VINITHA SREE;ROBERTO MONTISCI;S. GUERRIERO;MICHELE ANZIDEI;JUAN LUIS ALCÁZAR;FRANCESCO MARROSU;PIER LUIGI DI PAOLO;CARLO CIANCHETTI","16;7;6;6;5;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2","LUCA SABA;U. RAJENDRA ACHARYA;EYTAN RAZ;JASJIT S. SURI;MARIO PIGA;FILIPPO MOLINARI;VASSILIOS FANOS;ROBERTO MONTISCI;HAO GAO;MICHELE ANZIDEI;CARLO CIANCHETTI;MARIA GIUSEPPINA LEDDA;G. MALLARINI;NIRANJAN TALLAPALLY;S. VINITHA SREE;KRISTEN M. MEIBURGER;ANDREW NICOLAIDES;MICHELE MUSSAP;JOHANNES N. VAN DEN ANKER;ANTONIO DEL VECCHIO","2.74;0.67;0.66;0.62;0.61;0.58;0.55;0.39;0.36;0.32;0.32;0.32;0.32;0.32;0.31;0.26;0.26;0.25;0.25;0.25","LUCA SABA;MARIO PIGA;VASSILIOS FANOS;G. MALLARINI;ROBERTO MONTISCI;S. GUERRIERO;FRANCESCO MARROSU;CARLO CIANCHETTI;FRANCESCO ATZORI;ROBERTO SANFILIPPO;MARIA GIUSEPPINA LEDDA;LUCA FAMIGLIETTI;MONICA PULIGHEDDU;ALBERTO BOI;CARMELA PORCU;ROBERTA MONTISCI;GIORGIO TAMBURINI;LUIGI DEMELIA;LUIGI MELONI;LEWIS C. STRAUSS","16;4;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","LUCA SABA;MARIO PIGA;VASSILIOS FANOS;ROBERTO MONTISCI;CARLO CIANCHETTI;MARIA GIUSEPPINA LEDDA;G. MALLARINI;FRANCESCO MARROSU;S. GUERRIERO;ROBERTO SANFILIPPO;CARMELA PORCU;G FUMO;LUCA FAMIGLIETTI;ALBERTO BOI;ROBERTA MONTISCI;LUIGI MELONI;MASSIMO RUSCAZIO;LAURA SAU;ANDREA MARINI;LUIGI DEMELIA","2.74;0.61;0.55;0.39;0.32;0.32;0.32;0.24;0.23;0.22;0.2;0.2;0.2;0.17;0.17;0.17;0.17;0.17;0.17;0.14","LUCA SABA;JASJIT S. SURI;U. RAJENDRA ACHARYA;FILIPPO MOLINARI;S. VINITHA SREE;FRANCESCO ATZORI;G. MALLARINI;EYTAN RAZ;ANDREW NICOLAIDES;HAO GAO;KRISTEN M. MEIBURGER;MARIO PIGA;FRANCESCO MARROSU;ALBERTO MALECI;GIORGIO TAMBURINI;LORENZO POLIZZI;MARCO BORTOLATO;MATTEO DEMURU;MATTEO FRASCHINI;MONICA PULIGHEDDU","377;206;193;118;113;106;97;94;80;75;71;70;67;65;65;65;65;65;65;65","LUCA SABA;FRANCESCO ATZORI;G. MALLARINI;FRANCESCO MARROSU;GIORGIO TAMBURINI;LORENZO POLIZZI;MONICA PULIGHEDDU;S. CONGIA;ROBERTO MONTISCI;MARIA DEL ZOMPO;MARIO PIGA;PAOLO CARTA;RAFFAELLA ARDAU;LUCA FAMIGLIETTI;ALISSA RYBICKI;GEORGE SOMLO;JAVIER CORTÉS;JENNIFER M. SPECHT;LEWIS C. STRAUSS;LINDA T. VAHDAT","336;106;97;67;65;65;65;65;62;57;57;57;57;51;43;43;43;43;43;43","LUCA SABA;G. MALLARINI;MARIO PIGA;ROBERTO MONTISCI;CARLO CIANCHETTI;FRANCESCO ATZORI;FRANCESCO MARROSU;LUCA FAMIGLIETTI;ROBERTO SANFILIPPO;VASSILIOS FANOS;ALBERTO BOI;ALBERTO CIVOLANI;ALESSANDRO ZUDDAS;ALISSA RYBICKI;ANDREA MARINI;ANTONINO CANNAS;ANTONIO NOTO;CARMELA PORCU;CLAUDIA MAIS;DAVIDE FIRINU","14;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","MEDICINE;COMPUTER SCIENCE;BIOLOGY;MATHEMATICS;CHEMISTRY;PSYCHOLOGY;ECONOMICS;PHYSICS;GEOLOGY","31;8;6;5;3;3;2;2;1","INTERNAL MEDICINE;RADIOLOGY;ARTIFICIAL INTELLIGENCE;NUCLEAR MEDICINE;CARDIOLOGY;PATHOLOGY;SURGERY;ANESTHESIA;GASTROENTEROLOGY;PSYCHIATRY;ENDOCRINOLOGY;GENETICS;BIOMEDICAL ENGINEERING;STATISTICS;ENVIRONMENTAL HEALTH;GEOMETRY;NEUROSCIENCE;ORGANIC CHEMISTRY;QUANTUM MECHANICS;AUDIOLOGY;BIOCHEMISTRY;BIOINFORMATICS;CLINICAL PSYCHOLOGY;DATA SCIENCE;ECONOMIC GROWTH;FAMILY MEDICINE;GYNECOLOGY;MACROECONOMICS;MICROBIOLOGY;ONCOLOGY;PALEONTOLOGY;PHYSICAL MEDICINE AND REHABILITATION;PHYSIOLOGY;PROGRAMMING LANGUAGE;REMOTE SENSING;UROLOGY","18;15;7;7;6;6;6;5;5;5;4;4;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CAROTID ARTERIES;MAGNETIC RESONANCE IMAGING;ULTRASOUND;CONFIDENCE INTERVAL;DISEASE;CANCER;DIABETES MELLITUS;DIAGNOSTIC ACCURACY;REPRODUCIBILITY;STENOSIS;ADVERSE EFFECT;CIRRHOSIS;COMPUTED TOMOGRAPHY;CONTRAST (VISION);CORRELATION;ELECTROENCEPHALOGRAPHY;EPILEPSY;GENE;ODDS RATIO;PATTERN RECOGNITION (PSYCHOLOGY);POPULATION;SUPPORT VECTOR MACHINE;WAVELET","7;5;5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","INTIMA-MEDIA THICKNESS;CAROTID ENDARTERECTOMY;COMMON CAROTID ARTERY;LIKELIHOOD RATIOS IN DIAGNOSTIC TESTING;TEMPORAL LOBE;WAVELET TRANSFORM;ADNEXAL DISEASES;ALLELE;AURA;BIFURCATION;BLAND–ALTMAN PLOT;BREAST CANCER;CAROTID BIFURCATION;CHRONIC LIVER DISEASE;COLORECTAL CANCER;COMPUTED TOMOGRAPHIC;COMPUTED TOMOGRAPHIC ANGIOGRAPHY;COMPUTED TOMOGRAPHY ANGIOGRAPHY;CUNEATE NUCLEUS;DIFFUSION MRI;DORSAL COLUMN NUCLEI;DYSLIPIDEMIA;EFFECTIVE DIFFUSION COEFFICIENT;EPILEPSY SURGERY;EPILEPTIC SEIZURE;FETUS;GENOTYPE;GROWTH HORMONE;HEMISPATIAL NEGLECT;HEPATIC FIBROSIS;HOUNSFIELD SCALE;HYDRONEPHROSIS;HYPERINTENSITY;HYPOXIA (ENVIRONMENTAL);ICTAL;IMAGE QUALITY;IMATINIB;INTERNAL CONSISTENCY;KERNEL METHOD;LIVER BIOPSY;LIVER FIBROSIS;LOW RESOLUTION;MESENTERIC ISCHEMIA;METABOLOME;NEUROPEPTIDE;NEURORADIOLOGY;NEUROTROPHIC FACTORS;NEUTROPENIA;POSTCENTRAL GYRUS;PROSTATE CANCER;PROTEOMICS;TARGETED THERAPY;TYPE 2 DIABETES MELLITUS;VAGUS NERVE;VASCULAR ENDOTHELIAL GROWTH FACTOR;VENOGRAPHY;WHITE MATTER;WILSON'S DISEASE","3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACROMEGALY;BIOMARKER DISCOVERY;CAPECITABINE;CAROTID ARTERY DISEASE;DASATINIB;DISCRETE WAVELET TRANSFORM;DISCRIMINANT VALIDITY;GENOTYPING;MIGRAINE WITH AURA;PROSTATE BIOPSY;RADIAL BASIS FUNCTION KERNEL;VAGUS NERVE STIMULATION","1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;CAROTID ARTERIES;CAROTID STENOSIS;AGED, 80 AND OVER;REPRODUCIBILITY OF RESULTS;MAGNETIC RESONANCE IMAGING;;ABSCESS;ALGORITHMS;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;CAROTID ARTERY DISEASES;CAROTID INTIMA-MEDIA THICKNESS;IMAGE INTERPRETATION, COMPUTER-ASSISTED;IMAGE PROCESSING, COMPUTER-ASSISTED;LIVER CIRRHOSIS","26;23;20;18;17;14;8;8;7;7;6;5;5;5;5;5;5;5;5;5","DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;ADVANCES IN METABOLOMICS RESEARCH;BREAST MAGNETIC RESONANCE IMAGING IN ONCOLOGY;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;COPPER AND ZINC IN HEALTH AND DISEASE;DEEP LEARNING IN MEDICAL IMAGE ANALYSIS;DIAGNOSIS AND MANAGEMENT OF CEREBRAL VEIN THROMBOSIS;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;EMOTION REGULATION AND PSYCHOPATHOLOGY IN CHILDREN AND ADOLESCENTS;EPIDEMIOLOGY AND MANAGEMENT OF BIPOLAR DISORDER;ETHICAL CONSIDERATIONS IN CLINICAL PHOTOGRAPHY AND DOCUMENTATION;GYNECOLOGIC ONCOLOGY;IMPACT OF HYPERGLYCEMIA ON HEALTH OUTCOMES;MANAGEMENT OF CARDIAC ARREST AND RESUSCITATION;MANAGEMENT OF MESENTERIC ISCHEMIA AND ANEURYSMS;MECHANISMS AND MANAGEMENT OF NEUROPATHIC PAIN;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT","7;3;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CAROTID INTIMA-MEDIA THICKNESS;CAROTID ARTERY STENOSIS;ARTERIAL STIFFNESS;BRACHIAL ARTERY ASSESSMENT;INTIMA-MEDIA THICKNESS;TREATMENT;ACCURACY AND PRECISION;ADNEXAL DISEASES;ADNEXAL MASS;ADOLESCENTS;ADRENAL INCIDENTALOMA;ANAMNESIS;ARTERIAL WALL;ATHEROSCLEROTIC PLAQUE;BIOMARKER DISCOVERY;BIOMARKERS;BIOMONITORING;BLAND–ALTMAN PLOT;BREAST CANCER;CANDIDIASIS","6;4;3;3;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CAROTID ARTERY;ARTERY WALL;AUTOMATED CAROTID;CAROTID IMT;COMPUTED TOMOGRAPHY;IMT MEASUREMENT;ACROMEGALIC PATIENTS;ACUTE ARTERIAL;ACUTE MYOCARDIAL;ADH GENE;ADMISSION HYPERGLYCEMIA;ADNEXAL MASSES;ADOLESCENT BEHAVIOR;ADVANCED BREAST;ARTERIAL MESENTERIC;ARTERY BIFURCATION;ARTERY DISEASE;ARTERY PLAQUE;ATHEROEDGE SOFTWARE;AUTOMATED ALGORITHMS;AUTOMATED ANALYSIS;AUTOMATED IMT;BANDS CORRELATES;BEHAVIOR INVENTORY;BMI CORRELATION;BREAST CANCER;CANCER SAFETY;CANDIDA INFECTION;CARCINOMA RESULTS;CAROTID SIPHON","4;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FISSURED FIBROUS;FIBROUS CAP;CONTRAST PLAQUE;PLAQUE ENHANCEMENT;ARTERIAL WALL;PATIENTS TREATED;BOWEL WALL;DAILY DL;HEMIPLEGIC MIGRAINE;LFT ABNORMALITIES;LITHIUM TREATMENT;REGRESSION ANALYSIS;SIMPLE RULES;AUTOSOMAL DOMINANT;PEG-V THERAPY;PLAQUE SCORE;TLR TLR;UGTA ALLELE;WALL THICKNESS;ACUTE ARTERIAL;ADNEXAL MASS;AELR IMT;AELR SYSTEM;AFFECTIVE DISORDERS;ARTERY DISEASE;AUTOMATED IMT;AUTOSOMAL RECESSIVE;CANDIDA ALBICANS;CANDIDA INFECTION;CANDIDA SPECIES","13;12;11;11;9;5;4;4;4;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2",12,0.38,6.44,3.25,1,2,0,1,1,0,1.75,4,0,0,3.5,0,1.75,1,1,2.75,0,0,0,37,37,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,12,15000,1.69,0,0,36,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,"Italy","2","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","1;1","CANCER;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;RARE DISEASES","1;1;1;1;1","CANCER","1",NA,NA,"THYROID CANCER","1","5.7 RESOURCES AND INFRASTRUCTURE RELATED TO TREATMENT AND THE PREVENTION OF RECURRENCE","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2014,35,11.8285714285714,2.68571428571429,0.457142857142857,0.314285714285714,0.457142857142857,2.04347826086957,1.6,1.57142857142857,1.6,0.257142857142857,0,9,14,3,6,0.26,0.4,0.09,0.17,33.11,0.876231679804219,3.15625,0.428571428571429,1,0.48,0.492,0.438,0.492,"VASSILIOS FANOS;LUCA SABA;EYTAN RAZ;ANTONIO NOTO;MARIO PIGA;MAURO STRONATI;GIOVANNI CORSELLO;GAVINO FAA;GIAN BENEDETTO MELIS;JASJIT S. SURI;ANGELICA DESSÌ;MICHELE DI MARTINO;FRANCESCA SERRAINO;ALBERTO VERROTTI;MILENA LUSSU;PASQUALE PARISI;DARIO PRUNA;CARLO CATALANO;GIANGENNARO COPPOLA;LUIGI ATZORI","13;10;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3","VASSILIOS FANOS;LUCA SABA;MARIO PIGA;EYTAN RAZ;MICHELE DI MARTINO;JASJIT S. SURI;GAVINO FAA;MAURO STRONATI;GIOVANNI CORSELLO;ANGELICA DESSÌ;GIAN BENEDETTO MELIS;CARLO CATALANO;ANTONIO NOTO;MARIA CRISTINA PINTUS;MARIA ANTONIETTA MARCIALIS;DIEGO GAZZOLO;CARLO N. DE CECCO;ROSSANO AMBU;DANIELA FANNI;CLARA GEROSA","1.61;1.39;0.72;0.66;0.6;0.55;0.54;0.47;0.47;0.45;0.43;0.4;0.39;0.34;0.34;0.31;0.31;0.31;0.31;0.31","VASSILIOS FANOS;LUCA SABA;ANTONIO NOTO;MARIO PIGA;GAVINO FAA;GIAN BENEDETTO MELIS;ANGELICA DESSÌ;DARIO PRUNA;SARA DEIANA;MARIA CRISTINA PINTUS;MARIA ANTONIETTA MARCIALIS;S. GUERRIERO;ANNA MARIA PAOLETTI;CARLO CIANCHETTI;ROSSELLA MEREU;FRANCESCO ATZORI;PIER PAOLO BASSAREO;ALESSANDRA MELONI;ROBERTO MONTISCI;B. MASSIDDA","13;10;5;5;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2","VASSILIOS FANOS;LUCA SABA;MARIO PIGA;GAVINO FAA;ANGELICA DESSÌ;GIAN BENEDETTO MELIS;ANTONIO NOTO;MARIA CRISTINA PINTUS;MARIA ANTONIETTA MARCIALIS;SARA DEIANA;ROBERTO MONTISCI;PIER PAOLO BASSAREO;ALESSANDRA MELONI;DARIO PRUNA;ROSSELLA MEREU;CARLO CIANCHETTI;S. GUERRIERO;DANILA MANUS;FABIANA SAU;GIOVANNI OTTONELLO","1.61;1.39;0.72;0.54;0.45;0.43;0.39;0.34;0.34;0.3;0.29;0.25;0.23;0.22;0.22;0.22;0.18;0.17;0.17;0.17","S. GUERRIERO;A. C. TESTA;ARTUR CZEKIERDOWSKI;BEN VAN CALSTER;C. VAN HOLSBEKE;CHIARA LANZANI;D. FISCHEROVÁ;D. FRANCHI;D. TIMMERMAN;E. EPSTEIN;FELICE SCALA;J. KAIJSER;KIRSTEN VAN HOORDE;L. SAVELLI;L. VALENTIN;ROBERT FRUSCIO;T. BOURNE;V. VAN BELLE;VASSILIOS FANOS;ANTONIO NOTO","432;388;388;388;388;388;388;388;388;388;388;388;388;388;388;388;388;388;230;186","S. GUERRIERO;VASSILIOS FANOS;ANTONIO NOTO;LUCA SABA;ANGELICA DESSÌ;CARLO CIANCHETTI;ROBERTA CARBONI;DARIO PRUNA;FRANCESCO ATZORI;MARIA ANTONIETTA MARCIALIS;MARIA CRISTINA PINTUS;SILVIA PUDDU;M. DEL FIACCO;MARIA PINA SERRA;MARIANNA BOI;MARINA QUARTU;TIZIANA MELIS;FRANCESCO MARROSU;LORENZO POLIZZI;MARIO PIGA","388;216;172;161;151;139;91;76;75;58;58;55;53;53;53;53;53;49;49;42","VASSILIOS FANOS;LUCA SABA;MARIO PIGA;ANGELICA DESSÌ;ANTONIO NOTO;ALESSANDRA MELONI;DARIO PRUNA;MARIA ANTONIETTA MARCIALIS;MARIA CRISTINA PINTUS;GIAN BENEDETTO MELIS;SARA DEIANA;ANNA MARIA PAOLETTI;B. MASSIDDA;CARLO CIANCHETTI;FRANCESCO ATZORI;PIER PAOLO BASSAREO;ROBERTO MONTISCI;ROSSELLA MEREU;ALESSANDRA ATZEI;ANNA PAOLA PINNA","12;10;5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;1;1","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;MATHEMATICS;PHILOSOPHY;PHYSICS","32;12;5;4;3;3;2;2","INTERNAL MEDICINE;RADIOLOGY;PSYCHIATRY;PEDIATRICS;GENETICS;ONCOLOGY;PATHOLOGY;BIOCHEMISTRY;BIOINFORMATICS;CARDIOLOGY;NUCLEAR MEDICINE;ANESTHESIA;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;NEUROSCIENCE;PHYSIOLOGY;ANATOMY;ARTIFICIAL INTELLIGENCE;CHROMATOGRAPHY;GYNECOLOGY;INTENSIVE CARE MEDICINE;OBSTETRICS;SURGERY","23;9;8;7;5;5;5;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2","METABOLOMICS;EPILEPSY;MAGNETIC RESONANCE IMAGING;PREGNANCY;URINE;CANCER;PATHOLOGICAL;METABOLITE;POPULATION;RECEIVER OPERATING CHARACTERISTIC;SEPSIS;URINARY SYSTEM;AREA UNDER THE CURVE;ASYMPTOMATIC;CAROTID ARTERIES;DIAGNOSTIC ACCURACY;DISEASE;LINEAR DISCRIMINANT ANALYSIS;LOGISTIC REGRESSION;LUNG;RENAL CELL CARCINOMA;STENOSIS","6;5;5;5;5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","FLUID-ATTENUATED INVERSION RECOVERY;GESTATIONAL AGE;HYPERINTENSITY;METABOLOME;CLEAR CELL RENAL CELL CARCINOMA;COLORECTAL CANCER;FETUS;NEONATAL SEPSIS;NEONATOLOGY;WHITE MATTER;ANTERIOR PITUITARY;AUTISM SPECTRUM DISORDER;AUTOANTIBODY;BIRTH WEIGHT;BREAST CANCER;CAROTID ENDARTERECTOMY;COMMON CAROTID ARTERY;DIAGNOSTIC BIOMARKER;DRAVET SYNDROME;FEBRILE CONVULSIONS;GAS CHROMATOGRAPHY–MASS SPECTROMETRY;GENOTYPE;GRAYSCALE;HYPOXIA (ENVIRONMENTAL);ICTAL;INTIMA-MEDIA THICKNESS;IRRITABILITY;KETONE BODIES;KIDNEY CANCER;LENNOX–GASTAUT SYNDROME;LOW BIRTH WEIGHT;LUNG BIOPSY;METASTASIS;MYOFIBROBLAST;NEONATAL ENCEPHALOPATHY;NEONATAL RESUSCITATION;NEPHRECTOMY;NEUROMYELITIS OPTICA;NEUROPEPTIDE;NEURORADIOLOGY;NOCICEPTION;OBSTETRICS AND GYNAECOLOGY;OVARIAN CANCER;PERFORMANCE STATUS;PREECLAMPSIA;PROTEIN KINASE B;SORAFENIB;SUNITINIB;TARGETED THERAPY;TITER;TOLERABILITY;TRANSIENT RECEPTOR POTENTIAL CHANNEL;TYPE 1 DIABETES;VAGUS NERVE;VALPROIC ACID","3;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BRONCHOPULMONARY DYSPLASIA;LEUKOARAIOSIS;ADJUVANT CHEMOTHERAPY;CALCITONIN GENE-RELATED PEPTIDE;CARDIOTOCOGRAPHY;DISCOVERY AND DEVELOPMENT OF MTOR INHIBITORS;GSTP1;OXALIPLATIN;PAZOPANIB;PERVASIVE DEVELOPMENTAL DISORDER;PLACENTA;PLACENTAL GROWTH FACTOR;TRPV1;VAGUS NERVE STIMULATION","2;2;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;EPILEPSY;;BIOMARKERS;MIDDLE AGED;ADULT;AGED;ANTICONVULSANTS;METABOLOMICS;RETROSPECTIVE STUDIES;CARCINOMA, RENAL CELL;LEUKOARAIOSIS;MAGNETIC RESONANCE IMAGING;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;ITALY;ADOLESCENT;CAROTID ARTERIES;CHILD, PRESCHOOL","23;21;19;15;11;11;10;8;8;8;8;7;6;6;6;5;5;4;4;4","ADVANCES IN METABOLOMICS RESEARCH;EPILEPSY AND SEIZURES;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;NEONATAL BRAIN INJURY AND DEVELOPMENTAL CONSEQUENCES;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;RENAL CELL CARCINOMA;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;BRAIN-COMPUTER INTERFACES IN NEUROSCIENCE AND MEDICINE;DEVELOPMENTAL PHARMACOLOGY IN PEDIATRIC DRUG USE;DIAGNOSIS AND MANAGEMENT OF ADRENAL INSUFFICIENCY;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIAGNOSIS AND TREATMENT OF LUNG CANCER;EPIDEMIOLOGY AND MANAGEMENT OF NEONATAL SEPSIS;ETIOLOGY AND MANAGEMENT OF PERITONEAL ADHESIONS;GASTROINTESTINAL VIRAL INFECTIONS AND VACCINES DEVELOPMENT;GENOMIC REARRANGEMENT DISORDERS IN SKIN DISEASES;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA","3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","FLUID-ATTENUATED INVERSION RECOVERY;METABOLOME;BRONCHOPULMONARY DYSPLASIA;CAROTID INTIMA-MEDIA THICKNESS;FETAL LUNG DEVELOPMENT;INBORN ERRORS OF METABOLISM;LEUKOARAIOSIS;METABOLOMICS;NEONATAL SEPSIS;NEONATOLOGY;PULMONARY HYPOPLASIA;RENAL CELL CARCINOMA;ACUTE GASTROENTERITIS;ADJUVANT CHEMOTHERAPY;ANTIEPILEPTIC DRUGS;BILIRUBIN MEASUREMENT;CARDIOTOCOGRAPHY;CAROTID ARTERY DISSECTION;CAROTID ARTERY STENOSIS;CEREBRAL ANOXIA","3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","BRONCHOPULMONARY DYSPLASIA;CELL CARCINOMA;COLON CANCER;METASTATIC RENAL;PHASE III;RENAL CELL;TOSCA TRIAL;URINARY METABOLOMICS;WALL THICKNESS;ACUTE PYELONEPHRITIS;ADJUVANT CHEMOTHERAPY;ADJUVANT OXALIPLATIN;ADNEX MODEL;ADVANCED STAGE;AGA NEWBORNS;ANTERIOR PITUITARY;ARTERY WALL;AUTOMATED TECHNIQUE;BASED URINE;BENIGN BORDERLINE;BENIGN CONVULSIONS;BIRTH SUGGEST;BOWEL OBSTRUCTION;BPD PRELIMINARY;BRAIN NETWORKS;CANCER COMPLIANCE;CANCER PATIENTS;CAROTID ARTERY;CEREBRAL HYPOXIA;CEREBRAL MICROBLEEDS","2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BENIGN VERSUS;DAWSONS FINGERS;DEEP ENDOMETRIOSIS;ADJUVANT CHEMOTHERAPY;COLON CANCER;DIAGNOSTIC ACCURACY;INTESTINAL INVOLVEMENT;MONTH ARM;MS PATIENTS;NEGATIVE PREDICTIVE;NMOSD PATIENTS;POSTERIOR LOCATIONS;SECONDARY METASTATIC;STAGE II-IV;VERSUS STAGE;ADNEX MODEL;APPROACH BASED;CANCER PATIENTS;COLORECTAL CANCER;COMBINED APPROACH;CURVE AUC;DIAGNOSTIC PERFORMANCE;EVENTS OCCURRED;IMTV POLY;INTRAOBSERVER AGREEMENT;ITT POPULATION;MALIGNANT TUMOURS;METABOLIC PROFILE;NEUROTOXICITY EVENTS;PATIENTS RECRUITED","4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",10,0.29,9.21,6.5,7.25,3,3,5,1,0,1,6.75,0,0,5,0,0,2,5.5,5.75,2,0,0,93.5,93.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,7,334,2.27,1,1,181,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","1;1","CHRONIC LIVER DISEASE AND CIRRHOSIS;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;LIVER DISEASE;PATIENT SAFETY;RARE DISEASES","1;1;1;1;1;1;1","ORAL AND GASTROINTESTINAL","1","5.1 PHARMACEUTICALS;6.1 PHARMACEUTICALS","1;1","LIVER CANCER","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2015,46,9.47826086956522,2.32608695652174,0.260869565217391,0.369565217391304,0.326086956521739,1.52857142857143,1,1.30769230769231,1.15384615384615,0.543478260869565,3,14,21,1,1,0.3,0.46,0.02,0.02,33.65,0.902972689905971,3.11627906976744,0.391304347826087,0.956521739130435,0.457,0.593,0.555,0.576,"LUCA SABA;JASJIT S. SURI;MICHELE ANZIDEI;CARLO CATALANO;VASSILIOS FANOS;MARIO SCARTOZZI;ANDREW NICOLAIDES;SOUMYO BOSE;RICCARDO GIAMPIERI;JOHN R. LAIRD;STEFANO CASCINU;MAURO GIOVANNI CARTA;PIERLEONE LUCATELLI;NOBUTAKA IKEDA;ROBERTO SANFILIPPO;BEATRICE SACCONI;ROBERTO MONTISCI;NILANJAN DEY;LUCA FALOPPI;ALESSANDRO NAPOLI","20;9;7;7;6;6;5;4;4;4;4;4;4;4;4;4;4;3;3;3","LUCA SABA;VASSILIOS FANOS;JASJIT S. SURI;FRANCESCA MANUNZA;CARLO CATALANO;MICHELE ANZIDEI;MARIO SCARTOZZI;ANDREW NICOLAIDES;ROBERTO SANFILIPPO;ROBERTO MONTISCI;BEATRICE SACCONI;PIERLEONE LUCATELLI;SOUMYO BOSE;JOHN R. LAIRD;NOBUTAKA IKEDA;RICCARDO GIAMPIERI;STEFANO CASCINU;MAURO GIOVANNI CARTA;NILANJAN DEY;MICHELE DI MARTINO","3.02;1.68;1.04;1;0.74;0.73;0.62;0.53;0.43;0.43;0.43;0.41;0.41;0.41;0.41;0.35;0.35;0.35;0.34;0.34","LUCA SABA;VASSILIOS FANOS;MARIO SCARTOZZI;MAURO GIOVANNI CARTA;ROBERTO SANFILIPPO;ROBERTO MONTISCI;MARIA FRANCESCA MORO;ELISA PINTUS;FRANCESCO ATZORI;MARIO PIGA;MARIA TERESA IONTA;VALENTINA MASILE;FRANCO CORONELLA;L. ORGIANO;S. GUERRIERO;MICHELE PORCU;ALESSANDRO DESSÌ;FILIPPO CARTA;DAVIDE CRABOLEDDA;VALERIA PUSCEDDU","20;6;6;4;4;4;3;2;2;2;2;1;1;1;1;1;1;1;1;1","LUCA SABA;VASSILIOS FANOS;FRANCESCA MANUNZA;MARIO SCARTOZZI;ROBERTO SANFILIPPO;ROBERTO MONTISCI;MAURO GIOVANNI CARTA;FRANCO CORONELLA;FILIPPO CARTA;PIETRO EMANUELE NAPOLI;MAURIZIO FOSSARELLO;CLARA GEROSA;SARA SIONIS;ROBERTO PUXEDDU;GIOVANNI MARIA SATTA;MARIA FRANCESCA MORO;MARIO PIGA;MAURO PODDA;FRANCESCO MARROSU;ISABELLA RECCIA","3.02;1.68;1;0.62;0.43;0.43;0.35;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.24;0.2;0.2;0.2","A. VOTINO;ARNAUD INSTALLÉ;BART DE MOOR;BERYL R. BENACERRAF;C RASMUSSEN;C. EXACOUSTÒS;C. LANDOLFO;D. TIMMERMAN;DOMINIQUE VAN SCHOUBROECK;E. EPSTEIN;F. LEONE;HANS A.M. BRÖLMANN;L. VALENTIN;MARGIT DUEHOLM;S. GUERRIERO;STEPHAN GORDTS;STEVEN R. GOLDSTEIN;T. BOURNE;T. VAN DEN BOSCH;THOMAS D’HOOGHE","560;560;560;560;560;560;560;560;560;560;560;560;560;560;560;560;560;560;560;560","S. GUERRIERO;LUCA SABA;MARIO SCARTOZZI;MAURO GIOVANNI CARTA;VASSILIOS FANOS;ROBERTO MONTISCI;ROBERTO SANFILIPPO;MARIA DEL ZOMPO;RAFFAELLA ARDAU;ANGELO RESTIVO;FRANCESCO CABRAS;FRANCESCO SCINTU;G. CASULA;IVANA MARIA FRANCESCA COCCO;LUIGI ZORCOLO;ELISABETTA PUXEDDU;FERDINANDO COGHE;GIOVANNI OTTONELLO;MELANIA PUDDU;ADOLFO PISANU","560;401;186;135;132;87;87;64;64;56;56;56;56;56;56;43;43;43;43;37","LUCA SABA;MARIO SCARTOZZI;VASSILIOS FANOS;ROBERTO MONTISCI;ROBERTO SANFILIPPO;MAURO GIOVANNI CARTA;ADOLFO PISANU;ALBERTO CIVOLANI;ALESSANDRA SABA;ANGELICA DESSÌ;ANGELO RESTIVO;ANTONIO PRETI;CHIARA LO GIUDICE;CLARA GEROSA;DAVIDE CRABOLEDDA;ELISA PINTUS;ELISABETTA CONI;ELISABETTA PUXEDDU;ELISABETTA TAMPONI;ENRICO DEMELIA","21;6;6;4;4;3;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;COMPUTER SCIENCE;PHYSICS;BIOLOGY;CHEMISTRY;MATHEMATICS;PSYCHOLOGY;ECONOMICS;PHILOSOPHY;MATERIALS SCIENCE;POLITICAL SCIENCE","44;9;8;6;5;5;5;2;2;1;1","INTERNAL MEDICINE;RADIOLOGY;ARTIFICIAL INTELLIGENCE;NUCLEAR MEDICINE;ONCOLOGY;PATHOLOGY;PSYCHIATRY;SURGERY;BIOCHEMISTRY;CARDIOLOGY;GASTROENTEROLOGY;ENVIRONMENTAL HEALTH;GENETICS;GEOMETRY;QUANTUM MECHANICS;ANATOMY;COMPUTER VISION;ENDOCRINOLOGY;PEDIATRICS;FAMILY MEDICINE;GYNECOLOGY;IMMUNOLOGY;INTENSIVE CARE MEDICINE;OPTICS;PHYSIOLOGY;PSYCHOTHERAPIST;STATISTICS;THERMODYNAMICS","28;18;8;7;7;7;7;7;6;6;5;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2","ULTRASOUND;CANCER;IMAGE (MATHEMATICS);CAROTID ARTERIES;GENE;MAGNETIC RESONANCE IMAGING;BIOPSY;CHEMOTHERAPY;CORRELATION;MENTAL HEALTH;PATTERN RECOGNITION (PSYCHOLOGY);POPULATION;STENOSIS;ALTERNATIVE MEDICINE;ANGIOGRAPHY;BIOMARKER;BLOOD PRESSURE;COHORT;COMPUTED TOMOGRAPHY;CORONARY ARTERY DISEASE;DISEASE;HEPATOCELLULAR CARCINOMA;INCIDENCE (GEOMETRY);LESION;METABOLOMICS;PERCUTANEOUS;RECEIVER OPERATING CHARACTERISTIC;RETROSPECTIVE COHORT STUDY;SEGMENTATION;THYROID","9;7;6;5;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","COLORECTAL CANCER;BREAST CANCER;CAROTID ENDARTERECTOMY;COMMON CAROTID ARTERY;IMAGE QUALITY;INTIMA-MEDIA THICKNESS;SONOGRAPHER;ABDOMINAL AORTIC ANEURYSM;ACOUSTIC RADIATION FORCE;ADENOMYOSIS;ARTERIAL DISEASE;CHEMOTHERAPY REGIMEN;CHRONIC LIVER DISEASE;CLINICAL ENDPOINT;COLOR DOPPLER;COMPUTED TOMOGRAPHY ANGIOGRAPHY;DIASTOLE;DIGITAL WATERMARKING;DISCRETE COSINE TRANSFORM;EMBRYONIC STEM CELL;ENDARTERECTOMY;FATTY LIVER;FETUS;GADOBUTROL;GENOTYPE;GERMLINE;GESTATION;GESTATIONAL AGE;HEMIFACIAL SPASM;HOUNSFIELD SCALE;HUMAN FACTORS AND ERGONOMICS;IMAGE REGISTRATION;IMAGE SEGMENTATION;INJURY PREVENTION;IRBESARTAN;JACCARD INDEX;LACTATE DEHYDROGENASE;LIQUID BIOPSY;LIVER BIOPSY;LOW BACK PAIN;LUMBAR SPINAL STENOSIS;LUNG BIOPSY;MEIBOMIAN GLAND;MENTAL HEALTH CARE;METASTASIS;MUTATION;MYOMETRIUM;NEONATAL SEPSIS;NEURORADIOLOGY;PALSY;PANCREATIC CANCER;PERCUTANEOUS CORONARY INTERVENTION;POWER DOPPLER;RHABDOMYOMA;ROBUSTNESS (EVOLUTION);SEPTIC SHOCK;SORAFENIB;SPINAL CANAL;SPINAL STENOSIS;STRENGTHS AND DIFFICULTIES QUESTIONNAIRE;SUICIDE PREVENTION;SUNITINIB;SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;TARGETED THERAPY;TAURINE;THRESHOLDING;THYROID CANCER;THYROID CARCINOMA;WHITE MATTER","4;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AMNIOTIC FLUID;AXITINIB;CAROTID STENTING;CIRCULATING TUMOR CELL;CLAUDICATION;DNA MISMATCH REPAIR;GERMLINE MUTATION;INDUCED PLURIPOTENT STEM CELL;LEUKOARAIOSIS;LIVER STEATOSIS;NEOADJUVANT THERAPY;NEUROGENIC CLAUDICATION;OSWESTRY DISABILITY INDEX;PRIMARY TUMOR;REGORAFENIB;SCALE-SPACE SEGMENTATION;SINGLE-NUCLEOTIDE POLYMORPHISM;SPINAL CANAL STENOSIS;SUICIDAL IDEATION;SYNKINESIS;TARGET LESION","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;AGED;MIDDLE AGED;ADULT;TOMOGRAPHY, X-RAY COMPUTED;CAROTID ARTERY DISEASES;AGED, 80 AND OVER;CAROTID STENOSIS;RETROSPECTIVE STUDIES;LIVER NEOPLASMS;ANTINEOPLASTIC AGENTS;DECOMPRESSION, SURGICAL;ENDARTERECTOMY, CAROTID;LIVER;TREATMENT OUTCOME;BETA-THALASSEMIA;HEMANGIOENDOTHELIOMA","29;25;23;17;17;16;11;11;9;8;8;8;7;6;6;6;6;6;5;5","DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;EMOTION REGULATION AND PSYCHOPATHOLOGY IN CHILDREN AND ADOLESCENTS;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;DUAL-ENERGY COMPUTED TOMOGRAPHY;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ADVANCES IN ULTRASOUND ELASTOGRAPHY IMAGING TECHNIQUES;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;COLORECTAL CANCER RESEARCH AND TREATMENT;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;COPPER AND ZINC IN HEALTH AND DISEASE;DEVELOPMENTAL ORIGINS OF ADULT HEALTH AND DISEASE;DIAGNOSIS AND MANAGEMENT OF DRY EYE DISEASE;DIAGNOSIS AND MANAGEMENT OF FACIAL PARALYSIS;DIAGNOSIS AND TREATMENT OF DIVERTICULITIS;DIAGNOSIS AND TREATMENT OF LUNG CANCER;DIGITAL IMAGE WATERMARKING TECHNIQUES;EPIDEMIOLOGY AND MANAGEMENT OF BIPOLAR DISORDER;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;EPIDEMIOLOGY AND MANAGEMENT OF NEONATAL SEPSIS","9;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CAROTID ARTERY STENOSIS;ADOLESCENTS;BRACHIAL ARTERY ASSESSMENT;CARDIAC IMAGING;CAROTID INTIMA-MEDIA THICKNESS;COMPUTED TOMOGRAPHY ANGIOGRAPHY;DIFFERENTIATED THYROID CANCER;INTIMA-MEDIA THICKNESS;INTRAVASCULAR ULTRASOUND;MAGNETIC RESONANCE IMAGING;SONOGRAPHER;1000 GENOMES PROJECT;ACOUSTIC RADIATION FORCE;ADENOMYOSIS;ADOLESCENT MENTAL HEALTH;ASCENDING COLON;ASSOCIATION (PSYCHOLOGY);AXITINIB;BACTERIAL MENINGITIS;BETAINE","5;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","CANCER PATIENTS;MENTAL HEALTH;BULB PLAQUE;CAROTID ARTERY;CAROTID ATHEROSCLEROSIS;CAROTID ENDARTERECTOMY;CAROTID ULTRASOUND;COLORECTAL CANCER;PATIENTS RECEIVING;SCHOOL CHILDREN;SYNTAX SCORE;ABDOMINAL AORTIC;ACOUSTIC RADIATION;ADOLESCENT MENTAL;ADULT-TYPE RHABDOMYOMA;ADVANCED GASTRIC;ADVANCED PANCREATIC;AGA NEWBORNS;ANEURYSM PLAQUE;ANGIOGRAPHIC CORONARY;AORTIC ANEURYSM;APHTHOUS STOMATITIS;ARTERY STENOSIS;ASSESSMENT MUSA;ASSESSMENT SYSTEM;ASSOCIATION STUDY;ATHEROSCLEROSIS SYNTAX;ATHEROSCLEROTIC BULB;ATHEROSCLEROTIC ULTRASOUND;AUTOMATED ULTRASOUND","4;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICAL ONCOLOGY;ITALY MEDICAL;ONCOLOGY UNIT;AUTOMATED CIMT;BREAST CANCER;BULB REGION;CAROTID ARTERY;COLORECTAL CANCER;NEUROVASCULAR IMAGING;SYNTAX SCORE;ERROR MM;HR CI;AZIENDA OSPEDALIERO-UNIVERSITARIA;BULB EDGE;CANCER PATIENTS;GBS MENINGITIS;IMAGE QUALITY;LDH SERUM;MENTAL HEALTH;SERUM LEVELS;BULB PLAQUE;GADOBUTROL-ENHANCED MRA;INCOMPLETE FISSURES;LITHIUM TREATMENT;MARIO SCARTOZZI;ONCOLOGY AZIENDA;PANCREATIC CANCER;RISK FACTORS;STATISTICALLY SIGNIFICANT;STEFANO CASCINU","15;13;9;8;8;7;7;7;7;7;6;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4",18,0.39,3.84,6.5,1,0,0,1,0,0,0,8.25,0,0,7.5,0,1,2,2.75,5,3.25,0,0,72.5,72.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,4.5,207,2.94,1,0.5,67.5,0,0,1,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,2,0,2,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES","2;2;1","CANCER;CLINICAL RESEARCH;BREAST CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;ORPHAN DRUG;OVARIAN CANCER;PATIENT SAFETY;RARE DISEASES;VACCINE RELATED","2;2;1;1;1;1;1;1;1","CANCER","2","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS","2;1","BREAST CANCER;OVARIAN CANCER","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2016,40,13.55,3.425,0.375,0.2,0.275,2.10769230769231,1.25,1.6,1.22222222222222,0.625,1,21,11,0,5,0.52,0.28,0,0.12,29.58,0.910475965310349,3.54304635761589,0.425,1,0.432,0.398,0.25,0.381,"LUCA SABA;MARIO SCARTOZZI;VASSILIOS FANOS;ANGELICA DESSÌ;JASJIT S. SURI;L. ORGIANO;GIORGIO ASTARA;ELENA MASSA;CLELIA MADEDDU;VALERIA PUSCEDDU;S. TOLU;ANTONIO NOTO;A. CUBEDDU;R. MASCIA;LAURA DEMURTAS;D. TIMMERMAN;S. GUERRIERO;MARCO PUZZONI;A. C. TESTA;ELIANA LAI","10;9;8;8;7;6;6;6;6;4;4;4;4;4;4;3;3;3;3;3","VASSILIOS FANOS;LUCA SABA;ANGELICA DESSÌ;JASJIT S. SURI;MARIO SCARTOZZI;MAX WINTERMARK;L. ORGIANO;GIORGIO ASTARA;ELENA MASSA;CLELIA MADEDDU;LUCA SABA;ANTONIO NOTO;ANDREW NICOLAIDES;PIERLEONE LUCATELLI;ROBERTO MONTISCI;MICHELE MUSSAP;CLAUDIA FATTUONI;LUIGI BARBERINI;FRANCESCO PALMAS;LUCHINO CHESSA","1.77;1.03;0.75;0.72;0.54;0.37;0.36;0.36;0.36;0.36;0.35;0.34;0.32;0.27;0.27;0.27;0.27;0.27;0.27;0.27","LUCA SABA;MARIO SCARTOZZI;VASSILIOS FANOS;ANGELICA DESSÌ;JASJIT S. SURI;L. ORGIANO;GIORGIO ASTARA;ELENA MASSA;CLELIA MADEDDU;VALERIA PUSCEDDU;S. TOLU;ANTONIO NOTO;A. CUBEDDU;R. MASCIA;LAURA DEMURTAS;S. GUERRIERO;MARCO PUZZONI;ELIANA LAI;G. PUSOLE;ANDREW NICOLAIDES","10;9;8;8;7;6;6;6;6;4;4;4;4;4;4;3;3;3;3;3","VASSILIOS FANOS;LUCA SABA;ANGELICA DESSÌ;JASJIT S. SURI;MARIO SCARTOZZI;L. ORGIANO;GIORGIO ASTARA;ELENA MASSA;CLELIA MADEDDU;LUCA SABA;ANTONIO NOTO;ANDREW NICOLAIDES;ROBERTO MONTISCI;CINZIA BALESTRIERI;G. SERRA;S. TOLU;A. CUBEDDU;R. MASCIA;LAURA DEMURTAS;VALERIA PUSCEDDU","1.77;1.03;0.75;0.72;0.54;0.36;0.36;0.36;0.36;0.35;0.34;0.32;0.27;0.27;0.27;0.26;0.26;0.26;0.23;0.23","LUCA SABA;JASJIT S. SURI;A. C. TESTA;A. ROSSI;ARTUR CZEKIERDOWSKI;BEN VAN CALSTER;C. LANDOLFO;CAROLINE VAN HOLSBEKE;D. FISCHEROVÁ;D. FRANCHI;D. TIMMERMAN;E. EPSTEIN;F. LEONE;IGNACE VERGOTE;J. KAIJSER;L. SAVELLI;L. VALENTIN;LAURE WYNANTS;ROBERT FRUSCIO;S. GUERRIERO","383;288;274;274;274;274;274;274;274;274;274;274;274;274;274;274;274;274;274;274","LUCA SABA;S. GUERRIERO;MAURO GIOVANNI CARTA;MARIO SCARTOZZI;VASSILIOS FANOS;ANGELICA DESSÌ;VALERIA PUSCEDDU;ANTONIO NOTO;ABDULRAJAK BURADI;ANDREW NICOLAIDES;ARUN MAHALINGAM;GIRISH KINI;JASJIT S. SURI;JOHN R. LAIRD;NOBUTAKA IKEDA;TADASHI ARAKI;UDHAV GAWANDALKAR;ANDREA SCHIRRU;GIUSEPPE BORGHERO;LAURA DEMURTAS","362;274;201;150;140;135;107;90;70;70;70;70;70;70;70;70;70;44;35;28","LUCA SABA;ANGELICA DESSÌ;MARIO SCARTOZZI;VASSILIOS FANOS;ANTONIO NOTO;LAURA DEMURTAS;S. GUERRIERO;VALERIA PUSCEDDU;CINZIA BALESTRIERI;G. SERRA;ROBERTO MONTISCI;ABDULRAJAK BURADI;ALESSIO MEREU;ANDREA SCHIRRU;ANDREW NICOLAIDES;ANNA DE MAGISTRIS;ANTONELLA BALESTRIERI;ANTONELLA MAMELI;ARUN MAHALINGAM;B. MASSIDDA","12;8;8;8;4;3;3;3;2;2;2;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;CHEMISTRY;ENGINEERING;PSYCHOLOGY;MATHEMATICS;PHILOSOPHY;SOCIOLOGY","40;9;7;5;4;3;3;1;1;1","INTERNAL MEDICINE;RADIOLOGY;ONCOLOGY;PSYCHIATRY;GASTROENTEROLOGY;CARDIOLOGY;GENETICS;ARTIFICIAL INTELLIGENCE;BIOCHEMISTRY;IMMUNOLOGY;NUCLEAR MEDICINE;CANCER RESEARCH;PATHOLOGY;PHYSIOLOGY;SURGERY;ANESTHESIA;BIOINFORMATICS;CHROMATOGRAPHY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;GYNECOLOGY;INTENSIVE CARE MEDICINE;MECHANICS;NURSING;PEDIATRICS","34;13;9;9;7;6;6;5;5;5;5;4;4;3;3;2;2;2;2;2;2;2;2;2;2","CANCER;CHEMOTHERAPY;ULTRASOUND;GENE;METABOLOMICS;PREGNANCY;ANGIOGENESIS;CAROTID ARTERIES;LYMPHOCYTE;MAGNETIC RESONANCE IMAGING;MELANOMA;METABOLITE;STENOSIS;URINE;ADNEXAL MASS;ADVERSE EFFECT;AMINO ACID;BREAST MILK;COGNITION;COMORBIDITY;CONTRAST (VISION);ELECTROENCEPHALOGRAPHY;HEMODYNAMICS;INTERNAL CAROTID ARTERY;INTERVENTIONAL RADIOLOGY;LOGISTIC REGRESSION;MALIGNANCY;NEUROLOGY;PANCREAS;POPULATION;PULSATILE FLOW;RECEIVER OPERATING CHARACTERISTIC;RETROSPECTIVE COHORT STUDY;SHEAR STRESS;URINARY SYSTEM;VIRUS","10;6;6;5;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","COLORECTAL CANCER;METABOLOME;BEVACIZUMAB;IMMUNOTHERAPY;NEUTROPENIA;COMMON CAROTID ARTERY;DIFFUSION MRI;FETUS;GENOTYPE;HUMAN CYTOMEGALOVIRUS;METASTATIC MELANOMA;NEURORADIOLOGY;NEUTROPHIL TO LYMPHOCYTE RATIO;ADNEXAL DISEASES;AMYOTROPHIC LATERAL SCLEROSIS;BIPOLAR DISORDER;BREAST CANCER;CANCER PAIN;CEREBRAL PERFUSION PRESSURE;CLEAR CELL RENAL CELL CARCINOMA;CLINICAL ENDPOINT;COGNITIVE IMPAIRMENT;COGNITIVE TEST;COMPUTED TOMOGRAPHY ANGIOGRAPHY;CORONARY ANGIOGRAPHY;CORONARY ARTERIES;DIGITAL WATERMARKING;DYNAMIC CONTRAST;EFFECTIVE DIFFUSION COEFFICIENT;EMBRYONIC STEM CELL;ENDOCRINE SYSTEM;EOSINOPHIL;EPIDERMAL GROWTH FACTOR RECEPTOR;EXTERNAL CAROTID ARTERY;FAECALIBACTERIUM PRAUSNITZII;FLUOROURACIL;GAS CHROMATOGRAPHY–MASS SPECTROMETRY;GESTATION;GESTATIONAL AGE;GLUTAMINE;HAZARD RATIO;HEPATIC ENCEPHALOPATHY;INTIMA-MEDIA THICKNESS;LIKELIHOOD RATIOS IN DIAGNOSTIC TESTING;MAJOR DEPRESSIVE DISORDER;MINI-INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW;MOOD DISORDERS;MUTATION;NEUROPSYCHOLOGY;NON-RAPID EYE MOVEMENT SLEEP;ODDS;OPIOID;OVARIAN CANCER;PANCREATIC DUCT;PANCREATIC FISTULA;PERFUSION SCANNING;PERINATAL ASPHYXIA;PHENOTYPE;POLYSOMNOGRAPHY;PROGENITOR CELL;RAPID EYE MOVEMENT SLEEP;REYNOLDS NUMBER;SEROLOGY;SLEEP DISORDER;SLEEP ONSET;SLOW-WAVE SLEEP;SORAFENIB;SPLENECTOMY;STRENGTHS AND DIFFICULTIES QUESTIONNAIRE;SUNITINIB;TAURINE;TOLERABILITY;TUNICA MEDIA;UNIVERSAL PRECAUTIONS;VASCULAR ENDOTHELIAL GROWTH FACTOR;WARFARIN;WHITE MATTER;WILCOXON SIGNED-RANK TEST","5;4;3;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","IPILIMUMAB;OXALIPLATIN;REGORAFENIB;ABSOLUTE NEUTROPHIL COUNT;AMNIOTIC FLUID;CAPECITABINE;CETUXIMAB;DABIGATRAN;DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING;ENTEROENDOCRINE CELL;FEBRILE NEUTROPENIA;GENE MUTATION;GENOTYPING;INDUCED PLURIPOTENT STEM CELL;INTRAUTERINE GROWTH RESTRICTION;INTRAVOXEL INCOHERENT MOTION;K-COMPLEX;KRAS;LEUKOARAIOSIS;MONTREAL COGNITIVE ASSESSMENT;NEUROPSYCHOLOGICAL ASSESSMENT;NIVOLUMAB;OVARIAN TUMOR;OXYCODONE;PAZOPANIB;PHARMACOGENETICS;REM SLEEP BEHAVIOR DISORDER;SEROPREVALENCE;SINGLE-NUCLEOTIDE POLYMORPHISM;THYMIDYLATE SYNTHASE;TRASTUZUMAB","3;3;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;AGED;MIDDLE AGED;ADULT;ANGIOGENESIS INHIBITORS;CARCINOMA, RENAL CELL;ESOPHAGEAL NEOPLASMS;KIDNEY NEOPLASMS;RETROSPECTIVE STUDIES;STOMACH NEOPLASMS;AGED, 80 AND OVER;BONE NEOPLASMS;CAROTID ARTERIES;ITALY;RECEPTOR, ERBB-2;STROKE;TOMOGRAPHY, X-RAY COMPUTED","23;17;11;11;8;8;5;5;5;5;5;5;5;4;4;4;4;4;4;4","ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;BREAST MAGNETIC RESONANCE IMAGING IN ONCOLOGY;CANCER IMMUNOTHERAPY;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCES IN METABOLOMICS RESEARCH;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;ATRIAL FIBRILLATION;CHALLENGES IN PAIN MANAGEMENT AND TREATMENT;CHRONIC CEREBRAL HYPOPERFUSION-RELATED NEURODEGENERATIVE DISEASES;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;COMPUTATIONAL METHODS IN DRUG DISCOVERY;DEVELOPMENTAL ORIGINS OF ADULT HEALTH AND DISEASE;DIAGNOSIS AND TREATMENT OF LUNG CANCER;DIGITAL IMAGE WATERMARKING TECHNIQUES;EMOTION REGULATION AND PSYCHOPATHOLOGY IN CHILDREN AND ADOLESCENTS;EPIDEMIOLOGY AND MANAGEMENT OF CYTOMEGALOVIRUS INFECTION;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD","4;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","METABOLOME;METASTATIC COLORECTAL CANCER;CARDIOVASCULAR RISK ASSESSMENT;CAROTID INTIMA-MEDIA THICKNESS;INBORN ERRORS OF METABOLISM;REGORAFENIB;TUMOR MODELS;ABSOLUTE NEUTROPHIL COUNT;ADNEXAL MASS;CARDIAC IMAGING;CAROTID ARTERY STENOSIS;DIFFUSION-WEIGHTED IMAGING;FOLFOX;INTERVENTIONAL RADIOLOGY;NEURORADIOLOGY;PERFUSION IMAGING;PULSATILE FLOW;ADNEXAL DISEASES;ARTIFICIAL PANCREAS;BETAINE","4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1","CANCER PATIENTS;COLORECTAL CANCER;MELANOMA PATIENTS;METASTATIC COLORECTAL;METASTATIC MELANOMA;STUDY CLINICAL;ADNEXAL MASSES;ANGIOGENESIS GENOTYPING;CARAMEL STUDY;CAROTID ARTERY;CLINICAL OUTCOME;CLINICAL PROGNOSTIC;COMPUTED TOMOGRAPHY;HCMV INFECTION;INTIMA-MEDIA THICKNESS;IPILIMUMAB-RELATED OUTCOME;PRIMARY HCMV;PROGNOSTIC BIOMARKERS;ACCURATE FEATURE;ACUTE HEPATITIS;ADJUVANT CHEMOTHERAPY;ADVANCED RENAL;ANGIOGENESIS PROTOCOL;ANGIOGRAPHY DESIGN;APPARENT DIFFUSION;ARTERY INTRA-PLAQUE;ASPHYXIATED NEWBORNS;ASSESSMENT TEST;ATHEROSCLEROTIC ULTRASOUND;ATTENUATION VARIABILITY","3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CANCER PATIENTS;CLINICAL PRACTICE;PATIENTS TREATED;STATISTICALLY SIGNIFICANT;COLORECTAL CANCER;MULTIVARIATE ANALYSIS;NURSING STUDENTS;OPERATING CHARACTERISTIC;PREVENTIVE MEASURES;RECEIVER OPERATING;SURVIVAL OS;ADNEX MODEL;ADNEXAL MASSES;BLOOD FLOW;CORONARY ARTERIES;DIAGNOSTIC PERFORMANCE;HR CI;IMMATURE TERATOMAS;INCOHERENT MOTION;INTRAVOXEL INCOHERENT;MENTAL HEALTH;METASTATIC COLORECTAL;METASTATIC MELANOMA;ONCOLOGY CENTERS;PERINATAL ASPHYXIA;PROSPECTIVE VALIDATION;REM SLEEP;RS GA;SIGNIFICANT DIFFERENCE;ULTRASOUND FEATURES","7;7;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4",12,0.3,9.69,4.25,5.75,2.5,3,15,1,0,1,4.5,0,0,2.5,0,0,1,6.25,2,1.25,0,0,75.25,75.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,262,1.72,0,0,21,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","1;1","CLINICAL RESEARCH;PATIENT SAFETY","1;1",NA,NA,"7.3 MANAGEMENT AND DECISION MAKING","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2017,47,13.4468085106383,2.34042553191489,0.234042553191489,0.234042553191489,0.212765957446809,1.52777777777778,1.22222222222222,1.375,1.42857142857143,0.531914893617021,0,21,16,1,4,0.45,0.34,0.02,0.09,20.66,0.700917912597522,3.64705882352941,0.361702127659574,0.978723404255319,0.442,0.542,0.516,0.57,"LUCA SABA;JASJIT S. SURI;CLAUDIA MUCCIARINI;MICHELE PORCU;MICHELE ANZIDEI;ROBERTO SANFILIPPO;LUIGI ATZORI;ROBERTO MONTISCI;MARIA TERESA IONTA;S. GUERRIERO;SEBASTIANO BUTI;LUCHINO CHESSA;FRANCESCO FIGORILLI;CINZIA BALESTRIERI;D. TURCI;JUAN LUIS ALCÁZAR;MARCO MARUZZO;GIUSEPPE PROCOPIO;PIERLEONE LUCATELLI;FRANCESCO ATZORI","14;9;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","LUCA SABA;JASJIT S. SURI;PIETRO EMANUELE NAPOLI;MAURIZIO FOSSARELLO;CLAUDIO IOVINO;ROBERTO SANFILIPPO;ROBERTO MONTISCI;MICHELE PORCU;MICHELE ANZIDEI;LUIGI ATZORI;ROBERTA FARCI;PIERLEONE LUCATELLI;LUCHINO CHESSA;FRANCESCO FIGORILLI;CINZIA BALESTRIERI;SIMONA ONALI;G. SERRA;GIOVANNI MARIA ARGIOLAS;FULVIO ZACCAGNA;MAURO PODDA","1.63;1.07;0.58;0.58;0.5;0.48;0.48;0.46;0.42;0.35;0.33;0.32;0.3;0.3;0.3;0.3;0.3;0.27;0.25;0.25","LUCA SABA;MICHELE PORCU;MICHELE ANZIDEI;ROBERTO SANFILIPPO;ROBERTO MONTISCI;MARIA TERESA IONTA;S. GUERRIERO;LUCHINO CHESSA;CINZIA BALESTRIERI;PIERLEONE LUCATELLI;FRANCESCO ATZORI;B. MASSIDDA;G. SERRA;CATERINA CHILLOTTI;PIETRO EMANUELE NAPOLI;ALBERTO BOCCHETTA;MARIO SCARTOZZI;MAURIZIO FOSSARELLO;MARCO FRANCONE;CLAUDIO IOVINO","14;4;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2","LUCA SABA;PIETRO EMANUELE NAPOLI;MAURIZIO FOSSARELLO;CLAUDIO IOVINO;ROBERTO SANFILIPPO;ROBERTO MONTISCI;MICHELE PORCU;MICHELE ANZIDEI;ROBERTA FARCI;PIERLEONE LUCATELLI;LUCHINO CHESSA;CINZIA BALESTRIERI;G. SERRA;MAURO PODDA;ENRICO PEIRETTI;ADOLFO PISANU;RITA SERRA;GIULIA CAMINITI;ALESSANDRA SABA;ANTONIO CAMPANELLA","1.63;0.58;0.58;0.5;0.48;0.48;0.46;0.42;0.33;0.32;0.3;0.3;0.3;0.25;0.25;0.25;0.25;0.25;0.25;0.25","LUCA SABA;JASJIT S. SURI;LUIGI ATZORI;HARMAN S. SURI;ALBERTO BOCCHETTA;CATERINA CHILLOTTI;ABHINAV SREEKUMAR;DAMODAR REDDY EDLA;JOÃO SANCHES;MAINAK BISWAS;RUI TATO MARINHOE;VENKATANARESHBABU KUPPILI;ROBERTO MONTISCI;ROBERTO SANFILIPPO;MICHELE ANZIDEI;ANDREAS REIF;ANDRÉA MURRU;B. MÜLLER‐OERLINGHAUSEN;CYNTHIA CALKIN;DANIELA REGINALDI","436;306;159;137;115;115;108;108;108;108;108;108;105;105;104;93;93;93;93;93","LUCA SABA;CATERINA CHILLOTTI;ROBERTO MONTISCI;ROBERTO SANFILIPPO;MICHELE PORCU;ALICE MASILI;ANGELICA DESSÌ;ANTONIO NOTO;VASSILIOS FANOS;B. MASSIDDA;MARIA TERESA IONTA;MAURO GIOVANNI CARTA;S. GUERRIERO;A. PIRAS;ANTONELLA MURONI;BRUNO PIRAS;FEDERICA SCHIRRU;LORENZO POLIZZI;M. PERNICIANO;MELIS GIAN BENEDETTO","375;115;105;105;65;62;62;62;62;60;59;58;47;45;45;45;45;45;45;45","LUCA SABA;MARIA TERESA IONTA;ROBERTO MONTISCI;ROBERTO SANFILIPPO;B. MASSIDDA;CINZIA BALESTRIERI;FRANCESCO ATZORI;G. SERRA;LUCHINO CHESSA;MICHELE PORCU;S. GUERRIERO;CATERINA CHILLOTTI;MARIO SCARTOZZI;MAURIZIO FOSSARELLO;A. PIRAS;ADOLFO PISANU;ALBERTO BOCCHETTA;ALBERTO CAULI;ALESSANDRA SABA;ALESSANDRO MATHIEU","14;4;4;4;3;3;3;3;3;3;3;2;2;2;1;1;1;1;1;1","MEDICINE;BIOLOGY;COMPUTER SCIENCE;CHEMISTRY;PHYSICS;PSYCHOLOGY;ENGINEERING;MATHEMATICS","45;10;5;3;3;3;2;2","INTERNAL MEDICINE;ONCOLOGY;RADIOLOGY;GASTROENTEROLOGY;SURGERY;PATHOLOGY;CARDIOLOGY;NUCLEAR MEDICINE;PSYCHIATRY;UROLOGY;BIOCHEMISTRY;GENETICS;ARTIFICIAL INTELLIGENCE;BIOINFORMATICS;CANCER RESEARCH;ENVIRONMENTAL HEALTH;OPHTHALMOLOGY;PALEONTOLOGY;ANATOMY;BIOMEDICAL ENGINEERING;ENDOCRINOLOGY;IMMUNOLOGY;MACHINE LEARNING;MECHANICAL ENGINEERING;MICROBIOLOGY;OPTICS;PHARMACOLOGY","37;13;13;10;10;9;8;7;5;5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","CANCER;CONFIDENCE INTERVAL;CHEMOTHERAPY;RECEIVER OPERATING CHARACTERISTIC;COMPUTED TOMOGRAPHY;ADVERSE EFFECT;CREATININE;GENE;RENAL FUNCTION;CREATINE;MAGNETIC RESONANCE IMAGING;MALIGNANCY;METABOLOMICS;POPULATION;PROSPECTIVE COHORT STUDY;RENAL CELL CARCINOMA;THYROID;ADNEXAL MASS;AUTISM;BLOOD PRESSURE;CAROTID ARTERIES;CLINICAL TRIAL;COHORT;CORONARY ARTERY DISEASE;DISEASE;LAPAROSCOPY;LITHIUM (MEDICATION);LUNG CANCER;MANN–WHITNEY U TEST;PATTERN RECOGNITION (PSYCHOLOGY);RANDOMIZED CONTROLLED TRIAL;RECEPTOR;STENOSIS;STROKE (ENGINE);TOMOGRAPHY;ULTRASOUND","12;7;6;6;5;4;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","COLORECTAL CANCER;PROGRESSION-FREE SURVIVAL;GENOTYPE;HAZARD RATIO;HOUNSFIELD SCALE;ADENOCARCINOMA;ADNEXAL DISEASES;AUTISM SPECTRUM DISORDER;CHEMOTHERAPY REGIMEN;COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS;EPIDERMAL GROWTH FACTOR RECEPTOR;FLUOROURACIL;PROGRESSIVE DISEASE;SUNITINIB;WHITE MATTER;ARTERIAL STIFFNESS;AUTOIMMUNE HEPATITIS;BEVACIZUMAB;BIPOLAR DISORDER;BLOOD UREA NITROGEN;BREAST CANCER;BUTYRATE;CANCER PAIN;CAROTID BIFURCATION;CAROTID ENDARTERECTOMY;CEREBELLAR VERMIS;CHOROID PLEXUS;CLINICAL ENDPOINT;COGNITIVE IMPAIRMENT;COGNITIVE TEST;COMPUTED TOMOGRAPHY ANGIOGRAPHY;CONE BEAM COMPUTED TOMOGRAPHY;CONE BEAM CT;CORONARY ARTERY CALCIUM;CORRECTION FOR ATTENUATION;DISCRIMINATION TESTING;DRUG RESISTANT EPILEPSY;EXTREME LEARNING MACHINE;GOITER;GONIOSCOPY;HEAD AND NECK CANCER;HUMAN LEUKOCYTE ANTIGEN;HYPERAEMIA;HYPERINTENSITY;HYPHEMA;IMAGE NOISE;IMAGE QUALITY;IMMUNOTHERAPY;INTERIM ANALYSIS;IONIC BONDING;KIDNEY CANCER;LASER TREATMENT;LEVOTHYROXINE;MAPK/ERK PATHWAY;METASTATIC MELANOMA;MULTIDETECTOR COMPUTED TOMOGRAPHY;MYRTUS COMMUNIS;NEURODEVELOPMENTAL DISORDER;NEUTROPENIA;NEUTROPHIL TO LYMPHOCYTE RATIO;OPIOID;PAIN MEDICINE;PARATHYROID HORMONE;PATHOGENIC BACTERIA;PHASES OF CLINICAL RESEARCH;PHOSPHOCREATINE;PISTACIA LENTISCUS;REACTIVE HYPEREMIA;ROBUSTNESS (EVOLUTION);SYSTEMIC SCLERODERMA;TARGETED THERAPY;TAURINE;THYROID CARCINOMA;THYROID NODULES;THYROIDECTOMY;THYROIDITIS;TOLERABILITY;TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION;UNIVARIATE ANALYSIS;VALINE","6;4;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","OXALIPLATIN;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;PAZOPANIB;AROMATASE;CETUXIMAB;COLONOSCOPY;CONTRAST-TO-NOISE RATIO;CORONARY CALCIUM SCORE;ERLOTINIB;ESTROGEN RECEPTOR;GEFITINIB;HAPLOTYPE;KRAS;LEUKOARAIOSIS;LITHIUM CARBONATE;MEK INHIBITOR;METASTATIC BREAST CANCER;MONTREAL COGNITIVE ASSESSMENT;NIVOLUMAB;OXYCODONE;PAIN LADDER;PHARMACOGENETICS;SINGLE-NUCLEOTIDE POLYMORPHISM;THYMIDYLATE SYNTHASE;TRAMETINIB;VEMURAFENIB","5;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;AGED;MIDDLE AGED;ADULT;CAROTID ARTERIES;AGED, 80 AND OVER;RETROSPECTIVE STUDIES;CAROTID STENOSIS;COMPUTED TOMOGRAPHY ANGIOGRAPHY;ERBB RECEPTORS;METABOLOMICS;ADENOCARCINOMA;BRAIN;BREAST NEOPLASMS;CARCINOMA, NON-SMALL-CELL LUNG;CARCINOMA, PAPILLARY;COLONIC NEOPLASMS","25;22;20;17;16;15;8;8;6;6;5;5;5;5;4;4;4;4;4;4","DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;RENAL CELL CARCINOMA;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;DUAL-ENERGY COMPUTED TOMOGRAPHY;EPIDEMIOLOGY AND MANAGEMENT OF BIPOLAR DISORDER;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;ADVANCES IN METABOLOMICS RESEARCH;AUTISM SPECTRUM DISORDERS;CANCER OF UNKNOWN PRIMARY SITE;CHALLENGES IN PAIN MANAGEMENT AND TREATMENT;COMPLICATIONS AND TECHNIQUES IN THYROID SURGERY;CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS IN BREAST CANCER;DEEP LEARNING IN MEDICAL IMAGE ANALYSIS;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF DRY EYE DISEASE;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION","4;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","TREATMENT;FOLFOX;PROGRESSION-FREE SURVIVAL;CREATINE;DUAL-ENERGY CT;HOUNSFIELD SCALE;MULTI-ENERGY CT;ADNEXAL DISEASES;ADNEXAL MASS;CARDIAC IMAGING;CAROTID INTIMA-MEDIA THICKNESS;CHEMOTHERAPY REGIMEN;COMPUTED TOMOGRAPHY;COMPUTED TOMOGRAPHY ANGIOGRAPHY;FOLFIRI;LIVER BIOPSY;METABOLOMICS;PAZOPANIB;PHARMACOMETABOLOMICS;STROKE (ENGINE)","6;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","CANCER PATIENTS;CARCINOMA MRCC;CELL CARCINOMA;METASTATIC RENAL;RENAL CELL;ADNEXAL MASSES;COLON CANCER;COLORECTAL CANCER;COMPUTED TOMOGRAPHY;CORE-URO- STUDY;FIRST-LINE METASTATIC;IMAGE QUALITY;METABOLOMIC FINGERPRINT;PATIENTS TREATED;RENAL FAILURE;STUDY COMPARISON;TOSCA TRIAL;ACCESS PROGRAM;ACUTE ANGLE-CLOSURE;ADENOCARCINOMA MGA;ADJUVANT CHEMOTHERAPY;ADJUVANT TOSCA;ADJUVANT TREATMENT;ADVANCED BREAST;ADVANCED EGFR-MUTATED;ANCILLARY STUDY;ANGLE-CLOSURE GLAUCOMA;ANTIVIRAL AGENTS;ARGON LASER;ARTERIAL HYPERTENSION","4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","INTRAPLAQUE HEMORRHAGE;LITHIUM TREATMENT;MEDIAN AGE;PERIPHERAL ED;PTS TREATED;ADVERSE EVENTS;CANCER PATIENTS;DISEASE CONTROL;FILTRATION RATE;GLOMERULAR FILTRATION;MONTHS CI;RENAL FUNCTION;STATISTICALLY SIGNIFICANT;SURVIVAL OS;ADVISORY BOARD;BRISTOL-MYERS SQUIB;CONFIDENCE INTERVAL;DRY EYE;FREE SURVIVAL;METASTATIC ORGANS;PATIENTS TREATED;REGRESSION ANALYSIS;RS GA;SURVIVAL PFS;ADJUVANT TREATMENT;ADNEXAL MASSES;CARRIERS FDR;COLON CANCER;COLORECTAL CANCER;CONTROL RATE","10;7;7;7;7;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4",17,0.36,2.5,5,1,1,1,1,1.75,0,0,7,1,0,4,0,0,1.5,2.75,4,1,0,0,67,67,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,2,181.75,6.15,1,0.25,49.5,0,0,1,0,0,0,0,3,0,3,1,0,0,0,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,"Italy;United States","3;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","4;2;1;1;1;1","CLINICAL RESEARCH;AUTOIMMUNE DISEASE;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;BRAIN DISORDERS;LUPUS;PATIENT SAFETY","3;2;2;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM","1","6.1 PHARMACEUTICALS","1","NOT SITE-SPECIFIC CANCER","1",NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2018,31,13,2.12903225806452,0.225806451612903,0.193548387096774,0.387096774193548,1.60975609756098,1,1.2,1.33333333333333,0.67741935483871,0,12,10,3,2,0.39,0.32,0.1,0.06,18.13,0.594233681604236,4.36458333333333,0.451612903225806,0.967741935483871,0.449,0.478,0.429,0.411,"LUCA SABA;S. GUERRIERO;VASSILIOS FANOS;ANTONIO NOTO;E. EPSTEIN;JUAN LUIS ALCÁZAR;MAX WINTERMARK;L. VALENTIN;PIERLEONE LUCATELLI;FRANCESCO ATZORI;CLAUDIO IOVINO;D. FRANCHI;JASJIT S. SURI;VALENTINA CHIAPPA;ANGELICA DESSÌ;D. TIMMERMAN;DOMINIK FLEISCHMANN;ROBERTA PINTUS;M. PASCUAL;A. C. TESTA","9;4;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2","LUCA SABA;CLAUDIO IOVINO;ENRICO PEIRETTI;FABIO SPANU;MAURIZIO FOSSARELLO;PIERLEONE LUCATELLI;JASJIT S. SURI;VASSILIOS FANOS;ANTONIO NOTO;GIAMBERTO CASINI;MAX WINTERMARK;FILIPPO CARTA;NATALIA CHUCHUEVA;CLARA GEROSA;ROBERTO PUXEDDU;ANGELICA DESSÌ;DORIS BARCELLONA;FRANCESCO MARONGIU;S. GUERRIERO;MILENA LUSSU","1.27;0.81;0.67;0.5;0.48;0.42;0.39;0.38;0.38;0.33;0.32;0.31;0.31;0.31;0.31;0.28;0.24;0.24;0.21;0.21","LUCA SABA;S. GUERRIERO;VASSILIOS FANOS;ANTONIO NOTO;FRANCESCO ATZORI;ANGELICA DESSÌ;ROBERTA PINTUS;FILIPPO CARTA;ENRICO PEIRETTI;DORIS BARCELLONA;MAURIZIO FOSSARELLO;CLARA GEROSA;FRANCESCO MARONGIU;ROBERTO PUXEDDU;VALENTINA MASILE;AURORA MARTA OLLA;CINZIA MARIANI;MARIO SCARTOZZI;MARCELLO CAMPAGNA;MAURO GIOVANNI CARTA","9;4;4;4;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1","LUCA SABA;ENRICO PEIRETTI;FABIO SPANU;MAURIZIO FOSSARELLO;VASSILIOS FANOS;ANTONIO NOTO;FILIPPO CARTA;CLARA GEROSA;ROBERTO PUXEDDU;ANGELICA DESSÌ;DORIS BARCELLONA;FRANCESCO MARONGIU;S. GUERRIERO;ROBERTA PINTUS;AURORA MARTA OLLA;FABRIZIO BANDINO;ORAZIO SORBELLO;FRANCESCO LAVRA;ALBERTO CIVOLANI;CINZIA MARIANI","1.27;0.67;0.5;0.48;0.38;0.38;0.31;0.31;0.31;0.28;0.24;0.24;0.21;0.17;0.17;0.17;0.17;0.17;0.17;0.14","LUCA SABA;S. GUERRIERO;JUAN LUIS ALCÁZAR;M. PASCUAL;D. FRANCHI;E. EPSTEIN;L. VALENTIN;VALENTINA CHIAPPA;F. MASCILINI;ANNA MARIA LISCIA;ANNACHIARA CAVAZZANA;ANTJE HAEHNER;ANTONINO CANNAS;ANTONIO NOTO;CARLA MASALA;GIOVANNI DEFAZIO;PAOLO SOLLA;THOMAS HUMMEL;VASSILIOS FANOS;MELANIA PUDDU","237;113;78;77;74;74;74;74;73;72;72;72;72;72;72;72;72;72;72;56","LUCA SABA;S. GUERRIERO;ANTONIO NOTO;VASSILIOS FANOS;MELANIA PUDDU;CLARA GEROSA;FILIPPO CARTA;ROBERTO PUXEDDU;ANGELICA DESSÌ;FRANCESCO ATZORI;ROBERTA PINTUS;AURORA MARTA OLLA;FABRIZIO BANDINO;MARIA ANTONIETTA MARCIALIS;MARIA CRISTINA PINTUS;MAURO GIOVANNI CARTA;VALENTINA MASILE;MARIO SCARTOZZI;MAURIZIO FOSSARELLO;ALBERTO CIVOLANI","237;74;72;72;56;44;44;44;41;36;35;29;29;25;25;25;25;22;18;16","LUCA SABA;ANTONIO NOTO;VASSILIOS FANOS;ANGELICA DESSÌ;FRANCESCO ATZORI;S. GUERRIERO;CLARA GEROSA;ENRICO PEIRETTI;FILIPPO CARTA;MELANIA PUDDU;ROBERTA PINTUS;ROBERTO PUXEDDU;ALBERTO CIVOLANI;AURORA MARTA OLLA;CINZIA MARIANI;DORIS BARCELLONA;ELISA LECIS;FABRIZIO BANDINO;FRANCESCO LAVRA;FRANCESCO MARONGIU","11;4;4;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;MATHEMATICS;PHYSICS;COMPUTER SCIENCE;PSYCHOLOGY;ECONOMICS;ENGINEERING;PHILOSOPHY","31;7;6;6;6;4;4;1;1;1","INTERNAL MEDICINE;RADIOLOGY;SURGERY;CARDIOLOGY;BIOCHEMISTRY;GENETICS;NUCLEAR MEDICINE;ONCOLOGY;OPTICS;PATHOLOGY;PSYCHIATRY;STATISTICS;ENVIRONMENTAL HEALTH;OPHTHALMOLOGY;PALEONTOLOGY;BIOINFORMATICS;CHROMATOGRAPHY;GYNECOLOGY;NEUROSCIENCE;OPERATING SYSTEM;PHYSICAL THERAPY;PHYSIOLOGY","26;12;6;5;4;4;4;4;4;4;4;4;3;3;3;2;2;2;2;2;2;2","CANCER;CAROTID ARTERIES;MANN–WHITNEY U TEST;ULTRASOUND;URINE;COHORT;DISEASE;POPULATION;PREGNANCY;STENOSIS;URINARY SYSTEM;ANGIOGRAPHY;CARCINOMA;CONCORDANCE;CORONARY ARTERY DISEASE;GENE;LARYNX;METABOLITE;METABOLOMICS;MULTIVARIATE ANALYSIS;RENAL CELL CARCINOMA;RETROSPECTIVE COHORT STUDY;SAMPLE (MATERIAL);STAGE (STRATIGRAPHY);STROKE (ENGINE)","6;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","METABOLOME;ATHEROSCLEROTIC CARDIOVASCULAR DISEASE;COMPUTED TOMOGRAPHY ANGIOGRAPHY;FRAMINGHAM RISK SCORE;INTIMA-MEDIA THICKNESS;TRANSCRIPTION FACTOR;UNIVARIATE ANALYSIS;WILCOXON SIGNED-RANK TEST;ABDOMINAL AORTIC ANEURYSM;ANHEDONIA;APATHY;ASPHYXIA NEONATORUM;BEVACIZUMAB;BONE MINERAL;BREAST CANCER;CAROTID ENDARTERECTOMY;CD68;CLEAR CELL RENAL CELL CARCINOMA;CLINICAL ENDPOINT;COGNITIVE IMPAIRMENT;COLORECTAL CANCER;COMMON CAROTID ARTERY;CORNEAL ENDOTHELIUM;CORONARY ANGIOGRAPHY;CORONARY ATHEROSCLEROSIS;CUMULATIVE INCIDENCE;ENDARTERECTOMY;ENDOMETRIAL CANCER;FLUORESCEIN ANGIOGRAPHY;GLOTTIS;HYPOXIC ISCHEMIC ENCEPHALOPATHY;INTER-RATER RELIABILITY;INTERIM ANALYSIS;INTERNAL CONSISTENCY;ISCHEMIC STROKE;KIDNEY CANCER;LARYNGEAL NEOPLASM;LARYNGECTOMY;LARYNGOSCOPY;LEAN BODY MASS;METASTASIS;MOVEMENT DISORDERS;NECK DISSECTION;NEONATAL ENCEPHALOPATHY;NEONATOLOGY;NEPHRECTOMY;NEURORADIOLOGY;NONPROBABILITY SAMPLING;OBSTETRICS AND GYNAECOLOGY;OVARIAN CANCER;PARAPLEGIA;PARKINSON'S DISEASE;PARTIAL THROMBOPLASTIN TIME;PERINATAL ASPHYXIA;PHOSPHOLIPID;RELATIVE RISK;RETINITIS PIGMENTOSA;SORAFENIB;STRENGTHS AND DIFFICULTIES QUESTIONNAIRE;SUNITINIB;TRANSVAGINAL ULTRASOUND;TRIMETHYLAMINE N-OXIDE;UNIVARIATE;WARFARIN","3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","TRANSORAL LASER MICROSURGERY;AFLIBERCEPT;AROMATASE;CIRCULATING TUMOR CELL;DUAL ENERGY;ENDOVASCULAR ANEURYSM REPAIR;KRAS;LACUNAR STROKE;METASTASECTOMY;MONTREAL COGNITIVE ASSESSMENT;NUCLEAR PROTEIN;OXALIPLATIN;PHOSPHATIDYLCHOLINE;REPRESSOR;VITAMIN K ANTAGONIST","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;AGED;RETROSPECTIVE STUDIES;MIDDLE AGED;ENDOMETRIOSIS;OPTIC NERVE DISEASES;ADULT;COMPUTED TOMOGRAPHY ANGIOGRAPHY;METABOLOMICS;CARCINOMA, SQUAMOUS CELL;LARYNGEAL NEOPLASMS;OPTIC DISK;TOMOGRAPHY, X-RAY COMPUTED;ULTRASONOGRAPHY;BRONCHOPULMONARY DYSPLASIA;CASE-CONTROL STUDIES;CHOROID DISEASES","21;15;13;10;9;9;8;7;7;6;6;6;5;5;5;5;5;4;4;4","ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;EPIDEMIOLOGY AND TREATMENT OF HEAD AND NECK CANCER;RENAL CELL CARCINOMA;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ATRIAL FIBRILLATION;BIOMECHANICAL PROPERTIES OF THE CORNEA AND RELATED DISEASES;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS IN BREAST CANCER;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DUAL-ENERGY COMPUTED TOMOGRAPHY;EMOTION REGULATION AND PSYCHOPATHOLOGY IN CHILDREN AND ADOLESCENTS;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;GRANULAR CELL TUMOR: CLINICAL AND PATHOLOGICAL CHARACTERISTICS;GYNECOLOGIC ONCOLOGY;IMPORTANCE OF COGNITIVE ERRORS IN DIAGNOSIS AND STRATEGIES;LIVER CIRRHOSIS AND ASSOCIATED COMPLICATIONS;MOLECULAR MECHANISMS OF RETINAL DEGENERATION AND REGENERATION","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","METABOLOME;ATHEROSCLEROTIC CARDIOVASCULAR DISEASE;CARDIAC IMAGING;CARDIOVASCULAR RISK ASSESSMENT;CAROTID ARTERY STENOSIS;CAROTID INTIMA-MEDIA THICKNESS;COMPUTED TOMOGRAPHY ANGIOGRAPHY;CONCORDANCE;ENDOMETRIAL CARCINOMA;FETAL PROGRAMMING;INTIMA-MEDIA THICKNESS;SAMPLE (MATERIAL);STROKE (ENGINE);TRANSORAL LASER MICROSURGERY;UNIVARIATE ANALYSIS;ADNEXAL MASS;AFLIBERCEPT;ANEURYSM SCREENING;ANHEDONIA;ANTERIOR COMMISSURE","3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1","CELL CARCINOMA;ARTERY IMAGING;ATHEROSCLEROTIC CARDIOVASCULAR;CARDIOVASCULAR DISEASE;CAROTID ARTERY;DISEASE RISK;II STUDY;IMAGING FINDINGS;METASTATIC RENAL;PHASE II;RANDOMIZED PHASE;RENAL CELL;RISK SCORE;TRANSORAL MICROSURGERY;ACCURATE COMPILING;ADIPOCYTE DIFFERENTIATION;ADNEXAL MASSES;ADVANCED BREAST;AGE SUBGLOTTIC;AGREEMENT INTERRATER;AMERICAN HEART;ANTERIOR COMMISSURE;ANTERIOR SEGMENT;ANTICIPATE BPD;ANTICOAGULATION RESULTS;ARTERY PLAQUE;ASSOCIATION ATHEROSCLEROTIC;ASTROCYTIC HAMARTOMAS;AUTOMATED CLOUD-BASED;BALANCING RISKS","3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ASCVD SCORE;PROTHROMBIN TIME;ARTERIAL STENOSIS;TIME RATIO;COLORECTAL CANCER;CONSERVATIVE MANAGEMENT;ELDERLY PATIENTS;MAXIMAL PLAQUE;METASTATIC COLORECTAL;OBS ARM;PATIENTS AGED;PLAQUE THICKNESS;TYPE IVB;URINE SAMPLES;ARTERY IMAGING;ASCVD RISK;CLOT WAVEFORM;COMPUTED TOMOGRAPHY;CORONARY ARTERY;CUMULATIVE INCIDENCE;ENDOMETRIAL CANCER;ENDOMETRIOID CARCINOMAS;IMAGING FINDINGS;INTERRATER RELIABILITY;METABOLIC PROFILES;MULTIVARIATE STATISTICAL;MYASTHENIC SYNDROME;PAPILLARY PROJECTIONS;PERINATAL ASPHYXIA;POSTMENOPAUSAL PATIENTS","11;9;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3",13,0.42,2.1,3,1.5,1,0,1,0,0,0,3,0,0,2,0,0,1,1,1,1,0,0,49,49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,6.75,1560.5,10.53,2,0.5,202.5,0,0,0,1,1,0,0,2,0,2,2,0,0,0,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,"United States","3","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING","3;3;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;PREVENTION;AUTOIMMUNE DISEASE;CANCER;CROHN'S DISEASE;DIGESTIVE DISEASES;INFLAMMATORY BOWEL DISEASE;PEDIATRIC","4;2;2;2;1;1;1;1;1;1","CANCER","1","6.1 PHARMACEUTICALS","3","NOT SITE-SPECIFIC CANCER","1","6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2019,42,14.047619047619,2.33333333333333,0.261904761904762,0.261904761904762,0.380952380952381,1.50769230769231,1.1,1.1,1.23076923076923,0.714285714285714,0,19,9,7,3,0.45,0.21,0.17,0.07,14.26,0.586502072054213,3.85576923076923,0.404761904761905,0.976190476190476,0.357,0.436,0.222,0.44,"LUCA SABA;FRANCESCO ATZORI;VASSILIOS FANOS;GIANLUCA DE RUBEIS;PIERLEONE LUCATELLI;JASJIT S. SURI;S. AJOSSA;VALERIO MAIS;FRANCESCO LAVRA;CARLO CATALANO;MARIO BEZZI;ANTONELLA BALESTRIERI;DANIELE SANTINI;MARIO CORONA;PIER GIORGIO NARDIS;S. GUERRIERO;MIRCO BRAGHIROLI;SARA CORBU;MICHELE PORCU;DOMINIK FLEISCHMANN","11;5;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2","LUCA SABA;VASSILIOS FANOS;PIETRO EMANUELE NAPOLI;MAURIZIO FOSSARELLO;JASJIT S. SURI;PIERLEONE LUCATELLI;FILIPPO CARTA;CINZIA MARIANI;EDOARDO GIOIA;ROBERTO PUXEDDU;MIRCO BRAGHIROLI;CLAUDIO IOVINO;FRANCESCO ATZORI;FRANCESCO LAVRA;VALERIO MAIS;S. AJOSSA;SARA CORBU;ROBERTA PINTUS;FLAMINIA CESARE MARINCOLA;ANGELICA DESSÌ","1.01;0.53;0.45;0.45;0.41;0.37;0.37;0.37;0.37;0.37;0.34;0.34;0.34;0.32;0.31;0.3;0.29;0.29;0.29;0.29","LUCA SABA;FRANCESCO ATZORI;VASSILIOS FANOS;S. AJOSSA;FRANCESCO LAVRA;ANTONELLA BALESTRIERI;S. GUERRIERO;MICHELE PORCU;ROBERTA PINTUS;FILIPPO CARTA;GIULIO MICHELETTI;CINZIA MARIANI;PIETRO EMANUELE NAPOLI;EDOARDO GIOIA;MATTEO PIGA;MARA PERSANO;PAOLO SOLLA;LUIGI ZORCOLO;MAURIZIO FOSSARELLO;ROBERTO SANFILIPPO","11;5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","LUCA SABA;VASSILIOS FANOS;PIETRO EMANUELE NAPOLI;MAURIZIO FOSSARELLO;FILIPPO CARTA;CINZIA MARIANI;EDOARDO GIOIA;ROBERTO PUXEDDU;FRANCESCO ATZORI;FRANCESCO LAVRA;S. AJOSSA;ROBERTA PINTUS;ANGELICA DESSÌ;MELANIA PUDDU;ANTONELLA BALESTRIERI;ALESSANDRA MELONI;MARA PERSANO;MATTEO PIGA;ROBERTO SANFILIPPO;ROBERTO MONTISCI","1.01;0.53;0.45;0.45;0.37;0.37;0.37;0.37;0.34;0.32;0.3;0.29;0.29;0.29;0.28;0.28;0.25;0.22;0.22;0.22","LUCA SABA;PIERLEONE LUCATELLI;VASSILIOS FANOS;JASJIT S. SURI;ANGELO RESTIVO;GIANLUCA DE RUBEIS;GIUSEPPE LANZINO;LUIGI ZORCOLO;ROBERTO MONTISCI;ROBERTO SANFILIPPO;CARLO CATALANO;MARIO BEZZI;MARIO CORONA;PAOLO SOLLA;PIER GIORGIO NARDIS;ALESSANDRO CANNAVALE;FABRIZIO BASILICO;LUCA GINNANI CORRADINI;ANTONELLA BALESTRIERI;FRANCESCO LAVRA","221;87;77;72;64;64;64;64;64;64;61;61;61;61;61;48;48;48;46;46","LUCA SABA;LUIGI ZORCOLO;ROBERTO MONTISCI;ROBERTO SANFILIPPO;PAOLO SOLLA;FRANCESCO LAVRA;MARIA ELENA MALUNE;STEFANO ANGIONI;VASSILIOS FANOS;CRISTINA LODDO;GIOVANNI DEFAZIO;LAURA FADDA;TOMMASO ERCOLI;FRANCESCO ATZORI;ANGELO RESTIVO;MATTEO PIGA;PIETRO EMANUELE NAPOLI;ANTONINO CANNAS;PAOLO TACCONI;FRANCESCO PERNA","150;64;64;64;61;46;45;45;44;40;35;35;35;32;31;30;27;26;26;20","LUCA SABA;FRANCESCO ATZORI;FRANCESCO LAVRA;VASSILIOS FANOS;ALESSANDRA MELONI;ANGELICA DESSÌ;ANTONELLA BALESTRIERI;CINZIA MARIANI;EDOARDO GIOIA;FILIPPO CARTA;LUIGI ZORCOLO;MARA PERSANO;MATTEO PIGA;MELANIA PUDDU;MICHELE PORCU;PAOLO SOLLA;ROBERTA PINTUS;ROBERTO MONTISCI;ROBERTO PUXEDDU;ROBERTO SANFILIPPO","10;5;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;ENGINEERING;PHYSICS;POLITICAL SCIENCE;ART;COMPUTER SCIENCE;MATERIALS SCIENCE;MATHEMATICS","40;10;3;3;2;2;2;1;1;1;1","INTERNAL MEDICINE;RADIOLOGY;SURGERY;CARDIOLOGY;ONCOLOGY;PATHOLOGY;GASTROENTEROLOGY;GENETICS;NUCLEAR MEDICINE;ENVIRONMENTAL HEALTH;BIOCHEMISTRY;GYNECOLOGY;IMMUNOLOGY;OPHTHALMOLOGY;BIOINFORMATICS;CHROMATOGRAPHY;LAW;NEUROSCIENCE;OBSTETRICS;OPTICS;PHYSIOLOGY;PSYCHIATRY;UROLOGY","31;15;10;7;6;6;5;5;5;4;3;3;3;3;2;2;2;2;2;2;2;2;2","CANCER;DISEASE;GENE;CAROTID ARTERIES;CHEMOTHERAPY;MAGNETIC RESONANCE IMAGING;METABOLOMICS;CONFIDENCE INTERVAL;CORONARY ARTERY DISEASE;ENDOMETRIOSIS;PREGNANCY;RENAL CELL CARCINOMA;ALTERNATIVE MEDICINE;ANGIOGRAPHY;CATHETER;COMPUTED TOMOGRAPHY;HEPATOCELLULAR CARCINOMA;HORMONE;ISCHEMIA;NEUROLOGY;ODDS RATIO;POPULATION;RECEIVER OPERATING CHARACTERISTIC;STENOSIS;URINE","9;5;5;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","BREAST CANCER;COLORECTAL CANCER;ATHEROSCLEROTIC CARDIOVASCULAR DISEASE;COMPUTED TOMOGRAPHY ANGIOGRAPHY;CYCLOPHOSPHAMIDE;DOCETAXEL;GENOTYPE;METABOLOME;PARKINSON'S DISEASE;ADENOMYOSIS;ALLELE;APATHY;BASAL (MEDICINE);BONE MINERAL;CABOZANTINIB;CAROTID ENDARTERECTOMY;CATHETER ABLATION;CD34;CD8;CHEMOTHERAPY REGIMEN;CHILDBIRTH;CISPLATIN;COLORECTAL SURGERY;COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS;CONE BEAM COMPUTED TOMOGRAPHY;CORONARY ARTERY CALCIUM;CORONARY ATHEROSCLEROSIS;COST-EFFECTIVENESS ANALYSIS;DIENOGEST;DOBUTAMINE;ENDOCRINE SYSTEM;FETUS;FIXATION (POPULATION GENETICS);GAS CHROMATOGRAPHY–MASS SPECTROMETRY;GESTATIONAL AGE;GLOTTIS;HAZARD RATIO;HOUNSFIELD SCALE;HUMAN GENETICS;HUMAN LEUKOCYTE ANTIGEN;IMAGE QUALITY;IMPRINTING (PSYCHOLOGY);INCLUSION AND EXCLUSION CRITERIA;INTRAPARENCHYMAL HEMORRHAGE;LEUCINE;LIVER FIBROSIS;METABOLIC PATHWAY;METASTASIS;METHIONINE;MYELOFIBROSIS;MYOCARDIAL ISCHEMIA;NEPHRECTOMY;NEURORADIOLOGY;NEUTROPENIA;OCCULT;OVARIAN CANCER;PAPILLARY RENAL CELL CARCINOMAS;PERFUSION SCANNING;PERINATAL PERIOD;PROGESTIN;PROTEOMICS;PROTOCOL (SCIENCE);PYRIFORM SINUS;REVASCULARIZATION;SYSTEMIC MASTOCYTOSIS;T CELL;TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION;VALINE;VITRECTOMY;VOCAL FOLDS","3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EPIRUBICIN;AGATSTON SCORE;ALLELE FREQUENCY;BRONCHOPULMONARY DYSPLASIA;CARBOPLATIN;CAROTID ARTERY DISEASE;CD38;CORONARY CALCIUM SCORE;DISTANT METASTASIS;DUAL ENERGY;EPIRETINAL MEMBRANE;HLA-B27;ISOLEUCINE;LEVODOPA;LYMPHOCYTE SUBSETS;METHYLENETETRAHYDROFOLATE REDUCTASE;OXALIPLATIN;PARS PLANA;PREMATURE RUPTURE OF MEMBRANES;SINGLE-NUCLEOTIDE POLYMORPHISM;TAMOXIFEN;TRASTUZUMAB","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;FEMALE;MALE;MIDDLE AGED;AGED;CARCINOMA, HEPATOCELLULAR;LIVER NEOPLASMS;ADULT;CHEMOEMBOLIZATION, THERAPEUTIC;ENDOMETRIOSIS;LIVER CIRRHOSIS;OVARIAN DISEASES;CAROTID STENOSIS;RETROSPECTIVE STUDIES;ANTIBIOTICS, ANTINEOPLASTIC;CORONARY VESSELS;EPIRUBICIN;MAGNETIC RESONANCE IMAGING;MYOCARDIAL ISCHEMIA","22;20;20;18;16;12;12;12;10;7;7;7;7;6;6;5;5;5;5;5","DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;DIAGNOSIS AND MANAGEMENT OF DRY EYE DISEASE;HEPATOCELLULAR CARCINOMA;RENAL CELL CARCINOMA;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ADVANCES IN METABOLOMICS RESEARCH;BREAST PATHOLOGY AND IMAGING TECHNIQUES;CANCER OF UNKNOWN PRIMARY SITE;CATHETER ABLATION OF CARDIAC ARRHYTHMIAS;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS;CLINICAL MANAGEMENT OF TRACHEAL AND AIRWAY DISORDERS;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;COLORECTAL CANCER RESEARCH AND TREATMENT;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS IN BREAST CANCER;DUAL-ENERGY COMPUTED TOMOGRAPHY;EFFECTS OF BRAIN STIMULATION ON MOTOR CORTEX;EFFECTS OF KETOGENIC DIET ON HEALTH","5;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CARDIAC IMAGING;CARDIOVASCULAR RISK ASSESSMENT;COMPUTED TOMOGRAPHY ANGIOGRAPHY;ATHEROSCLEROTIC CARDIOVASCULAR DISEASE;BRACHIAL ARTERY ASSESSMENT;BREAST CANCER;CAROTID ARTERY STENOSIS;CEREBROVASCULAR EVENTS;ECHOCARDIOGRAPHY;EPIRUBICIN;INTRAOCULAR PRESSURE;METABOLOME;METASTASIS;MRI GUIDANCE;TREATMENT;ADENOMYOSIS;ADNEXAL MASS;AGATSTON SCORE;ANASTOMOTIC LEAKAGE;ANASTROZOLE","4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1","BREAST CANCER;CELL CARCINOMA;COMPUTED TOMOGRAPHY;RENAL CELL;ARTERIAL CHEMOEMBOLIZATION;ARTERY IMAGING;ATHEROSCLEROTIC CARDIOVASCULAR;CANCER PATIENTS;CARDIOVASCULAR DISEASE;CAROTID ARTERY;DEEP ENDOMETRIOSIS;MAGNETIC RESONANCE;METASTATIC RENAL;NMR-BASED METABOLOMICS;PATIENTS TREATED;PILOT STUDY;PRELIMINARY RESULTS;SEX-RELATED DIFFERENCES;TRANSCATHETER ARTERIAL;ADHERENCE RESULTS;ADJUVANT CHEMOTHERAPY;ADOLESCENT BEHAVIOR;ADVANCED BREAST;ADVANCED STAGE;AFFECTS HUMAN;AMBRA STUDIES;AMINO ACIDS;AMINOPEPTIDASES INTERGENIC;ANKYLOSING SPONDYLITIS;ANTERIOR RESECTION","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","INTRAPLAQUE HEMORRHAGE;SLIDING SIGN;TEAR FILM;RS RS;ASCVD RISK;CLINICAL INFORMATION;COMPUTED TOMOGRAPHY;CAROTID ARTERY;CELL CARCINOMA;CEREBROVASCULAR EVENTS;DRY EYE;EYE DROPS;HR CI;IPI PERCENTAGE;PRE-PROCEDURAL SLIM;RA PATIENTS;RENAL CELL;STATISTICALLY SIGNIFICANT;ABC PATIENTS;ASCVD SCORES;BILATERAL INTRAPLAQUE;BREAST CANCER;BRONCHOPULMONARY DYSPLASIA;HEART RATE;HEMORRHAGE VOLUME;IMAGE QUALITY;INDETERMINATE MASSES;INFARCTED MYOCARDIUM;INTRAPLAQUE HEMORRHAGELIPID;IODINE CONCENTRATIONS","13;8;8;7;6;6;6;5;5;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4",19,0.45,3.55,5.5,1,0,0,1,4,0,0,6,1,0,3.5,0,0,1,2.5,3,4,0,0,36.5,36.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,4.25,251.25,6.78,4,1,63,0,0,1,0,3,0,0,0,0,4,0,0,0,0,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,"United States;Italy","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","4;3;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;AUTOIMMUNE DISEASE;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;GENETICS;LIVER CANCER;LIVER DISEASE;PEDIATRIC;PSORIASIS;RARE DISEASES;UROLOGIC DISEASES","4;3;2;1;1;1;1;1;1;1;1;1;1","CANCER;SKIN","1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","4;1","BLADDER CANCER;LIVER CANCER","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,"PUBLIC LIBRARY OF SCIENCE","4","32 BIOMEDICAL AND CLINICAL SCIENCES;49 MATHEMATICAL SCIENCES;3204 IMMUNOLOGY;4905 STATISTICS","2;2;1;1",NA,NA,"INFECTION","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1",NA,NA,"CLINICAL MEDICINE AND SCIENCE","1",NA,NA,NA,NA
"AOUSSN_CAGLIARI",2020,51,13.6274509803922,2.86274509803922,0.313725490196078,0.372549019607843,0.411764705882353,1.53684210526316,1.14285714285714,1.26666666666667,1.23529411764706,0.705882352941177,1,21,18,3,2,0.41,0.35,0.06,0.04,18.06,0.716660747327352,4.98,0.509803921568627,0.96078431372549,0.508,0.455,0.5,0.449,"LUCA SABA;FILIPPO CARTA;VALERIA MARROSU;JASJIT S. SURI;ROBERTO PUXEDDU;SIGITA LESINSKIENĖ;CINZIA MARIANI;ZLATKA MIHOVA;ADINA BITFOI;JOHN R. LAIRD;MATHILDE M. HUSKY;MAURO GIOVANNI CARTA;VIJAY VISWANATHAN;CLARA GEROSA;ROY OTTEN;AMER M. JOHRI;ANTONELLA BALESTRIERI;CEREN KOÇ;GEORGE D. KITAS;MICHELE PORCU","15;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3","ANTONELLA BALESTRIERI;LUCA SABA;VASSILIOS FANOS;FILIPPO CARTA;VALERIA MARROSU;ROBERTO PUXEDDU;CLARA GEROSA;CINZIA MARIANI;JASJIT S. SURI;SIGITA LESINSKIENĖ;ZLATKA MIHOVA;ADINA BITFOI;MATHILDE M. HUSKY;MAURO GIOVANNI CARTA;ROY OTTEN;CEREN KOÇ;DANIELE DE SETA;AMER M. JOHRI;FILIPPO TATTI;ENRICO PEIRETTI","1.34;1.22;0.78;0.65;0.65;0.65;0.53;0.45;0.38;0.37;0.37;0.37;0.37;0.37;0.37;0.37;0.35;0.35;0.33;0.33","LUCA SABA;FILIPPO CARTA;VALERIA MARROSU;ROBERTO PUXEDDU;CINZIA MARIANI;MAURO GIOVANNI CARTA;CLARA GEROSA;ANTONELLA BALESTRIERI;MICHELE PORCU;GIOVANNI DEFAZIO;ALESSANDRO CARRIERO;VASSILIOS FANOS;PAOLA CRIVELLI;DANIELE DE SETA;FRANCESCO ATZORI;DANIELA QUARTU;MAURO PODDA;PIETRO EMANUELE NAPOLI;MARIO SCARTOZZI;GAVINO FAA","15;5;5;5;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2","ANTONELLA BALESTRIERI;LUCA SABA;VASSILIOS FANOS;FILIPPO CARTA;VALERIA MARROSU;ROBERTO PUXEDDU;CLARA GEROSA;CINZIA MARIANI;MAURO GIOVANNI CARTA;DANIELE DE SETA;ENRICO PEIRETTI;FEDERICO MECARINI;GIANGIORGIO CRISPONI;PIETRO EMANUELE NAPOLI;MAURIZIO FOSSARELLO;PAOLA CRIVELLI;GIOVANNI DEFAZIO;ANTONELLA MAMELI;MARIA CRISTINA PINTUS;MARIA ANTONIETTA MARCIALIS","1.34;1.22;0.78;0.65;0.65;0.65;0.53;0.45;0.37;0.35;0.33;0.33;0.33;0.31;0.31;0.29;0.27;0.25;0.25;0.25","LUCA SABA;ALESSANDRO CARRIERO;JASJIT S. SURI;ALESSIO PASCHÈ;PAOLA CRIVELLI;JOHN R. LAIRD;AMER M. JOHRI;ABDELKADER MAHAMMEDI;ACHALA VAGAL;ALESSANDRO PADOVANI;ANDREA ROSSI;BIN ZHANG;ENRICO PREMI;MARY F. GASKILL;MICHELA LEALI;ROBERTO GASPAROTTI;SOMA SENGUPTA;SUHA BACHIR;VIJAY VISWANATHAN;GIANLUCA PELLINO","565;271;260;236;206;178;175;174;174;174;174;174;174;174;174;174;174;174;142;123","LUCA SABA;ABDELKADER MAHAMMEDI;ACHALA VAGAL;ALESSANDRO CARRIERO;ALESSANDRO PADOVANI;ALESSIO PASCHÈ;ANDREA ROSSI;BIN ZHANG;ENRICO PREMI;MARY F. GASKILL;MICHELA LEALI;PAOLA CRIVELLI;ROBERTO GASPAROTTI;SOMA SENGUPTA;SUHA BACHIR;MAURO PODDA;MICHELE PORCU;MAURO GIOVANNI CARTA;ANTONELLA BALESTRIERI;GAVINO FAA","565;174;174;174;174;174;174;174;174;174;174;174;174;174;174;110;69;56;48;46","LUCA SABA;FILIPPO CARTA;ROBERTO PUXEDDU;VALERIA MARROSU;CINZIA MARIANI;MAURO GIOVANNI CARTA;ANTONELLA BALESTRIERI;GIOVANNI DEFAZIO;MICHELE PORCU;CLARA GEROSA;DANIELE DE SETA;FRANCESCO ATZORI;VASSILIOS FANOS;DANIELA QUARTU;GAVINO FAA;MAURO PODDA;MELANIA TATTI;ABDELKADER MAHAMMEDI;ACHALA VAGAL;ALESSANDRA ATZEI","16;5;5;5;4;4;4;3;3;3;3;3;3;2;2;2;2;1;1;1","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PSYCHOLOGY;CHEMISTRY;MATHEMATICS;ECONOMICS;ENGINEERING;PHYSICS;POLITICAL SCIENCE;SOCIOLOGY;GEOGRAPHY","48;8;8;8;4;4;3;3;2;2;2;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;RADIOLOGY;CARDIOLOGY;PSYCHIATRY;GASTROENTEROLOGY;ARTIFICIAL INTELLIGENCE;GENETICS;ONCOLOGY;CLINICAL PSYCHOLOGY;DEVELOPMENTAL PSYCHOLOGY;ENVIRONMENTAL HEALTH;NURSING;PEDIATRICS;ENDOCRINOLOGY;INTENSIVE CARE MEDICINE;MECHANICAL ENGINEERING;NUCLEAR MEDICINE;OPHTHALMOLOGY","34;17;13;11;10;8;6;5;5;5;4;4;4;4;4;3;3;3;3;3","DISEASE;CANCER;EPIDEMIOLOGY;MENTAL HEALTH;POPULATION;BODY MASS INDEX;COHORT;MAGNETIC RESONANCE IMAGING;MYOCARDIAL INFARCTION;OUTBREAK;PATTERN RECOGNITION (PSYCHOLOGY);QUALITY OF LIFE (HEALTHCARE);RANDOMIZED CONTROLLED TRIAL;STROKE (ENGINE);ABDOMINAL SURGERY;ACADEMIC ACHIEVEMENT;ALTERNATIVE MEDICINE;ASYMPTOMATIC;CAROTID ARTERIES;CONFIDENCE INTERVAL;CORRELATION;DEEP LEARNING;DEPRESSION (ECONOMICS);DIABETES MELLITUS;DISSECTION (MEDICAL);GENE;INTERQUARTILE RANGE;KIDNEY DISEASE;LUMBAR;NEUROLOGY;ODDS RATIO;OPTICAL COHERENCE TOMOGRAPHY;OSTEOPOROSIS;PNEUMONIA;PREGNANCY;PUBLIC HEALTH;READING (PROCESS);RENAL CELL CARCINOMA;RETROSPECTIVE COHORT STUDY;STENOSIS;THROMBOSIS;THYROID;ULTRASOUND;URINARY SYSTEM","15;9;5;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","INFECTIOUS DISEASE (MEDICAL SPECIALTY);IMMUNOTHERAPY;2019-20 CORONAVIRUS OUTBREAK;BREAST CANCER;COLORECTAL CANCER;CORONARY ANGIOGRAPHY;GENOTYPE;HYPERINTENSITY;METASTASIS;NEURORADIOLOGY;WHITE MATTER;ANAPHYLAXIS;ANHEDONIA;ANTIPHOSPHOLIPID SYNDROME;APATHY;AUTOIMMUNE DISEASE;BACTERIOCIN;BENIGN PAROXYSMAL POSITIONAL VERTIGO;BIOFILM;BIRTH ORDER;BLADDER CANCER;BRAIN SIZE;C-REACTIVE PROTEIN;CASE FATALITY RATE;CHOLECYSTITIS;CLINICAL ENDPOINT;COLORECTAL SURGERY;COMMON CAROTID ARTERY;COPPER METABOLISM;DIGITAL ENHANCED CORDLESS TELECOMMUNICATIONS;DORMANCY;ENDOCRINE SURGERY;EPICARDIAL FAT;EPIGENETICS;FRAMINGHAM RISK SCORE;GENE EXPRESSION;GESTATIONAL AGE;HAZARD RATIO;HISTIOCYTOSIS;HUMAN FACTORS AND ERGONOMICS;INJURY PREVENTION;ISCHEMIC STROKE;KERATOCONUS;LARYNGECTOMY;LOW BACK PAIN;MENTAL ILLNESS;METABOLOME;MUTATION;NECK DISSECTION;NEPHRECTOMY;NEUTROPHIL TO LYMPHOCYTE RATIO;OPIOID;OSTEOARTHRITIS;PARKINSON'S DISEASE;PAROTIDECTOMY;PERCUTANEOUS CORONARY INTERVENTION;PERINEURAL INVASION;PHENOTYPE;PREVALENCE;PROBIOTIC;RANDOMIZATION;RECURRENT LARYNGEAL NERVE;REGENERATIVE MEDICINE;SEROSITIS;SOCIOECONOMIC STATUS;SORAFENIB;STEM-CELL THERAPY;STRENGTHS AND DIFFICULTIES QUESTIONNAIRE;STREPTOCOCCUS;STREPTOCOCCUS MUTANS;STROMA;SUICIDE PREVENTION;T-STAGE;TYPE 2 DIABETES;TYPE 2 DIABETES MELLITUS;VITAMIN D DEFICIENCY;VITRECTOMY","9;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CORONAVIRUS DISEASE 2019 (COVID-19);ADJUVANT CHEMOTHERAPY;APGAR SCORE;BIORESORBABLE SCAFFOLD;BREAST SURGERY;CONNECTIVE TISSUE DISEASE;DNA METHYLATION;ERDHEIM–CHESTER DISEASE;FIRSTBORN;FRACTIONAL FLOW RESERVE;IPILIMUMAB;KOUNIS SYNDROME;LACTOBACILLUS SALIVARIUS;LEVODOPA;LYMPHOVASCULAR INVASION;METASTASECTOMY;NIVOLUMAB;OSWESTRY DISABILITY INDEX;OXALIPLATIN;OXYCODONE;PEMBROLIZUMAB;PHARMACOGENETICS;SEED DORMANCY;STREPTOCOCCUS INTERMEDIUS;STREPTOCOCCUS SALIVARIUS;STREPTOCOCCUS SANGUINIS;STROKE RISK;TAPENTADOL;TARGET LESION;UROTHELIAL CANCER;UROTHELIAL CARCINOMA;VITREORETINAL SURGERY","9;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;MIDDLE AGED;ITALY;ADULT;AGED;CORONARY ARTERY DISEASE;CORONARY STENOSIS;COVID-19;PREDICTIVE VALUE OF TESTS;LUPUS ERYTHEMATOSUS, SYSTEMIC;POSTOPERATIVE COMPLICATIONS;RECTAL NEOPLASMS;RENAL INSUFFICIENCY, CHRONIC;RETROSPECTIVE STUDIES;SARS-COV-2;TOMOGRAPHY, OPTICAL COHERENCE;ANASTOMOSIS, SURGICAL","33;18;14;13;9;8;6;6;6;6;5;5;4;4;4;4;4;4;4;3","ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;APPLICATIONS OF DEEP LEARNING IN MEDICAL IMAGING;BIOMECHANICAL PROPERTIES OF THE CORNEA AND RELATED DISEASES;COPPER AND ZINC IN HEALTH AND DISEASE;INFLAMMATION'S ROLE IN CANCER DEVELOPMENT AND PROGRESSION;RENAL CELL CARCINOMA;;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ADVANCES IN METABOLOMICS RESEARCH;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;BULLYING BEHAVIORS AND PSYCHOLOGICAL IMPACT;CEREBELLAR CONTRIBUTIONS TO NEUROLOGICAL DISORDERS AND FUNCTIONS;CLASSIFICATION AND TREATMENT OF HISTIOCYTIC DISORDERS;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;COLORECTAL CANCER RESEARCH AND TREATMENT;DENTAL IMPLANTOLOGY AND PERI-IMPLANT DISEASES;DIAGNOSIS AND MANAGEMENT OF APPENDICITIS;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;DIAGNOSIS AND TREATMENT OF BLADDER CANCER","3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","CARDIAC IMAGING;CARDIOVASCULAR RISK ASSESSMENT;COMPUTED TOMOGRAPHY ANGIOGRAPHY;PANDEMIC;STROKE (ENGINE);2019-20 CORONAVIRUS OUTBREAK;CAROTID INTIMA-MEDIA THICKNESS;CORNEAL BIOMECHANICS;CORNEAL THICKNESS;CT SCAN;DEPRESSION (ECONOMICS);INTERQUARTILE RANGE;NEURORADIOLOGY;NEUTROPHIL-TO-LYMPHOCYTE RATIO;OPTICAL COHERENCE TOMOGRAPHY;PNEUMONIA DETECTION;TREATMENT;ADJUVANT CHEMOTHERAPY;ADOLESCENT MENTAL HEALTH;ANHEDONIA","4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1","CELL CARCINOMA;MENTAL HEALTH;CARCINOMA PATIENTS;CAROTID PLAQUE;COHERENCE TOMOGRAPHY;INFLAMMATION INDEX;MACHINE LEARNING;METASTATIC RENAL;OPTICAL COHERENCE;PATIENTS TREATED;RENAL CELL;RISK STRATIFICATION;SCHOOL CHILDREN;SELF-REPORTED MENTAL;VERTEBRAL BODY;ABDOMINAL PAIN;ABSORB LONG-TERM;ACADEMIC ACHIEVEMENTRESULTS;ACIE APPY;ACUTE APPENDICITIS;ADJUVANT CHEMOTHERAPY;ADVANCED URINARY;AJCC TNM;ANGIOGRAPHY SCORES;ANIMAL MODEL;ANTERIOR RESECTION;APPY STUDY;ARTERIOSUS ANTICIPATES;ARTERY DISEASE;ARTIFICIAL INTELLIGENCE","3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","RELEVANT RELATIONSHIPS;COVID- PNEUMONIA;MENTAL HEALTH;CORONAVIRUS DISEASE;DE LA;CROSSREF MEDLINE;MEDLINE GOOGLE;HOSPITALIZED PATIENTS;LINK GOOGLE;PULMONARY VASCULAR;DISEASE COVID-;DUAL-ENERGY CT;GENDER GAP;LA PANDEMIA;NEUROLOGIC IMAGING;PUBLISHED ONLINE;STATISTICALLY SIGNIFICANT;AL PULMONARY;AOR CI;BIOFILM FORMATION;DE LOS;DR BALESTRIERI;FAT DENSITY;PERIVASCULAR FAT;SCHOOL CHILDREN;UPDATED DF;WHITE MATTER;ARTICLE DISCLOSED;CONTRAST PLAQUE;COVID- PATIENTS","26;19;14;12;12;11;11;9;9;9;7;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6;5;5;5",28,0.55,2.7,5,1,1,0,8.5,0,0,0,5,0,0,4,0,0,1.25,9.5,2.25,3.5,0,0,41.5,41.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,7,436,2.13,2,1,285,0,0,0,0,2,0,0,0,0,2,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,"United States","2","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","2;2;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;AUTOIMMUNE DISEASE;CANCER;CROHN'S DISEASE;DIGESTIVE DISEASES;INFLAMMATORY BOWEL DISEASE;LUNG;LUNG CANCER;PREVENTION","2;2;1;1;1;1;1;1;1;1","CANCER;ORAL AND GASTROINTESTINAL","1;1","6.1 PHARMACEUTICALS","2","LUNG CANCER","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_CAGLIARI",2021,76,18.2236842105263,2.69736842105263,0.368421052631579,0.302631578947368,0.355263157894737,1.70833333333333,1.55555555555556,1.4375,1.5,0.671052631578947,0,34,23,2,2,0.45,0.3,0.03,0.03,27.8,1.80294091142599,5.69078947368421,0.513157894736842,0.973684210526316,0.453,0.484,0.526,0.543,"LUCA SABA;JASJIT S. SURI;AMER M. JOHRI;ANDREW NICOLAIDES;MAURO PODDA;JOHN R. LAIRD;MANNUDEEP K. KALRA;ALESSANDRO CARRIERO;ANTONELLA MURONI;TOMMASO ERCOLI;GEORGE D. KITAS;GIOVANNI DEFAZIO;ALESSIO PASCHÈ;LUCA SABA;RICCARDO CAU;NARENDRA N. KHANNA;ZENO FALASCHI;FERDINANDO AGRESTA;SUNEET GUPTA;MAURO GIOVANNI CARTA","23;17;11;10;8;8;8;7;7;7;6;6;6;6;5;5;5;5;5;5","LUCA SABA;JASJIT S. SURI;ANTONELLA MURONI;AMER M. JOHRI;ANDREW NICOLAIDES;GIOVANNI DEFAZIO;TOMMASO ERCOLI;GIOVANNI DEFAZIO;RICCARDO CAU;JOHN R. LAIRD;LUCA SABA;ALESSANDRO CARRIERO;MANNUDEEP K. KALRA;CARLA MASALA;PAOLO SOLLA;GIANNI OROFINO;MAURO PODDA;VIJAYA KUMAR KOPPULA;SIVA SKANDHA SANAGALA;SUNEET GUPTA","2.01;1.64;0.88;0.88;0.83;0.76;0.7;0.69;0.67;0.54;0.53;0.52;0.46;0.43;0.43;0.43;0.43;0.42;0.42;0.41","LUCA SABA;MAURO PODDA;ANTONELLA MURONI;GIOVANNI DEFAZIO;ALESSIO PASCHÈ;LUCA SABA;RICCARDO CAU;MAURO GIOVANNI CARTA;ADOLFO PISANU;CHIARA D. ARRU;ANTONELLA BALESTRIERI;GIOVANNI DEFAZIO;FERNANDA VELLUZZI;ANDREA LOVISELLI;PIETRO GIORGIO CALÒ;GAVINO FAA;PIETRO DANNA;ALBERTO CAULI;MARIA MARGHERITA SECHI;MARTA COLUMBU","23;8;7;6;6;6;5;5;5;5;5;5;4;4;4;4;3;3;3;3","LUCA SABA;ANTONELLA MURONI;GIOVANNI DEFAZIO;GIOVANNI DEFAZIO;RICCARDO CAU;LUCA SABA;GIANNI OROFINO;MAURO PODDA;GIULIA PRIMICERIO;CHIARA D. ARRU;ALESSIO PASCHÈ;MAURO GIOVANNI CARTA;MARIA MARGHERITA SECHI;FERNANDA VELLUZZI;ANDREA LOVISELLI;MAURIZIO FOSSARELLO;FILIPPO CARTA;CINZIA MARIANI;GLORIA CAREDDA;VALERIA MARROSU","2.01;0.88;0.76;0.69;0.67;0.53;0.43;0.43;0.39;0.39;0.38;0.38;0.36;0.34;0.34;0.33;0.31;0.31;0.31;0.31","LUCA SABA;JASJIT S. SURI;ANDREW NICOLAIDES;AMER M. JOHRI;CLELIA MADEDDU;CARLA RIPAMONTI;CHRISTINE BALDWIN;FLORIAN STRASSER;JANN ARENDS;LOREDANA BUONACCORSO;M.A.E. DE VAN DER SCHUEREN;MARTIN CHASEN;PAULA RAVASCO;SILVIA GONELLA;TORA S. SOLHEIM;ANDREA LOVISELLI;FERNANDA VELLUZZI;JOHN R. LAIRD;ALBERTO CAULI;ALDO MANZIN","808;719;438;415;297;294;294;294;294;294;294;294;294;294;294;289;289;287;248;236","LUCA SABA;CLELIA MADEDDU;ALDO MANZIN;EMANUELA CASULA;SARAH VASCELLARI;SILVIA PISANU;VANESSA PALMAS;VERONICA MADAU;ALBERTO CAULI;MAURO PODDA;RICCARDO CAU;ANTONELLA BALESTRIERI;MARTA COLUMBU;CHIARA D. ARRU;ADOLFO PISANU;FRANCESCA PIGLIARU;E. LONGONI;GLORIA CAREDDA;MAURIZIO FOSSARELLO;GIOVANNI DEFAZIO","808;297;236;236;236;236;236;236;216;152;126;89;85;82;77;61;60;57;57;55","LUCA SABA;MAURO PODDA;ANTONELLA MURONI;RICCARDO CAU;ADOLFO PISANU;ANTONELLA BALESTRIERI;CHIARA D. ARRU;GIOVANNI DEFAZIO;MARTA COLUMBU;MAURO GIOVANNI CARTA;ALBERTO CAULI;ANDREA LOVISELLI;ANDREA PRETTA;ANGELICA DESSÌ;CINZIA MARIANI;CLELIA DONISI;CLELIA MADEDDU;ENRICO ERDAS;FERNANDA VELLUZZI;FILIPPO CARTA","28;8;7;5;4;4;4;4;3;3;2;2;2;2;2;2;2;2;2;2","MEDICINE;COMPUTER SCIENCE;BIOLOGY;PHYSICS;SOCIOLOGY;ENGINEERING;MATHEMATICS;PSYCHOLOGY;GEOGRAPHY;POLITICAL SCIENCE;BUSINESS;CHEMISTRY;MATERIALS SCIENCE;PHILOSOPHY;ENVIRONMENTAL SCIENCE;HISTORY","74;19;8;8;6;5;5;5;3;3;2;2;2;2;1;1","INTERNAL MEDICINE;RADIOLOGY;PATHOLOGY;SURGERY;ARTIFICIAL INTELLIGENCE;PSYCHIATRY;CARDIOLOGY;NUCLEAR MEDICINE;ENVIRONMENTAL HEALTH;IMMUNOLOGY;MACHINE LEARNING;GENERAL SURGERY;VIROLOGY;MECHANICAL ENGINEERING;OPTICS;INTENSIVE CARE MEDICINE;PHYSICAL THERAPY;STATISTICS;CLINICAL PSYCHOLOGY;DEMOGRAPHY;DERMATOLOGY;ENDOCRINOLOGY;GENETICS;LAW;MICROBIOLOGY;NEUROSCIENCE;ONCOLOGY;OPERATING SYSTEM;PEDIATRICS","54;23;18;17;13;12;9;9;8;7;7;6;6;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3","DISEASE;OUTBREAK;DEEP LEARNING;POPULATION;CANCER;MAGNETIC RESONANCE IMAGING;PATTERN RECOGNITION (PSYCHOLOGY);RETROSPECTIVE COHORT STUDY;COMPUTED TOMOGRAPHY;INCIDENCE (GEOMETRY);LUNG;PNEUMONIA;SEGMENTATION;STROKE (ENGINE);ULTRASOUND;ANGIOGRAPHY;APPENDICITIS;EPIDEMIOLOGY;RECEIVER OPERATING CHARACTERISTIC;ANTIBODY;ARTIFICIAL NEURAL NETWORK;ASYMPTOMATIC;CAROTID ARTERIES;COHORT;COMPLICATION;GROUND TRUTH;INTERNAL CAROTID ARTERY;LOGISTIC REGRESSION;OBSERVATIONAL STUDY;OLFACTION;PROSPECTIVE COHORT STUDY;RANDOMIZED CONTROLLED TRIAL","26;9;8;8;7;7;6;6;5;5;5;5;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","INFECTIOUS DISEASE (MEDICAL SPECIALTY);2019-20 CORONAVIRUS OUTBREAK;COLORECTAL CANCER;BREAST CANCER;CARDIAC MAGNETIC RESONANCE;CARDIAC MAGNETIC RESONANCE IMAGING;COMMON CAROTID ARTERY;IMMUNOTHERAPY;NEURORADIOLOGY;PARKINSON'S DISEASE;PROTOCOL (SCIENCE);THYROID CANCER;THYROIDITIS;UNIVARIATE ANALYSIS;16S RIBOSOMAL RNA;ABDOMINAL AORTA;ABDOMINAL AORTIC ANEURYSM;AMYOTROPHIC LATERAL SCLEROSIS;AORTIC ANEURYSM;APATHY;AUTOANTIBODY;AUTOIMMUNITY;BACTEROIDACEAE;BACTEROIDES;BASAL (MEDICINE);BEVACIZUMAB;BICUSPID AORTIC VALVE;CACHEXIA;CAESAREAN SECTION;CARDIOMYOPATHY;CAROTID ENDARTERECTOMY;CD20;CHILD PSYCHOPATHOLOGY;CHILDBIRTH;COGNITIVE IMPAIRMENT;COMPUTED TOMOGRAPHY ANGIOGRAPHY;CROSS ENTROPY;DEMENTIA;DIGITAL SUBTRACTION ANGIOGRAPHY;DORMANCY;DRUG RESISTANT EPILEPSY;EUBACTERIUM;EUTHYROID;FEATURE TRACKING;GERIATRIC ONCOLOGY;HAZARD RATIO;HIPPURIC ACID;HOUNSFIELD SCALE;HUNTINGTON'S DISEASE;HYPERAEMIA;HYPERINTENSITY;ICTAL;IMMUNOGENICITY;INJURY PREVENTION;INTRACLASS CORRELATION;ISCHEMIC STROKE;LARYNGECTOMY;LEUKOENCEPHALOPATHY;LIQUID BIOPSY;MAGNETIC RESONANCE ANGIOGRAPHY;MECHANICAL HEART-VALVE;METABOLOME;MULTICENTER STUDY;NEUROMYELITIS OPTICA;PI3K/AKT/MTOR PATHWAY;PITUITARY GLAND;POLYDIPSIA;POLYURIA;POPULATION AGEING;POSTERIOR POLE;PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;PULMONARY ANGIOGRAPHY;PULMONARY SARCOIDOSIS;RITUXIMAB;RUMINOCOCCUS;STREPTOCOCCUS;SUICIDE PREVENTION;TASTE DISORDER;TAURINE;THYROIDECTOMY;TOCILIZUMAB;TORTUOSITY;TYROSINE KINASE;ULCERATIVE COLITIS;UNIVARIATE;VAGINAL DELIVERY;VITRECTOMY;WARFARIN;WHITE MATTER","20;9;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CORONAVIRUS DISEASE 2019 (COVID-19);MOTOR SYMPTOMS;NIVOLUMAB;ABATACEPT;ANTI-THYROID AUTOANTIBODIES;BACTEROIDETES;CANCER CACHEXIA;CETUXIMAB;CORDECTOMY;ENDOVASCULAR ANEURYSM REPAIR;EPIRETINAL MEMBRANE;FIRMICUTES;FRONTOTEMPORAL DEMENTIA;HYPOPHYSITIS;IRINOTECAN;KRAS;MACULAR HOLE;METASTATIC BREAST CANCER;PTEN;REM SLEEP BEHAVIOR DISORDER;SEED DORMANCY;SLOW VIRUS;STROKE RISK;SUICIDAL IDEATION;SULFASALAZINE;VEILLONELLA;VITAMIN K ANTAGONIST","20;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;COVID-19;MALE;ITALY;FEMALE;AGED;SARS-COV-2;MIDDLE AGED;RETROSPECTIVE STUDIES;TOMOGRAPHY, X-RAY COMPUTED;LUNG;ADULT;CAROTID ARTERIES;AGED, 80 AND OVER;APPENDICITIS;ARTIFICIAL INTELLIGENCE;CAROTID ARTERY, INTERNAL;DEEP LEARNING;EUROPE","39;37;16;15;14;13;12;11;10;10;9;8;7;6;5;5;5;5;5;5","DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;APPLICATIONS OF DEEP LEARNING IN MEDICAL IMAGING;DIAGNOSIS AND MANAGEMENT OF APPENDICITIS;OLFACTORY DYSFUNCTION IN HEALTH AND DISEASE;ADVANCES IN METABOLOMICS RESEARCH;GLIOMAS;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;PATHOPHYSIOLOGY AND CLINICAL CHARACTERISTICS OF STRESS-INDUCED CARDIOMYOPATHY;RHEUMATOID ARTHRITIS;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;AIRBORNE TRANSMISSION OF RESPIRATORY VIRUSES;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;ATRIAL FIBRILLATION;BULLYING BEHAVIORS AND PSYCHOLOGICAL IMPACT;CEREBELLAR CONTRIBUTIONS TO NEUROLOGICAL DISORDERS AND FUNCTIONS;CHALLENGES AND INNOVATIONS IN BIOINFORMATICS EDUCATION;COGNITIVE MECHANISMS OF ANXIETY AND DEPRESSION;COLORECTAL CANCER RESEARCH AND TREATMENT;COPPER AND ZINC IN HEALTH AND DISEASE;CORONAVIRUS DISEASE 2019 RESEARCH","8;6;4;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","2019-20 CORONAVIRUS OUTBREAK;PANDEMIC;CAROTID INTIMA-MEDIA THICKNESS;CARDIAC IMAGING;STROKE (ENGINE);COMPUTED TOMOGRAPHY ANGIOGRAPHY;APPENDICITIS;CARDIOVASCULAR RISK ASSESSMENT;CT SCREENING;DUAL-ENERGY CT;GROUND TRUTH;OLFACTORY DYSFUNCTION;PNEUMONIA DETECTION;TRANSFER LEARNING;;ARTERIAL STIFFNESS;ARTIFICIAL INTELLIGENCES;BETACORONAVIRUS;BRAIN TUMOR EPIDEMIOLOGY;CARDIAC MAGNETIC RESONANCE","8;8;7;6;5;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2","ARTIFICIAL INTELLIGENCE;COMPUTED TOMOGRAPHY;DEEP LEARNING;CAROTID ULTRASOUND;HYBRID DEEP;INTELLIGENCE MODELS;ITALIAN SOCIETY;ACUTE APPENDICITIS;CAROTID ARTERY;COVID- PANDEMIC;COVID- PNEUMONIA;LEARNING PARADIGM;LUNG SEGMENTATION;PLAQUE TISSUE;SARDINIA ITALY;TISSUE CHARACTERIZATION;ACTUAA PROSPECTIVE;APPENDECTOMY VERSUS;ATHEROSCLEROTIC PLAQUE;CLOUD STUDY;CONSERVATIVE TREATMENT;CONTROLLED TRIAL;COVID- COMPUTED;COVID- PATIENTS;CT FINDINGS;DOMINANT SUBTYPE;ELEMENTARY SCHOOL;ENDOSCOPIC SURGERY;HUNTINGTONS DISEASE;INTERNAL CAROTID","6;6;6;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CHEST CT;COVID- PNEUMONIA;CT LUNG;DEEP LEARNING;FILLING DEFECTS;COMPUTED TOMOGRAPHY;COVID- PATIENTS;KRAS GC;TOMOGRAPHY CT;AI MODELS;GROUND-GLASS OPACITIES;LUNG SEGMENTATION;RHEUMATOID ARTHRITIS;SEVERITY SCORE;ARTERIAL FILLING;ARTIFICIAL INTELLIGENCE;CAROTID ARTERY;COVLIAS HDL;CT SEVERITY;ENDOTHELIAL FUNCTION;INTRALUMINAL THROMBUS;LUNG SEVERITY;PULMONARY OPACITIES;UNSEEN AI;ACADEMIC PUBMED;ARTERY STENOSIS;B-CELL POOR;CLINICAL OUTCOMES;CLINICAL PRACTICE;CORONAVIRUS DISEASE","15;14;14;13;10;9;8;8;8;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5",46,0.61,7.56,6,1,1.5,0,2.75,1,0,0,8,1,0,6.25,0,0,1.25,5,7,2.5,0,0,56,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,4.4,375.4,4.81,4,0.8,78.8,0,0,1,0,0,0,1,3,0,2,3,0,0,0,0,0,0,5,0,0,5,0,0,0,0,0,0,0,0,0,"United States;Japan","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE","5;3;1;1;1","CLINICAL RESEARCH;RARE DISEASES;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;ARTHRITIS;AUTOIMMUNE DISEASE;AGING;ASSISTIVE TECHNOLOGY;BIOENGINEERING;BRAIN DISORDERS;CANCER;CARDIOVASCULAR;DIGESTIVE DISEASES;HEART DISEASE;LIVER CANCER;LIVER DISEASE;NEURODEGENERATIVE;NEUROSCIENCES;PARKINSON'S DISEASE;PATIENT SAFETY;PSORIASIS","5;4;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;CARDIOVASCULAR;NEUROLOGICAL","2;1;1","6.1 PHARMACEUTICALS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.2 CELLULAR AND GENE THERAPIES","3;1;1;1","LIVER CANCER;NOT SITE-SPECIFIC CANCER","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,"PUBLIC LIBRARY OF SCIENCE","6","34 CHEMICAL SCIENCES;3403 MACROMOLECULAR AND MATERIALS CHEMISTRY;40 ENGINEERING;46 INFORMATION AND COMPUTING SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;4006 COMMUNICATIONS ENGINEERING;4603 COMPUTER VISION AND MULTIMEDIA COMPUTATION;51 PHYSICAL SCIENCES;5105 MEDICAL AND BIOLOGICAL PHYSICS","3;2;2;2;1;1;1;1;1",NA,NA,NA,NA,NA,NA,NA,NA,"CLINICAL MEDICINE AND SCIENCE","1",NA,NA,NA,NA
"AOUSSN_CAGLIARI",2022,68,16.1911764705882,3.26470588235294,0.397058823529412,0.323529411764706,0.455882352941176,1.63235294117647,1.22727272727273,1.22222222222222,1.29166666666667,0.735294117647059,0,22,17,6,8,0.32,0.25,0.09,0.12,12.74,1.42663463288076,6.39825581395349,0.470588235294118,0.955882352941177,0.434,0.462,0.451,0.453,"LUCA SABA;JASJIT S. SURI;RICCARDO CAU;NARENDRA N. KHANNA;JOHN R. LAIRD;ALBERTO CAULI;KLAUDIJA VIŠKOVIĆ;AMER M. JOHRI;INDER M. SINGH;LUCA SABA;PETROS P. SFIKAKIS;VIKAS AGARWAL;ZOLTÁN RUZSA;MATTEO PIGA;MAURO GIOVANNI CARTA;JAGJIT S. TEJI;ADITYA SHARMA;MOSTAFA M. FOUDA;MANNUDEEP K. KALRA;LUIGI MINERBA","16;13;7;7;7;7;6;6;6;6;5;5;5;5;5;5;5;5;5;5","LUCA SABA;JASJIT S. SURI;RICCARDO CAU;CHRISTIAN CADEDDU DESSALVI;DARIO ALARIO;FEDERICO MECARINI;GIORGIO BRACAGLIA;GIUSEPPE GIACALONE;AJAY GUPTA;LUIGI MINERBA;NEERAJ SHARMA;PANKAJ K. JAIN;MANNUDEEP K. KALRA;LUCA SABA;MICHELE PORCU;PAOLA MELIS;NARENDRA N. KHANNA;MAURO GIOVANNI CARTA;FILIPPO CARTA;CINZIA MARIANI","2.06;1.17;0.8;0.7;0.67;0.67;0.67;0.5;0.5;0.45;0.42;0.42;0.41;0.41;0.4;0.4;0.4;0.4;0.39;0.39","LUCA SABA;RICCARDO CAU;ALBERTO CAULI;LUCA SABA;MATTEO PIGA;MAURO GIOVANNI CARTA;LUIGI MINERBA;MICHELE PORCU;ALESSANDRO CARRIERO;PIETRO DANNA;FERDINANDO COGHE;ALESSIO PASCHÈ;GIAN LUCA CHABERT;GERMANO ORRÙ;GAVINO FAA;CESAR IVÁN AVILÉS GONZÁLEZ;FILIPPO CARTA;FERNANDA VELLUZZI;CINZIA MARIANI;ALBERTO FLORIS","16;7;7;6;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3","LUCA SABA;RICCARDO CAU;CHRISTIAN CADEDDU DESSALVI;FEDERICO MECARINI;GIUSEPPE GIACALONE;LUIGI MINERBA;LUCA SABA;MICHELE PORCU;PAOLA MELIS;MAURO GIOVANNI CARTA;FILIPPO CARTA;CINZIA MARIANI;MELANIA TATTI;VALERIA MARROSU;ALBERTO CAULI;GERMANO ORRÙ;LUCA SERCHISU;ANTONELLA MANDAS;MARIA MONICA PERALTA;FERDINANDO COGHE","2.06;0.8;0.7;0.67;0.5;0.45;0.41;0.4;0.4;0.4;0.39;0.39;0.39;0.39;0.37;0.35;0.33;0.33;0.33;0.31","LUCA SABA;JASJIT S. SURI;NARENDRA N. KHANNA;JOHN R. LAIRD;AMER M. JOHRI;KLAUDIJA VIŠKOVIĆ;MOSTAFA M. FOUDA;INDER M. SINGH;MANNUDEEP K. KALRA;ADITYA SHARMA;JAGJIT S. TEJI;VIKAS AGARWAL;ZOLTÁN RUZSA;AZRA ALIZAD;DAVID SOBEL;GEORGE D. KITAS;GEORGE TSOULFAS;MARTIN MINER;MONIKA TURK;MOSTAFA FATEMI","491;467;308;281;258;254;252;249;238;235;220;220;220;206;206;206;206;206;206;206","LUCA SABA;GIAN LUCA CHABERT;ANTONELLA BALESTRIERI;MARIO SCARTOZZI;MARA PERSANO;RICCARDO CAU;ALESSIO PASCHÈ;PIETRO DANNA;GAVINO FAA;FRANCESCO PISU;MICHELE PORCU;ALESSANDRO CARRIERO;ANTONIO URBAN;ALBERTO CAULI;LUIGI MINERBA;ROBERTA MONTISCI;S. ONALI;ANTONELLA MANDAS;LUCA SERCHISU;MARIA MONICA PERALTA","490;117;103;92;90;80;75;75;61;60;51;42;40;39;38;38;37;36;36;36","LUCA SABA;ALBERTO CAULI;RICCARDO CAU;FERDINANDO COGHE;GIAN LUCA CHABERT;MICHELE PORCU;ALESSIO PASCHÈ;ANTONELLA BALESTRIERI;CESAR IVÁN AVILÉS GONZÁLEZ;CINZIA MARIANI;DAVIDE FIRINU;FILIPPO CARTA;GIULIA COSTANZO;LUIGI MINERBA;MARIO SCARTOZZI;MATTEO PIGA;MELANIA TATTI;PIETRO DANNA;ROBERTO PUXEDDU;STEFANO DEL GIACCO","21;6;6;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","MEDICINE;COMPUTER SCIENCE;BIOLOGY;PSYCHOLOGY;ECONOMICS;ENGINEERING;MATHEMATICS;PHILOSOPHY;POLITICAL SCIENCE;BUSINESS;PHYSICS;CHEMISTRY;SOCIOLOGY","66;15;11;10;7;7;5;4;4;2;2;1;1","INTERNAL MEDICINE;CARDIOLOGY;RADIOLOGY;SURGERY;ENVIRONMENTAL HEALTH;PATHOLOGY;PSYCHIATRY;ARTIFICIAL INTELLIGENCE;MECHANICAL ENGINEERING;PHYSICAL THERAPY;FAMILY MEDICINE;IMMUNOLOGY;PALEONTOLOGY;PEDIATRICS;GASTROENTEROLOGY;MACHINE LEARNING;NUCLEAR MEDICINE;ONCOLOGY;DERMATOLOGY;LAW;STATISTICS;VIROLOGY","44;15;15;14;13;13;12;11;7;7;6;6;6;6;5;5;5;5;4;4;4;4","DISEASE;POPULATION;PATTERN RECOGNITION (PSYCHOLOGY);SEGMENTATION;CANCER;DEEP LEARNING;CAROTID ARTERIES;STROKE (ENGINE);COGNITION;GENE;HEALTH CARE;INTERNAL CAROTID ARTERY;MAGNETIC RESONANCE IMAGING;NEUROLOGY;STENOSIS;ADVERSE EFFECT;ANTIBODY;ATRIAL FIBRILLATION;COMPUTED TOMOGRAPHY;CONTEXT (ARCHAEOLOGY);DEPRESSION (ECONOMICS);HEART FAILURE;LOGISTIC REGRESSION;MYOCARDITIS;OUTBREAK;PSORIASIS;RETROSPECTIVE COHORT STUDY;RHEUMATOID ARTHRITIS;RHEUMATOLOGY;VACCINATION","21;13;8;7;6;6;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","INFECTIOUS DISEASE (MEDICAL SPECIALTY);2019-20 CORONAVIRUS OUTBREAK;CARDIAC MAGNETIC RESONANCE;CARDIOMYOPATHY;IMMUNOTHERAPY;JACCARD INDEX;NEURORADIOLOGY;PSORIATIC ARTHRITIS;SYSTEMIC LUPUS ERYTHEMATOSUS;CARDIAC MAGNETIC RESONANCE IMAGING;CAROTID ENDARTERECTOMY;COMMON CAROTID ARTERY;DEPRESSIVE SYMPTOMS;HOUNSFIELD SCALE;IMMUNOGENICITY;MOVEMENT DISORDERS;MUTATION;NEUROPSYCHOLOGY;ACCRUAL;ADALIMUMAB;ADENOCARCINOMA;AMAUROSIS FUGAX;AMYOTROPHIC LATERAL SCLEROSIS;ANTIBIOTIC RESISTANCE;AORTIC ARCH;AORTIC DISSECTION;AORTIC VALVE REPLACEMENT;AORTIC VALVE STENOSIS;ARTERIAL STIFFNESS;ASCENDING AORTA;AUTOANTIBODY;AUTOIMMUNITY;BEERS CRITERIA;BEVACIZUMAB;CABOZANTINIB;CALCINOSIS;CARCINOGENESIS;CATHETER ABLATION;CD20;CDKN2A;CHARLSON COMORBIDITY INDEX;COGNITIVE IMPAIRMENT;COLORECTAL CANCER;CROHN'S DISEASE;DATA SHARING;DEFINED DAILY DOSE;DEMENTIA;DISEASE REGISTRY;EJECTION FRACTION;ELECTRONIC DATA CAPTURE;ENDARTERECTOMY;ENDOTRACHEAL TUBE;EPIGENETICS;ETANERCEPT;EUTHYROID;FEATURE TRACKING;FETUS;GENE EXPRESSION;GENETIC DIVERSITY;GENOME;GRAVES' DISEASE;HEART RATE;HEPATITIS C VIRUS;IMAGE SEGMENTATION;IMMUNOGLOBULIN E;INFLAMMATORY BOWEL DISEASE;INFLIXIMAB;INTRACLASS CORRELATION;KIDNEY CANCER;LARYNGECTOMY;LINEAGE (GENETIC);LIQUID BIOPSY;MEAN PLATELET VOLUME;MENTAL HEALTH CARE;METASTASIS;MITRAL VALVE PROLAPSE;MOOD DISORDERS;MULTICLASS CLASSIFICATION;NEPHRECTOMY;NEUTRALIZATION;NEUTRALIZING ANTIBODY;PALSY;PARKINSON'S DISEASE;PARTIAL THROMBOPLASTIN TIME;PENICILLIN;PHARMACIST;PHYLOGENETIC TREE;PLATELET ACTIVATION;POPULATION AGEING;POSTURAL TREMOR;PROGRESSIVE DISEASE;RECURRENT LARYNGEAL NERVE;SINUS RHYTHM;SOCIOECONOMIC STATUS;SORAFENIB;STATISTICAL PARAMETRIC MAPPING;SUBGLOTTIC STENOSIS;SUPERIOR LARYNGEAL NERVE;SYNOVITIS;THYROID DISEASE;THYROID FUNCTION;THYROID FUNCTION TESTS;THYROIDECTOMY;THYROIDITIS;TITER;TRACHEAL STENOSIS;TROPONIN;TROPONIN I;TROPONIN T;ULCERATIVE COLITIS;UNIVARIATE ANALYSIS;WARFARIN;WILCOXON SIGNED-RANK TEST;WNT SIGNALING PATHWAY","12;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CORONAVIRUS DISEASE 2019 (COVID-19);NIVOLUMAB;IPILIMUMAB;USTEKINUMAB;ACENOCOUMAROL;ANTIMICROBIAL STEWARDSHIP;ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA;ATRIAL APPENDAGE;AUTOIMMUNE THYROIDITIS;BASDAI;BENTALL PROCEDURE;CALPROTECTIN;CARDIAC SKELETON;CAROTID ARTERY DISEASE;CATENIN;CETUXIMAB;CLADE;DNA METHYLATION;FRONTOTEMPORAL DEMENTIA;GERIATRIC DEPRESSION SCALE;GOLIMUMAB;GROUND-GLASS OPACITY;KRAS;LARYNGOTRACHEAL STENOSIS;LENVATINIB;MONTREAL COGNITIVE ASSESSMENT;OMALIZUMAB;PRIMARY TUMOR;REACTOGENICITY;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;RESTING TREMOR;RIBAVIRIN;SØRENSEN–DICE COEFFICIENT;TAKOTSUBO SYNDROME;VEDOLIZUMAB;WHOLE GENOME SEQUENCING","12;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;COVID-19;CAROTID STENOSIS;RETROSPECTIVE STUDIES;PLAQUE, ATHEROSCLEROTIC;FEMALE;CAROTID ARTERIES;TOMOGRAPHY, X-RAY COMPUTED;CAROTID ARTERY DISEASES;MALE;HEMORRHAGE;PARKINSON DISEASE;STROKE;TREATMENT OUTCOME;AGED;HEART ATRIA;LUNG;MIDDLE AGED;PROSPECTIVE STUDIES","39;29;15;12;10;9;8;7;7;6;6;5;5;5;5;4;4;4;4;4","APPLICATIONS OF DEEP LEARNING IN MEDICAL IMAGING;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;IMPACT OF COVID-19 ON MENTAL HEALTH;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;BIOLOGY AND PATHOLOGY OF KERATINS AND RELATED DISORDERS;CORONAVIRUS DISEASE 2019;CORONAVIRUS DISEASE 2019 RESEARCH;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;MANAGEMENT OF VALVULAR HEART DISEASE;PATHOPHYSIOLOGY AND CLINICAL CHARACTERISTICS OF STRESS-INDUCED CARDIOMYOPATHY;RENAL CELL CARCINOMA;RHEUMATOID ARTHRITIS;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;ANALYSIS AND APPLICATIONS OF HEART RATE VARIABILITY;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;ARTIFICIAL INTELLIGENCE IN MEDICINE;ASSESSMENT OF DECISIONAL CAPACITY IN PSYCHIATRY;ATRIAL FIBRILLATION;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS","7;6;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","STROKE (ENGINE);CAROTID ARTERY STENOSIS;2019-20 CORONAVIRUS OUTBREAK;CARDIAC IMAGING;CARDIAC MAGNETIC RESONANCE;CARDIOVASCULAR RISK ASSESSMENT;DEEP LEARNING;DEPRESSION (ECONOMICS);JACCARD INDEX;MENTAL HEALTH;NEURORADIOLOGY;PANDEMIC;PNEUMONIA DETECTION;TAKOTSUBO SYNDROME;TRANSFER LEARNING;AORTIC DISSECTION;ASSOCIATION (PSYCHOLOGY);CAROTID ARTERY DISSECTION;CEREBROVASCULAR EVENTS;CLINICAL CHARACTERISTICS","5;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2","ARTIFICIAL INTELLIGENCE;DEEP LEARNING;CAROTID ARTERY;COMPUTED TOMOGRAPHY;LEARNING ARTIFICIAL;LUPUS ERYTHEMATOSUS;OBSERVATIONAL STUDY;SYSTEMIC LUPUS;ARTERY DISEASE;BEHAVIORAL COGNITIVE;CAROTID ULTRASOUND;CONGENITAL SKIN;COVID- LUNG;COVID- PANDEMIC;COVID- PATIENTS;HUMAN RIGHTS;INTELLIGENCE FRAMEWORK;INTELLIGENCE PARADIGM;INTENSIVE CARE;LEARNING MODEL;LESION LOCALIZATION;LUNG COMPUTED;MAGNETIC RESONANCE;MENTAL HEALTH;MRNA COVID-;MULTICENTER STUDY;PARKINSONS DISEASE;PLAQUE SEGMENTATION;RARE ASSOCIATION;RHEUMATOID ARTHRITIS","7;7;5;5;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","DAMAGE ACCRUAL;DEPRESSIVE SYMPTOMS;DISEASE ACTIVITY;HUMAN RIGHTS;COVID- PATIENTS;MENTAL HEALTH;AORTIC DISSECTION;CAROTID ARTERY;DEEP LEARNING;DISEASE DURATION;STATISTICALLY SIGNIFICANT;AI MODELS;ARTIFICIAL INTELLIGENCE;CCA IMAGES;CLINICAL PRACTICE;COVLIAS -CXAI;DAILY DOSE;DEPRESSIVE EPISODES;HEALTH SERVICES;INTELLIGENCE AI;LT MGDAY;MINIMALLY INVASIVE;MONTHS HR;NUTRITIONAL STATUS;PDN LT;PHYSICAL EXERCISE;SEGMENTATION-BASED CLASSIFICATION;SIGNIFICANT ASSOCIATION;SLE PATIENTS;SR PARAMETERS","9;8;8;8;7;7;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5",39,0.57,9.5,6,1,1,0,1,0,0,1,6,0,0,5,1,1,1,2,4,4,0,0,24.5,22.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,2.8,341.9,7.94,2,0.2,115.8,0,0,2,0,2,0,1,5,0,7,3,0,0,0,0,0,0,10,0,0,9,0,0,1,0,0,0,0,0,0,"Italy;United States;United Kingdom","4;4;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3203 DENTISTRY;3211 ONCOLOGY AND CARCINOGENESIS","10;4;4;2","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;AUTOIMMUNE DISEASE;DENTAL/ORAL AND CRANIOFACIAL DISEASE;DIGESTIVE DISEASES;PATIENT SAFETY;BIOENGINEERING;CANCER;INFLAMMATORY BOWEL DISEASE;NUTRITION;ARTHRITIS;CHRONIC PAIN;COLO-RECTAL CANCER;CROHN'S DISEASE;PAIN RESEARCH;PREVENTION;RHEUMATOID ARTHRITIS","9;5;3;3;3;3;2;2;2;2;1;1;1;1;1;1;1","CANCER;ORAL AND GASTROINTESTINAL;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM","2;2;1;1","6.1 PHARMACEUTICALS;6.4 SURGERY","5;1","COLON AND RECTAL CANCER;SARCOMA;STOMACH CANCER","1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,"FRONTIERS","1","42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","2;1","BEHAVIORAL AND SOCIAL SCIENCE;CLINICAL RESEARCH;DEPRESSION;MENTAL HEALTH;MIND AND BODY","1;1;1;1;1",NA,NA,NA,NA,"POPULATION & SOCIETY","1","PUBLIC HEALTH","1",NA,NA,"16 PEACE, JUSTICE AND STRONG INSTITUTIONS","1"
"AOUSSN_CAGLIARI",2023,78,19,2.75641025641026,0.307692307692308,0.397435897435897,0.371794871794872,1.6796875,1.5,2.21428571428571,1.52631578947368,0.730769230769231,0,25,14,8,5,0.32,0.18,0.1,0.06,5.69,1.29869759265814,5.95538057742782,0.576923076923077,0.987179487179487,0.5,0.315,0.464,0.39,"LUCA SABA;JASJIT S. SURI;RICCARDO CAU;FRANCESCO SALIS;ANTONELLA MANDAS;SEBASTIANO BUTI;ALBERTO CAULI;FRANCESCO ATZORI;S. GUERRIERO;ROBERTA MONTISCI;MAURO PODDA;GIANDOMENICO ROVIELLO;LORENZO MANNELLI;PAOLO ANDREA ZUCALI;FRANCESCO MASSARI;FRANCESCO PISU;ROBERTO IACOVELLI;GIUSEPPE FORNARINI;ONDŘEJ FIALA;ZIN MYINT","16;9;8;8;8;6;6;6;5;5;5;5;5;5;5;5;5;5;4;4","FRANCESCO SALIS;ANTONELLA MANDAS;LUCA SABA;JASJIT S. SURI;RICCARDO CAU;MAURO PODDA;LORENZO MANNELLI;ROBERTA MONTISCI;FRANCESCO PISU;S. GUERRIERO;LUISA MARRAS;VALENTINA CORONEO;GIACOMO BERTOLINO;BENEDETTO IELPO;ANTONELLA PALIMODDE;GIUSEPPE MUSCOGIURI;S. AJOSSA;EFISIO COSSU;ALBERTO CAULI;FILIPPO CARTA","1.94;1.94;1.85;1.29;0.94;0.67;0.66;0.57;0.56;0.55;0.53;0.53;0.53;0.51;0.45;0.45;0.44;0.43;0.41;0.39","LUCA SABA;RICCARDO CAU;ANTONELLA MANDAS;ALBERTO CAULI;FRANCESCO ATZORI;S. GUERRIERO;ROBERTA MONTISCI;MAURO PODDA;FRANCESCO PISU;S. AJOSSA;FILIPPO CARTA;ROBERTO PUXEDDU;MICHELE PORCU;CINZIA MARIANI;MATTEO PIGA;ALBERTO FLORIS;MARIO SCARTOZZI;MELANIA TATTI;TOMMASO ERCOLI;MARCO FRANCONE","16;8;8;6;6;5;5;5;5;4;4;4;3;3;3;3;3;3;3;3","ANTONELLA MANDAS;LUCA SABA;RICCARDO CAU;MAURO PODDA;ROBERTA MONTISCI;FRANCESCO PISU;S. GUERRIERO;LUISA MARRAS;VALENTINA CORONEO;GIACOMO BERTOLINO;S. AJOSSA;EFISIO COSSU;ALBERTO CAULI;FILIPPO CARTA;ROBERTO PUXEDDU;TOMMASO ERCOLI;CINZIA MARIANI;MELANIA TATTI;VALERIA MARROSU;MICHELE PORCU","1.94;1.85;0.94;0.67;0.57;0.56;0.55;0.53;0.53;0.53;0.44;0.43;0.41;0.39;0.39;0.33;0.33;0.33;0.33;0.33","LUCA SABA;JASJIT S. SURI;FRANCESCO ATZORI;SEBASTIANO BUTI;FRANCESCO MASSARI;GIANDOMENICO ROVIELLO;GIUSEPPE FORNARINI;PAOLO ANDREA ZUCALI;ROBERTO IACOVELLI;ALESSANDRA MOSCA;ALESSANDRO RIZZO;ANCA ZGURĂ;CAMILLO PORTA;CARLO CATTRINI;CARLO MESSINA;EMMANUEL SERONT;ENRIQUE GRANDE;FABIO CALABRÒ;FERNANDO SABINO MARQUES MONTEIRO;GAETANO AURILIO","84;75;62;62;60;60;60;60;60;58;58;58;58;58;58;58;58;58;58;58","LUCA SABA;FRANCESCO ATZORI;MAURO PODDA;ANTONELLA MANDAS;MARIO SCARTOZZI;MARIO MUSU;RICCARDO CAU;S. GUERRIERO;ANDREA PRETTA;CLELIA DONISI;CLELIA MADEDDU;ELEONORA LAI;ALESSANDRO CARRIERO;GIAN LUCA CHABERT;GIOVANNI DEFAZIO;TOMMASO ERCOLI;S. AJOSSA;FRANCESCO PISU;M. PAGLIUCA;ROBERTA MONTISCI","81;62;55;51;51;49;28;26;23;23;23;23;22;22;21;20;19;14;13;12","LUCA SABA;ANTONELLA MANDAS;RICCARDO CAU;ALBERTO CAULI;FRANCESCO ATZORI;MAURO PODDA;ROBERTA MONTISCI;S. GUERRIERO;FILIPPO CARTA;FRANCESCO PISU;ROBERTO PUXEDDU;ALBERTO FLORIS;MARIO SCARTOZZI;MATTEO PIGA;MATTIA CONGIA;MICHELE PORCU;S. AJOSSA;CINZIA MARIANI;MELANIA TATTI;VALERIA MARROSU","17;8;7;6;6;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PSYCHOLOGY;ENGINEERING;PHYSICS;MATHEMATICS;SOCIOLOGY;ENVIRONMENTAL SCIENCE;CHEMISTRY;ECONOMICS;MATERIALS SCIENCE;POLITICAL SCIENCE","76;17;11;9;6;6;3;3;2;1;1;1;1","INTERNAL MEDICINE;RADIOLOGY;SURGERY;CARDIOLOGY;ONCOLOGY;PATHOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;PHYSICAL THERAPY;PSYCHIATRY;GENETICS;ARTIFICIAL INTELLIGENCE;PALEONTOLOGY;MACHINE LEARNING;NEUROSCIENCE;ANESTHESIA;CLINICAL PSYCHOLOGY;ENDOCRINOLOGY;GENERAL SURGERY;INTENSIVE CARE MEDICINE;QUANTUM MECHANICS","58;21;19;13;10;10;9;9;8;8;7;6;6;5;5;4;4;4;4;4;4","DISEASE;MAGNETIC RESONANCE IMAGING;CANCER;COHORT;MULTIVARIATE ANALYSIS;POPULATION;PROPORTIONAL HAZARDS MODEL;ULTRASOUND;ANGIOGRAPHY;GENE;MYOCARDIAL INFARCTION;PROSPECTIVE COHORT STUDY;RENAL CELL CARCINOMA;RETROSPECTIVE COHORT STUDY;ATRIAL FIBRILLATION;COGNITION;CONFIDENCE INTERVAL;HEART FAILURE;ADVERSE EFFECT;BODY MASS INDEX;CONTEXT (ARCHAEOLOGY);DEEP LEARNING;DIABETES MELLITUS;NEUROLOGY;ODDS RATIO;PATTERN RECOGNITION (PSYCHOLOGY);VENTRICLE","15;11;10;7;7;6;6;6;5;5;5;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3","PARKINSON'S DISEASE;CARDIOMYOPATHY;HAZARD RATIO;BREAST CANCER;CARDIAC MAGNETIC RESONANCE;IMMUNOTHERAPY;NEURORADIOLOGY;CARDIAC MAGNETIC RESONANCE IMAGING;CLINICAL ENDPOINT;COGNITIVE IMPAIRMENT;COMPUTED TOMOGRAPHY ANGIOGRAPHY;INFECTIOUS DISEASE (MEDICAL SPECIALTY);LEGIONELLA;MAGNETIC RESONANCE ANGIOGRAPHY;NEUROPSYCHOLOGY;PSORIATIC ARTHRITIS;TOLERABILITY;TYPE 2 DIABETES;UNIVARIATE ANALYSIS;2019-20 CORONAVIRUS OUTBREAK;ABDOMINAL COMPARTMENT SYNDROME;ABDOMINAL TRAUMA;ACUTE MYOCARDITIS;ALKALINE PHOSPHATASE;AMYOTROPHIC LATERAL SCLEROSIS;ANTIBIOTIC RESISTANCE;AORTIC VALVE REGURGITATION;AUTOCRINE SIGNALLING;BASAL (MEDICINE);BASAL CELL CARCINOMA;BIOELECTRICAL IMPEDANCE ANALYSIS;BONE MINERAL;CABOZANTINIB;CACHEXIA;CANDIDATE GENE;CD44;CELL TYPE;CELLULAR DIFFERENTIATION;CERVICAL CANCER;CERVICAL DYSTONIA;CHRONOTYPE;CLEAR CELL;COGNITIVE TEST;COLORECTAL CANCER;COMPUTED TOMOGRAPHIC ANGIOGRAPHY;CONTRAST-ENHANCED ULTRASOUND;CORONARY ANGIOGRAPHY;DEMENTIA;DIASTOLE;DIFFUSION MRI;DYSLIPIDEMIA;ECHOGENICITY;EMBRYONIC STEM CELL;ENDOMETRIAL CANCER;EPICARDIAL FAT;EXECUTIVE FUNCTIONS;FEATURE TRACKING;FLUOROURACIL;GENE EXPRESSION;GENOTYPE;GROWTH FACTOR;HERNIA REPAIR;HIP FRACTURE;HUMAN GASTROINTESTINAL TRACT;IMMUNE DYSREGULATION;INGUINAL HERNIA;INJURY PREVENTION;L1;LARYNGEAL NEOPLASM;METASTASIS;METFORMIN;METHYLATION;MOVEMENT DISORDERS;MULTICLASS CLASSIFICATION;MYOMA;NASAL VESTIBULE;NECK DISSECTION;NEUROTROPHIC FACTORS;OBSTETRICS AND GYNAECOLOGY;PARACRINE SIGNALLING;PERINEURAL INVASION;PI3K/AKT/MTOR PATHWAY;POLYARTHRITIS;POLYSOMNOGRAPHY;PRESENTEEISM;PROGENITOR CELL;PROGRESSION-FREE SURVIVAL;PROGRESSIVE DISEASE;PROTEIN KINASE B;PSEUDOANEURYSM;REFLUX;RELIABILITY (SEMICONDUCTOR);SALVAGE THERAPY;SEPTIC SHOCK;SOFTMAX FUNCTION;STEADY-STATE FREE PRECESSION IMAGING;STEM CELL MARKER;STRENGTHS AND DIFFICULTIES QUESTIONNAIRE;SUNITINIB;SURGICAL MARGIN;T-STAGE;TARGETED THERAPY;TEMOZOLOMIDE;TORTUOSITY;TRANSCRIPTION FACTOR;TROPONIN;TYPE 2 DIABETES MELLITUS;TYROSINE-KINASE INHIBITOR;UTERINE SARCOMA;VASCULAR SURGERY;VENOUS THROMBOEMBOLISM;WAIST;WARFARIN;YOUDEN'S J STATISTIC","5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CORONAVIRUS DISEASE 2019 (COVID-19);GLYCATED HEMOGLOBIN;MONTREAL COGNITIVE ASSESSMENT;SYSTEMIC THERAPY;AXITINIB;BRAIN-DERIVED NEUROTROPHIC FACTOR;BREAST RECONSTRUCTION;CHROMOPHOBE CELL;DEEP BRAIN STIMULATION;ENTHESITIS;EXECUTIVE DYSFUNCTION;FALLS IN OLDER ADULTS;FEAR OF FALLING;FRACTIONAL ANISOTROPY;FRAGILITY FRACTURE;FRONTOTEMPORAL DEMENTIA;GENE EXPRESSION PROFILING;GERD;HEARTBURN;HIGH RESOLUTION MANOMETRY;HYPOPHOSPHATASIA;INDUCED PLURIPOTENT STEM CELL;INSULIN-LIKE GROWTH FACTOR;INSULIN-LIKE GROWTH FACTOR 2;IPILIMUMAB;KRAS;LINEAGE MARKERS;LYMPHOVASCULAR INVASION;MEROPENEM;METHYLTRANSFERASE;NISSEN FUNDOPLICATION;NIVOLUMAB;OLIGOARTHRITIS;ORAL ANTICOAGULANT;OXALIPLATIN;PARAMETRIUM;PEMBROLIZUMAB;POLYMORPHISM (COMPUTER SCIENCE);RADICAL HYSTERECTOMY;SOD1;SOX2;TAKOTSUBO SYNDROME;TRANSCRIPTOME;TRANSORAL LASER MICROSURGERY","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;RETROSPECTIVE STUDIES;FEMALE;AGED;MALE;CAROTID STENOSIS;ADULT;ATRIAL FIBRILLATION;MIDDLE AGED;ITALY;MAGNETIC RESONANCE IMAGING;CARCINOMA, RENAL CELL;CAROTID ARTERIES;HEMORRHAGE;KIDNEY NEOPLASMS;MAGNETIC RESONANCE IMAGING, CINE;PLAQUE, ATHEROSCLEROTIC;TREATMENT OUTCOME;AGED, 80 AND OVER","41;37;14;12;11;11;8;7;7;7;6;6;5;5;5;5;5;5;5;4","RENAL CELL CARCINOMA;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;PATHOPHYSIOLOGY AND CLINICAL CHARACTERISTICS OF STRESS-INDUCED CARDIOMYOPATHY;ATRIAL FIBRILLATION;AETIOLOGY, DIAGNOSIS, AND MANAGEMENT OF MYOCARDITIS;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;INTERACTIONS OF LEGIONELLA AND AMOEBAE IN DISEASE;SARCOPENIA: DEFINITION, DIAGNOSIS, AND IMPLICATIONS;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;APPLICATIONS OF DEEP LEARNING IN MEDICAL IMAGING;ASTHMA;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CEREBELLAR CONTRIBUTIONS TO NEUROLOGICAL DISORDERS AND FUNCTIONS;CLASSIFICATION AND INTERVENTIONS FOR CEREBRAL PALSY;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION","5;4;4;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","CARDIAC IMAGING;CARDIOVASCULAR RISK ASSESSMENT;CARDIAC MAGNETIC RESONANCE;COMPUTED TOMOGRAPHY ANGIOGRAPHY;NEURORADIOLOGY;TAKOTSUBO SYNDROME;ANTICOAGULANT THERAPY;CARDIAC MAGNETIC RESONANCE IMAGING;CARDIAC SURGERY RISK MODELS;CARDIAC TROPONIN ELEVATION;CAROTID ARTERY STENOSIS;CLINICAL ENDPOINT;COMBINATION THERAPIES;COMPREHENSIVE GERIATRIC ASSESSMENT;CT IMAGING;DISCONTINUATION;DISEASE-MODIFYING ANTIRHEUMATIC DRUGS;ENSEMBLE LEARNING;GERIATRIC ASSESSMENT;GLYCATED HEMOGLOBIN","6;5;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CELL CARCINOMA;RENAL CELL;MAGNETIC RESONANCE;ADVANCED RENAL;COHORT STUDY;DEEP LEARNING;GISEA REGISTRY;METASTATIC RENAL;PARKINSONS DISEASE;TAKOTSUBO CARDIOMYOPATHY;ARTHRITIS PATIENTS;ATRIAL FIBRILLATION;CARCINOMA TREATED;CARDIAC MAGNETIC;CARDIOVASCULAR MAGNETIC;CAROTID ARTERY;CORONARY ARTERY;CUT-OFF LEVELS;DIABETES MELLITUS;GADOLINIUM ENHANCEMENT;IMMUNO-ONCOLOGY COMBINATIONS;LATE GADOLINIUM;LEARNING PARADIGM;MACHINE LEARNING;OBSERVATIONAL COHORT;PATIENTS DATA;PSORIATIC ARTHRITIS;RHEUMATOID ARTHRITIS;SARDINIA ITALY;TAKOTSUBO SYNDROME","8;6;5;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ELI LILLY;SPEAKERS BUREAU;AOR NA;LILLY GALAPAGOS;MAGNETIC RESONANCE;SYSTEMIC STEROIDS;BREAST MILK;GROIN HERNIA;HR CI;BUREAU ABBVIE;CERVICAL DYSTONIA;CONTINUOUS ADMINISTRATION;INTERMITTENT ADMINISTRATION;JAK INHIBITORS;JOB SEARCH;MYOMETRIAL INFILTRATION;ASTHMA INDICATORS;CLINICAL REMISSION;CONSECUTIVE PATIENTS;CT SCAN;DIEP FLAP;EPICARDIAL FAT;GOLD STANDARD;HEALTHY CONTROLS;HUMAN BREAST;NUTRITIONAL STATUS;PATIENTS TREATED;SUPERFICIAL ENDOMETRIOSIS;ABBVIE BMS;ABBVIE ELI","13;11;10;9;8;8;7;7;7;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5;5;5;4;4",34,0.44,7,7.5,0,2,0,1.75,0,1,0,9,1,0,11.75,1,0,1,9.75,7.75,4,0,0,7,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,4,118,0.81,0,0,25,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,"United States","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES","1;1",NA,NA,"6.1 PHARMACEUTICALS","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,"FRONTIERS","7","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY","14;7;5;5","CLINICAL RESEARCH;ARTHRITIS;AUTOIMMUNE DISEASE;GENETICS;RARE DISEASES;BIOMEDICAL IMAGING;BRAIN DISORDERS;PHYSICAL INJURY - ACCIDENTS AND ADVERSE EFFECTS","6;5;5;5;5;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;MUSCULOSKELETAL;INJURIES AND ACCIDENTS","5;5;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","5;1;1","CLINICAL","6","CLINICAL MEDICINE AND SCIENCE","1",NA,NA,NA,NA
"AOUSSN_CAGLIARI",2024,90,17.0888888888889,2.83333333333333,0.333333333333333,0.366666666666667,0.5,1.97674418604651,1.25,2.0625,1.60714285714286,0.666666666666667,0,33,18,5,8,0.37,0.2,0.06,0.09,1.32,1.38350523724197,5.08108108108108,0.533333333333333,0.988888888888889,0.493,0.52,0.557,0.477,"LUCA SABA;RICCARDO CAU;JASJIT S. SURI;FEDERICA SANCASSIANI;ALBERTO CAULI;FRANCESCO PISU;CESAR IVÁN AVILÉS GONZÁLEZ;MAURO GIOVANNI CARTA;DIEGO PRIMAVERA;ANTONELLA MELONI;ANTÔNIO EGÍDIO NARDI;ELISABETTA CHESSA;FILIPPO CADEMARTIRI;JOHN R. LAIRD;LAURA PISTOIA;MARIO MELONI;VINCENZO POSITANO;MONICA PULIGHEDDU;MARCELLO NONNIS;ROBERTA MONTISCI","27;15;11;8;8;8;7;7;7;6;6;6;6;5;5;5;5;4;4;4","LUCA SABA;RICCARDO CAU;JASJIT S. SURI;FRANCESCO PISU;CARLOTTA ONNIS;ELISABETTA CHESSA;MARLY VAN ASSEN;FRANCESCO SALIS;ANTONELLA MANDAS;MARISTELLA BELFIORI;ALBERTO CAULI;FEDERICA SANCASSIANI;ROBERTA MONTISCI;CESAR IVÁN AVILÉS GONZÁLEZ;RODRIGO SALGADO;DIEGO PRIMAVERA;MAURO GIOVANNI CARTA;FILIPPO CADEMARTIRI;ANTONELLA MELONI;MARIO MELONI","2.48;1.54;1.21;1;0.73;0.65;0.64;0.62;0.62;0.62;0.6;0.58;0.56;0.55;0.52;0.52;0.48;0.48;0.47;0.46","LUCA SABA;RICCARDO CAU;JASJIT S. SURI;ALBERTO CAULI;FRANCESCO PISU;ELISABETTA CHESSA;MARIO MELONI;MONICA PULIGHEDDU;ROBERTA MONTISCI;MATTEO PIGA;ALBERTO FLORIS;FRANCESCO ATZORI;ANTONELLA MANDAS;MATTIA CONGIA;CATERINA FERRELI;ANTONIO URBAN;GERMANO ORRÙ;ANDREA PRETTA;MICHELE PORCU;NARENDRA N. KHANNA","27;15;11;8;8;6;5;4;4;4;4;4;4;4;4;4;4;3;3;3","LUCA SABA;RICCARDO CAU;JASJIT S. SURI;FRANCESCO PISU;CARLOTTA ONNIS;ELISABETTA CHESSA;MARLY VAN ASSEN;ANTONELLA MANDAS;ALBERTO CAULI;ROBERTA MONTISCI;MARIO MELONI;MONICA PULIGHEDDU;MICHELA FIGORILLI;MASSIMO CLAUDIO FANTINI;ANTONELLA MAMELI;MATTEO PIGA;VALENTINA NARDI;ALBERTO FLORIS;GERMANO ORRÙ;CATERINA FERRELI","2.48;1.54;1.21;1;0.73;0.65;0.64;0.62;0.6;0.56;0.46;0.39;0.35;0.35;0.34;0.34;0.27;0.27;0.27;0.27","LUCA SABA;FILIPPO CADEMARTIRI;JASJIT S. SURI;RICCARDO CAU;VALENTINA NARDI;CARLOTTA ONNIS;ROBERTA SCICOLONE;GAVINO FAA;ALBERTO BOI;AMIR LERMAN;KENJI KAWAI;PETER LIBBY;RENU VIRMANI;TERENZIO CONGIU;FRANCESCO PISU;MARIO MELONI;BABAK B. NAVI;BERNARD IUNG;CHRISTIAN PRISTIPINO;ELENI KOROMPOKI","70;29;29;27;26;25;25;24;23;23;23;23;23;23;15;11;9;9;9;9","LUCA SABA;RICCARDO CAU;ROBERTA SCICOLONE;CARLOTTA ONNIS;FRANCESCO PISU;MARIO MELONI;ROBERTA MONTISCI;MARTA MELIS;ALBERTO CAULI;ALESSANDRA PINTUS;ANTONELLA MANDAS;ANTONIO URBAN;FRANCESCO ATZORI;MASSIMO CLAUDIO FANTINI;MAURO PODDA;S. ONALI;VIVIANA PIRAS;ALBERTO FLORIS;ANDREA PRETTA;ANTONELLA BALESTRIERI","69;27;25;23;15;11;9;8;4;4;4;4;4;4;4;4;4;3;3;3","LUCA SABA;RICCARDO CAU;ALBERTO CAULI;FRANCESCO PISU;ELISABETTA CHESSA;MARIO MELONI;ALBERTO FLORIS;ANTONELLA MANDAS;ANTONIO URBAN;FRANCESCO ATZORI;MATTEO PIGA;MATTIA CONGIA;ROBERTA MONTISCI;ANDREA PRETTA;ANTONELLA BALESTRIERI;ELEONORA LAI;MAURO PODDA;MICHELE PORCU;MASSIMO CLAUDIO FANTINI;ANTONELLA MAMELI","27;16;8;8;6;5;4;4;4;4;4;4;4;3;3;3;3;3;3;2","MEDICINE;COMPUTER SCIENCE;BIOLOGY;PSYCHOLOGY;PHYSICS;ENGINEERING;POLITICAL SCIENCE;ECONOMICS;MATHEMATICS;PHILOSOPHY;CHEMISTRY;GEOGRAPHY;SOCIOLOGY;ART;GEOLOGY","85;20;15;13;12;8;7;6;4;4;3;3;3;2;1","INTERNAL MEDICINE;CARDIOLOGY;PATHOLOGY;PSYCHIATRY;RADIOLOGY;SURGERY;ARTIFICIAL INTELLIGENCE;IMMUNOLOGY;DERMATOLOGY;GENETICS;LAW;NEUROSCIENCE;NURSING;ONCOLOGY;CLINICAL PSYCHOLOGY;MECHANICAL ENGINEERING;QUANTUM MECHANICS;OPERATING SYSTEM;PHYSICAL THERAPY;INTENSIVE CARE MEDICINE;MACHINE LEARNING;MEDICAL PHYSICS;OPTICS;PHYSICAL MEDICINE AND REHABILITATION","60;20;17;17;16;13;12;9;7;7;7;7;7;7;6;6;6;5;5;4;4;4;4;4","COHORT;DISEASE;CANCER;RETROSPECTIVE COHORT STUDY;MAGNETIC RESONANCE IMAGING;CROSS-SECTIONAL STUDY;RANDOMIZED CONTROLLED TRIAL;COGNITION;GENE;HEALTH CARE;HEART FAILURE;MOOD;STENOSIS;STROKE (ENGINE);THALASSEMIA;CAROTID ARTERIES;CONFIDENCE INTERVAL;CORONARY ARTERY DISEASE;MULTIVARIATE ANALYSIS;NEUROLOGY;PERCEPTION;RECEIVER OPERATING CHARACTERISTIC","13;13;9;8;7;6;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4","PARKINSON'S DISEASE;BETA THALASSEMIA;BIPOLAR DISORDER;BREAST CANCER;CARDIAC MAGNETIC RESONANCE;CARDIAC MAGNETIC RESONANCE IMAGING;CARDIOMYOPATHY;IMMUNOTHERAPY;INFECTIOUS DISEASE (MEDICAL SPECIALTY);MOOD DISORDERS;PSORIATIC ARTHRITIS;ACUTE PERICARDITIS;BLADDER CANCER;CLINICAL ENDPOINT;COGNITIVE IMPAIRMENT;CONVENTION ON THE RIGHTS OF PERSONS WITH DISABILITIES;CORONARY ATHEROSCLEROSIS;DEPRESSIVE SYMPTOMS;EJECTION FRACTION;HAZARD RATIO;INTERMEDIA;NEURORADIOLOGY;PHYLOGENETIC TREE;RELIABILITY (SEMICONDUCTOR);TUMOR MICROENVIRONMENT;ULCERATIVE COLITIS;UNIVARIATE ANALYSIS","4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CORONAVIRUS DISEASE 2019 (COVID-19);MAMMOGRAPHY;MONTREAL COGNITIVE ASSESSMENT;PEMBROLIZUMAB;UROTHELIAL CARCINOMA;ABATACEPT;CANCER IMMUNOTHERAPY;CAROTID STENTING;CONNECTIVE TISSUE DISEASE;DISCRIMINANT VALIDITY;DYSKINESIA;EMBOLIC STROKE;EXCESSIVE DAYTIME SLEEPINESS;GERIATRIC DEPRESSION SCALE;GROWTH HORMONE DEFICIENCY;HUMAN GROWTH HORMONE;IMMUNE CHECKPOINT;ISCHEMIC CARDIOMYOPATHY;K-COMPLEX;LENVATINIB;LEVODOPA;LYMPHOVASCULAR INVASION;MALE BREAST CANCER;MEPOLIZUMAB;NUMBER NEEDED TO TREAT;OLIGOARTHRITIS;OMALIZUMAB;PATIENT HEALTH QUESTIONNAIRE;REM SLEEP BEHAVIOR DISORDER;REPEATABLE BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS;REUPTAKE INHIBITOR;SECUKINUMAB;UROTHELIAL CANCER;VEDOLIZUMAB","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;RETROSPECTIVE STUDIES;PARKINSON DISEASE;PLAQUE, ATHEROSCLEROTIC;RISK FACTORS;ANTIBODIES, MONOCLONAL, HUMANIZED;CAROTID ARTERIES;CROSS-SECTIONAL STUDIES;MAGNETIC RESONANCE IMAGING;MAGNETIC RESONANCE IMAGING, CINE;PROGNOSIS;YOUNG ADULT;AGED, 80 AND OVER;ARTIFICIAL INTELLIGENCE","52;38;23;20;18;15;13;8;5;5;5;4;4;4;4;4;4;4;3;3","DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;EPIDEMIOLOGY AND MANAGEMENT OF BIPOLAR DISORDER;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;AETIOLOGY, DIAGNOSIS, AND MANAGEMENT OF MYOCARDITIS;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;DIAGNOSIS AND MANAGEMENT OF PERICARDIAL DISEASES;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;EPILEPSY AND SEIZURES;GAIT ANALYSIS AND FALL PREVENTION IN ELDERLY;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;HEALTH EFFECTS OF PRECARIOUS EMPLOYMENT AND UNEMPLOYMENT;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;APPLICATIONS OF DEEP LEARNING IN MEDICAL IMAGING;ASSESSMENT OF DECISIONAL CAPACITY IN PSYCHIATRY;ASTHMA","5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;1;1;1;1","CARDIAC IMAGING;CARDIOVASCULAR RISK ASSESSMENT;CROSS-SECTIONAL STUDY;COMPUTED TOMOGRAPHY ANGIOGRAPHY;STROKE (ENGINE);BETA THALASSEMIA;CAROTID ARTERY STENOSIS;CONCOMITANT;DEPRESSION (ECONOMICS);SYSTEMIC LUPUS ERYTHEMATOSUS;THALASSEMIA;TREATMENT;ACUTE PERICARDITIS;AFFECT (LINGUISTICS);ANGIOLOGY;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;BIOMARKERS FOR IMMUNOTHERAPY;BREAST CANCER;CANCER RISK;CANCER SUSCEPTIBILITY","13;8;6;5;5;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","PARKINSONS DISEASE;ARTIFICIAL INTELLIGENCE;CROSS-SECTIONAL STUDY;SYSTEMIC LUPUS;DEEP LEARNING;LUPUS ERYTHEMATOSUS;MAGNETIC RESONANCE;MULTICENTER STUDY;PSORIATIC ARTHRITIS;ADVANCED UROTHELIAL;BETA-THALASSEMIA MAJOR;BIPOLAR DISORDERS;BREAST CANCER;CARDIAC IRON;CARDIOVASCULAR DISEASE;CARDIOVASCULAR MAGNETIC;CHRONIC DISEASES;COHORT STUDY;CORONARY ARTERY;DISEASE RISK;GISEA REGISTRY;HUMAN RIGHTS;INFLAMMATORY BOWEL;INTERMEDIA PATIENTS;ITALIANA DI;LEARNING APPROACH;MACHINE LEARNING;RISK STRATIFICATION;SYSTEMATIC REVIEW;THALASSEMIA INTERMEDIA","6;5;5;5;4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PUBMED SCOPUS;ACUTE PERICARDITIS;COMPUTED TOMOGRAPHY;DIAGNOSTIC DELAY;CORONARY ARTERY;CROSSREF MEDLINE;MEDLINE GOOGLE;GASTRIC CANCER;MAGNETIC RESONANCE;DEEP LEARNING;MACHINE LEARNING;MASS RATIO;STUDY INCLUDED;CAROTID PLAQUES;CLINICAL PRACTICE;CROSSREF PUBMED;HUMAN RIGHTS;IMMUNE NUTRITION;NON-OPERATIVE TREATMENT;PRIMARY ENDPOINT;PROGRAMMED DEATH-LIGAND;RETROSPECTIVE STUDY;ATHEROEDGE HDL;BIOLOGICAL THERAPY;BIOPSY CONTROLS;CARDIOVASCULAR MAGNETIC;CDCD RATIO;COMBINED PROPORTION;CONCOMITANT ASMS;CONSECUTIVE PATIENTS","14;13;11;11;9;9;9;8;8;7;7;7;7;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
